Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	4772583	4772585	CCA	-	exonic	AJAP1	.	nonframeshift deletion	AJAP1:NM_001042478:exon2:c.653_655del:p.T225del,AJAP1:NM_018836:exon2:c.653_655del:p.T225del	0.977592767	0.022386032	2.12E-05	.	0.15431	0.12412	0.418953042	77.06416608	3783.30469	12.04609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	108	chr1	4772582	chr1:4772582	GCCA	G	56	PASS	AN=2;DP=108	GT	0/1
chr1	22928168	22928168	C	A	exonic	EPHA8	.	synonymous SNV	EPHA8:NM_020526:exon17:c.C2952A:p.I984I	1.14E-08	0.983030391	0.016969598	.	0.32535	0.12252	0.130330208	63.21066289	1372.14313	6.94837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	chr1	22928168	chr1:22928168	C	A	.	PASS	AN=0;DP=21	GT	0/1
chr1	24393491	24393491	C	-	intronic	MYOM3	.	.	.	9.28E-28	0.010284505	0.989715495	.	0.13881	0.09984	1.162914409	92.65156877	15097.7948	26.68075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	172	chr1	24393490	chr1:24393490	GC	G	121	PASS	AN=2;DP=172	GT	0/1
chr1	26349533	26349535	CCT	-	exonic	EXTL1	.	nonframeshift deletion	EXTL1:NM_004455:exon1:c.396_398del:p.L137del	1.18E-12	0.02326237	0.97673763	.	0.19886	0.09359	0.714657953	85.81623024	742.09286	5.41048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	42	chr1	26349532	chr1:26349532	GCCT	G	45	PASS	AN=2;DP=42	GT	0/1
chr1	27736326	27736328	GGA	-	exonic	WASF2	.	nonframeshift deletion	WASF2:NM_006990:exon8:c.1197_1199del:p.P400del	0.975317446	0.024677097	5.46E-06	.	0.44161	0.18052	-0.003562597	53.72729417	54.35937	1.47373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	89	chr1	27736325	chr1:27736325	CGGA	C	62	PASS	AN=2;DP=89	GT	0/1
chr1	39763275	39763275	A	C	intronic	MACF1	.	.	.	1	6.80E-31	4.02E-81	.	0.41854	.	-3.915490887	0.206416608	6684.15405	17.31418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	49	chr1	39763275	chr1:39763275	A	C	76	PASS	AN=2;DP=49	GT	0/1
chr1	40432399	40432399	C	A	intronic	MFSD2A	.	.	.	0.91767122	0.082324192	4.59E-06	DISEASE: Microcephaly 15, primary, autosomal recessive (MCPH15) [MIM:616486]: A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. {ECO:0000269|PubMed:26005865, ECO:0000269|PubMed:26005868}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08021	0.09539	-0.492218069	22.35786742	78.73994	1.87316	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	60	chr1	40432399	chr1:40432399	C	A	75	PASS	AN=2;DP=60	GT	0/1
chr1	43352369	43352369	G	C	ncRNA_exonic	LOC339539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	98	chr1	43352369	chr1:43352369	G	C	95	PASS	AN=2;DP=98	GT	0/1
chr1	43888342	43888342	C	-	intronic	SZT2	.	.	.	1.52E-07	0.999999848	4.70E-20	.	.	0.09202	.	.	2151.43823	8.5294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	501	chr1	43888341	chr1:43888341	AC	A	102	PASS	AN=2;DP=501	GT	0/1
chr1	65693067	65693067	-	T	UTR3	AK4	NM_203464:c.*1207_*1208insT;NM_001005353:c.*1207_*1208insT;NM_013410:c.*1207_*1208insT;NM_001330616:c.*1207_*1208insT	.	.	0.236133361	0.731312413	0.032554226	.	0.41612	0.13186	-0.075159878	47.78839349	1542.50701	7.28675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	28	chr1	65693067	chr1:65693067	A	AT	40	PASS	AN=2;DP=28	GT	0/1
chr1	70504364	70504364	C	A	exonic	LRRC7	.	nonsynonymous SNV	LRRC7:NM_020794:exon19:c.C2743A:p.R915S,LRRC7:NM_001350216:exon21:c.C2860A:p.R954S,LRRC7:NM_001330635:exon22:c.C2758A:p.R920S	0.999998533	1.47E-06	1.10E-17	.	0.42578	0.12755	-1.368693559	4.482189196	157.64981	2.74333	0.046	0.506	D	0.312	0.311	B	0.14	0.321	B	0.005	0.334	N	0.981	0.403	D	0.695	0.181	N	1.24	0.367	T	-0.55	0.168	N	0.663	0.747	-1.089	0.057	T	0.045	0.195	T	0.008	0.217	T	2.963	0.416	22.1	0.993	0.596	0.925	0.555	D	c	-0.078	0.089	0.993	0.329	0.487	0.133	0	5.67	0.876	3.398	0.521	0.892	0.403	1.000	0.715	0.986	0.517	18.749	0.917	.	.	.	0.5	76	44	chr1	70504364	chr1:70504364	C	A	76	PASS	AN=2;DP=44	GT	0/1
chr1	71352072	71352072	C	-	intronic	PTGER3	.	.	.	0.787642829	0.210975836	0.001381335	.	0.32291	0.24187	0.128714042	63.19886766	53.0037	1.44545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	33	chr1	71352071	chr1:71352071	TC	T	88	PASS	AN=2;DP=33	GT	0/1
chr1	74575212	74575212	-	T	exonic	LRRIQ3	.	frameshift insertion	LRRIQ3:NM_001105659:exon5:c.732dupA:p.Q245Tfs*6,LRRIQ3:NM_001322315:exon5:c.732dupA:p.Q245Tfs*6	3.22E-15	0.005170825	0.994829175	.	0.06919	.	1.379742765	94.60368011	1020.69778	6.14814	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	25	chr1	74575212	chr1:74575212	G	GT	51	PASS	AN=2;DP=25	GT	0/1
chr1	75038228	75038228	A	C	exonic	ERICH3	.	nonsynonymous SNV	ERICH3:NM_001002912:exon14:c.T3166G:p.L1056V	.	.	.	.	0.15022	.	2.043117123	97.75300778	.	.	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-1.59	0.004	N	2.83	0.108	T	0.78	0.019	N	0.015	0.002	-0.900	0.480	T	0.003	0.010	T	.	.	.	-1.961	0.008	0.001	0.044	0.000	0.001	0.005	N	c	-1.321	-1.249	0.000	0.035	0.549	0.223	0	2.51	0.293	0.067	0.143	-0.095	0.117	0.000	0.063	0.014	0.122	7.414	0.260	.	.	.	0.5	101	20	chr1	75038228	chr1:75038228	A	C	101	PASS	AN=2;DP=20	GT	1/0
chr1	86905932	86905932	C	A	exonic	CLCA2	.	nonsynonymous SNV	CLCA2:NM_006536:exon8:c.C1305A:p.S435R	1.91E-20	0.003028911	0.996971089	.	0.17798	0.15716	-0.036738982	50.53668318	3264.55081	10.90748	0.411	0.101	T	0.063	0.219	B	0.021	0.181	B	0.000	0.559	D	0.893	0.278	N	1.405	0.356	L	2.67	0.125	T	-0.4	0.138	N	0.23	0.282	-0.942	0.423	T	0.008	0.027	T	0.008	0.204	T	4.118	0.552	23.8	0.979	0.363	0.755	0.367	D	c	-0.375	-0.214	0.027	0.138	0.487	0.133	0	3.79	0.426	0.439	0.211	0.935	0.490	0.945	0.326	0.806	0.338	7.314	0.255	von Willebrand factor, type A	.	.	0.5	58	45	chr1	86905932	chr1:86905932	C	A	58	PASS	AN=2;DP=45	GT	0/1
chr1	98186380	98186380	C	A	UTR3	DPYD	NM_001160301:c.*64G>T	.	.	4.19E-09	0.996985954	0.003014042	.	0.29965	0.38628	1.431149089	95.02241095	1997.46528	8.23273	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	chr1	98186380	chr1:98186380	C	A	.	PASS	AN=0;DP=31	GT	0/1
chr1	99127459	99127459	T	C	exonic	SNX7	.	nonsynonymous SNV	SNX7:NM_015976:exon1:c.T172C:p.F58L,SNX7:NM_152238:exon1:c.T172C:p.F58L	0.028838862	0.960436827	0.010724311	.	0.29144	0.08752	0.018483465	55.44939844	558.45821	4.79951	0.069	0.355	T	0.956	0.527	P	0.899	0.620	P	.	.	.	1.000	0.810	D	1.795	0.474	L	2.23	0.299	T	-1.69	0.402	N	0.306	0.366	-1.103	0.038	T	0.049	0.209	T	0.113	0.793	D	3.390	0.466	23.0	0.993	0.571	0.609	0.311	D	c	-0.031	0.083	1.000	0.747	0.442	0.072	0	4.57	0.557	2.216	0.423	0.884	0.388	1.000	0.715	1.000	0.888	11.410	0.490	Phox homologous domain	.	.	0.5	101	124	chr1	99127459	chr1:99127459	T	C	101	PASS	AN=2;DP=124	GT	0/1
chr1	100358035	100358035	C	G	exonic	AGL	.	stopgain	AGL:NM_000028:exon24:c.C3131G:p.S1044X,AGL:NM_000642:exon24:c.C3131G:p.S1044X,AGL:NM_000643:exon24:c.C3131G:p.S1044X,AGL:NM_000644:exon24:c.C3131G:p.S1044X,AGL:NM_000646:exon24:c.C3083G:p.S1028X	2.31E-15	0.999885179	0.000114821	DISEASE: Glycogen storage disease 3 (GSD3) [MIM:232400]: A metabolic disorder associated with an accumulation of abnormal glycogen with short outer chains. It is clinically characterized by hepatomegaly, hypoglycemia, short stature, and variable myopathy. Glycogen storage disease type 3 includes different forms: GSD type 3A patients lack glycogen debrancher enzyme activity in both liver and muscle, while GSD type 3B patients are enzyme-deficient in liver only. In rare cases, selective loss of only 1 of the 2 debranching activities, glucosidase or transferase, results in GSD type 3C or type 3D, respectively. {ECO:0000269|PubMed:10571954}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.44349	0.24792	1.859295831	97.15734843	3139.05955	10.6731	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.699	0.993	43	0.996	0.729	0.984	0.823	D	c	1.117	0.954	1.000	0.747	0.732	0.924	0	5.2	0.716	7.280	0.778	0.883	0.387	1.000	0.715	0.954	0.431	19.102	0.932	.	.	.	0.5	101	79	chr1	100358035	chr1:100358035	C	G	101	PASS	AN=2;DP=79	GT	0/1
chr1	103404616	103404616	C	A	exonic	COL11A1	.	nonsynonymous SNV	COL11A1:NM_080630:exon42:c.G3065T:p.G1022V,COL11A1:NM_001190709:exon43:c.G3296T:p.G1099V,COL11A1:NM_001854:exon44:c.G3413T:p.G1138V,COL11A1:NM_080629:exon44:c.G3449T:p.G1150V	0.999980608	1.94E-05	6.79E-22	DISEASE: Stickler syndrome 2 (STL2) [MIM:604841]: An autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable. {ECO:0000269|PubMed:20513134, ECO:0000269|PubMed:8872475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Marshall syndrome (MRSHS) [MIM:154780]: An autosomal dominant disorder characterized by ocular abnormalities, deafness, craniofacial anomalies, and anhidrotic ectodermal dysplasia. Clinical features include short stature; flat or retruded midface with short, depressed nose, flat nasal bridge and anteverted nares; cleft palate with or without the Pierre Robin sequence; appearance of large eyes with ocular hypertelorism; cataracts, either congenital or juvenile; esotropia; high myopia; sensorineural hearing loss; spondyloepiphyseal abnormalities; calcification of the falx cerebri; ectodermal abnormalities, including defects in sweating and dental structures. {ECO:0000269|PubMed:10486316}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Fibrochondrogenesis 1 (FBCG1) [MIM:228520]: A severe short-limbed skeletal dysplasia characterized by broad long-bone metaphyses, pear-shaped vertebral bodies, and characteristic morphology of the growth plate, in which the chondrocytes have a fibroblastic appearance and there are regions of fibrous cartilage extracellular matrix. Clinical features include a flat midface with a small nose and anteverted nares, significant shortening of all limb segments but relatively normal hands and feet, and a small bell-shaped thorax with a protuberant abdomen. {ECO:0000269|PubMed:21035103}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35429	0.34658	-0.360177779	28.64472753	7076.86232	18.07025	0.014	0.531	D	1.0	0.899	D	0.998	0.971	D	0.000	0.843	D	1	0.810	D	4.18	0.978	H	-6.29	0.996	D	-7.76	0.971	D	0.981	0.993	0.951	0.964	D	0.993	0.998	D	0.858	0.989	D	5.614	0.765	26.6	0.991	0.516	0.993	0.940	D	c	1.040	0.934	1.000	0.747	0.706	0.609	0	5.28	0.740	7.689	0.833	0.892	0.403	1.000	0.715	0.979	0.486	19.269	0.940	.	.	.	0.5	.	42	chr1	103404616	chr1:103404616	C	A	.	PASS	AN=0;DP=42	GT	0/1
chr1	109812064	109812064	C	G	exonic	CELSR2	.	nonsynonymous SNV	CELSR2:NM_001408:exon21:c.C6831G:p.I2277M	0.9999992	8.00E-07	3.48E-23	.	0.2169	0.14994	-1.813160269	2.176220807	1933.01574	8.0888	0.011	0.555	D	0.589	0.371	P	0.766	0.548	P	.	.	.	0.990	0.242	N	1.585	0.400	L	2.75	0.116	T	-1.78	0.420	N	0.098	0.100	-0.966	0.381	T	0.017	0.071	T	0.010	0.256	T	4.255	0.570	23.9	0.992	0.542	0.490	0.281	N	c	-0.127	-0.138	0.997	0.352	0.696	0.567	0	2.5	0.292	0.461	0.215	0.935	0.490	0.994	0.380	0.998	0.697	7.066	0.242	GAIN domain, N-terminal	.	.	0.5	76	102	chr1	109812064	chr1:109812064	C	G	76	PASS	AN=2;DP=102	GT	0/1
chr1	109816029	109816029	G	A	intronic	CELSR2	.	.	.	0.9999992	8.00E-07	3.48E-23	.	0.2169	0.14994	-1.813160269	2.176220807	1933.01574	8.0888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	148	chr1	109816029	chr1:109816029	G	A	.	PASS	AN=0;DP=148	GT	0/1
chr1	114524905	114524905	C	G	downstream	OLFML3	dist=29	.	.	0.000588287	0.899372738	0.100038975	.	0.66863	0.10981	0.064394823	58.84642604	80.4714	1.89543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	71	chr1	114524905	chr1:114524905	C	G	110	PASS	AN=2;DP=71	GT	0/1
chr1	144854698	144854698	C	A	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	205	chr1	144854698	chr1:144854698	C	A	.	PASS	AN=0;DP=205	GT	0/1
chr1	144856817	144856817	T	C	exonic	PDE4DIP	.	nonsynonymous SNV	PDE4DIP:NM_001350520:exon36:c.A7154G:p.E2385G,PDE4DIP:NM_001198834:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_014644:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_001350522:exon41:c.A6509G:p.E2170G,PDE4DIP:NM_001198832:exon42:c.A6350G:p.E2117G,PDE4DIP:NM_001350521:exon42:c.A6962G:p.E2321G,PDE4DIP:NM_001350523:exon42:c.A6347G:p.E2116G	.	.	.	DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.; 	.	.	7.985992467	99.94692144	8042.34707	19.35299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	c	0.152	0.039	1.000	0.517	0.598	0.340	0	3.39	0.378	3.846	0.554	0.183	0.247	1.000	0.715	0.636	0.296	8.617	0.328	.	.	.	0.5	120	247	chr1	144856817	chr1:144856817	T	C	120	PASS	AN=2;DP=247	GT	0/1
chr1	146420119	146420119	T	C	exonic	NBPF12;NBPF20	.	nonsynonymous SNV	NBPF12:NM_001278141:exon25:c.T2767C:p.S923P,NBPF20:NM_001278267:exon100:c.T11089C:p.S3697P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.001	0.002	T	.	.	.	.	.	.	.	.	c	-1.171	-1.403	0.000	0.012	0.693	0.558	0	-1.45	0.083	0.885	0.277	0.095	0.197	0.970	0.340	0.532	0.276	4.744	0.123	Neuroblastoma breakpoint family (NBPF) domain	.	.	0.5	115	567	chr1	146420119	chr1:146420119	T	C	115	PASS	AN=2;DP=567	GT	0/1
chr1	146737572	146737572	-	T	intronic	CHD1L;NBPF19	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	121	chr1	146737572	chr1:146737572	A	AT	67	PASS	AN=2;DP=121	GT	0/1
chr1	150526093	150526093	G	-	exonic	ADAMTSL4	.	frameshift deletion	ADAMTSL4:NM_001288607:exon6:c.626delG:p.S209Tfs*22,ADAMTSL4:NM_001288608:exon6:c.626delG:p.S209Tfs*22,ADAMTSL4:NM_019032:exon6:c.626delG:p.S209Tfs*22,ADAMTSL4:NM_025008:exon6:c.626delG:p.S209Tfs*22	7.09E-16	0.34016242	0.65983758	DISEASE: Ectopia lentis 2, isolated, autosomal recessive (ECTOL2) [MIM:225100]: An ocular abnormality characterized by partial or complete displacement of the lens from its space resulting from defective zonule formation. {ECO:0000269|PubMed:19200529}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectopia lentis et pupillae (ECTOLP) [MIM:225200]: An ocular abnormality characterized by displacement of the lenses and the pupils, associated with other ocular anomalies, but without systemic manifestations. The condition is usually bilateral, with the lenses and pupils displaced in opposite directions. Additional signs include enlarged corneal diameter, increased corneal astigmatism, increased anterior chamber depth, thinning and flattening of the iris with loss of crypts, angle malformation caused by enlarged iris processes, persistent pupillary membrane, loss of zonular fibers, tilted disk, and increased axial length. Secondary manifestations include refractive errors, glaucoma, early cataract development, and retinal detachment. Membrane formation on the posterior aspect of the iris has been observed both in histologic sections and on ultrasound biomicroscopy. {ECO:0000269|PubMed:20702823}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10654	0.09865	-0.00377668	53.51497995	1103.99507	6.3513	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.09	174	chr1	150526092	chr1:150526092	AG	A	10.09	PASS	AN=0;DP=174	GT	0/1
chr1	150530506	150530506	G	-	exonic	ADAMTSL4	.	frameshift deletion	ADAMTSL4:NM_019032:exon14:c.2263delG:p.G757Vfs*61,ADAMTSL4:NM_025008:exon14:c.2263delG:p.G757Vfs*61,ADAMTSL4:NM_001288607:exon15:c.2146delG:p.G718Vfs*61,ADAMTSL4:NM_001288608:exon15:c.2332delG:p.G780Vfs*61	7.09E-16	0.34016242	0.65983758	DISEASE: Ectopia lentis 2, isolated, autosomal recessive (ECTOL2) [MIM:225100]: An ocular abnormality characterized by partial or complete displacement of the lens from its space resulting from defective zonule formation. {ECO:0000269|PubMed:19200529}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectopia lentis et pupillae (ECTOLP) [MIM:225200]: An ocular abnormality characterized by displacement of the lenses and the pupils, associated with other ocular anomalies, but without systemic manifestations. The condition is usually bilateral, with the lenses and pupils displaced in opposite directions. Additional signs include enlarged corneal diameter, increased corneal astigmatism, increased anterior chamber depth, thinning and flattening of the iris with loss of crypts, angle malformation caused by enlarged iris processes, persistent pupillary membrane, loss of zonular fibers, tilted disk, and increased axial length. Secondary manifestations include refractive errors, glaucoma, early cataract development, and retinal detachment. Membrane formation on the posterior aspect of the iris has been observed both in histologic sections and on ultrasound biomicroscopy. {ECO:0000269|PubMed:20702823}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10654	0.09865	-0.00377668	53.51497995	1103.99507	6.3513	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	702	chr1	150530505	chr1:150530505	TG	T	88	PASS	AN=2;DP=702	GT	0/1
chr1	151171498	151171498	C	G	exonic	PIP5K1A	.	nonsynonymous SNV	PIP5K1A:NM_001135636:exon1:c.C26G:p.S9W,PIP5K1A:NM_001135637:exon1:c.C26G:p.S9W,PIP5K1A:NM_001135638:exon1:c.C26G:p.S9W,PIP5K1A:NM_001330689:exon1:c.C26G:p.S9W,PIP5K1A:NM_003557:exon1:c.C26G:p.S9W	0.014586299	0.985162174	0.000251527	.	0.12043	0.12792	-0.514264485	21.41424864	69.18119	1.72333	0.003	0.784	D	0.969	0.571	D	0.57	0.480	P	0.575	0.055	U	0.981	0.398	D	0.69	0.170	N	1.58	0.346	T	-2.2	0.908	N	0.413	0.520	-1.067	0.100	T	0.070	0.286	T	0.030	0.527	D	4.247	0.569	23.9	0.855	0.154	0.741	0.360	D	c	0.235	0.221	1.000	0.747	0.442	0.072	0	4.59	0.561	3.318	0.514	0.935	0.490	1.000	0.715	0.165	0.209	12.781	0.567	.	.	.	0.5	126	488	chr1	151171498	chr1:151171498	C	G	126	PASS	AN=2;DP=488	GT	0/1
chr1	153920564	153920564	A	G	UTR3	CRTC2	NM_181715:c.*21T>C	.	.	0.996361791	0.003638199	1.01E-08	.	0.25674	0.23695	-0.690637458	15.12149092	1834.62554	7.89581	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	51	chr1	153920564	chr1:153920564	A	G	118	PASS	AN=2;DP=51	GT	0/1
chr1	155402991	155402991	G	A	ncRNA_exonic	POU5F1P4	.	.	.	.	.	.	.	0.49402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	356	chr1	155402991	chr1:155402991	G	A	.	PASS	AN=0;DP=356	GT	0/1
chr1	155942022	155942022	C	T	intronic	ARHGEF2	.	.	.	0.999993235	6.76E-06	4.54E-16	.	0.22628	0.11124	-0.93133804	9.613116301	94.75814	2.09761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	296	chr1	155942022	chr1:155942022	C	T	.	PASS	AN=0;DP=296	GT	0/1
chr1	156012038	156012038	G	A	intronic	UBQLN4	.	.	.	0.99752242	0.002477484	9.67E-08	.	0.27058	0.13363	0.062575634	58.74026893	4087.61153	12.68896	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	282	chr1	156012038	chr1:156012038	G	A	.	PASS	AN=0;DP=282	GT	0/1
chr1	162729685	162729685	G	T	exonic	DDR2	.	synonymous SNV	DDR2:NM_006182:exon8:c.G771T:p.V257V,DDR2:NM_001014796:exon9:c.G771T:p.V257V	0.990992372	0.009007624	3.79E-09	DISEASE: Spondyloepimetaphyseal dysplasia short limb-hand type (SEMD-SL) [MIM:271665]: A bone disease characterized by short- limbed dwarfism, a narrow chest with pectus excavatum, brachydactyly in the hands and feet, a characteristic craniofacial appearance and premature calcifications. The radiological findings are distinctive and comprise short long bones throughout the skeleton with striking epiphyses that are stippled, flattened and fragmented and flared, irregular metaphyses. Platyspondyly in the spine with wide intervertebral spaces is observed and some vertebral bodies are pear-shaped with central humps, anterior protrusions and posterior scalloping. {ECO:0000269|PubMed:19110212, ECO:0000269|PubMed:20223752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.85011	0.1349	-0.775187015	13.05142722	110.07197	2.27991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	chr1	162729685	chr1:162729685	G	T	.	PASS	AN=0;DP=53	GT	0/1
chr1	168066292	168066292	C	T	exonic	GPR161	.	nonsynonymous SNV	GPR161:NM_001267613:exon2:c.G319A:p.E107K,GPR161:NM_001267614:exon2:c.G211A:p.E71K,GPR161:NM_001349635:exon2:c.G157A:p.E53K,GPR161:NM_001267611:exon3:c.G604A:p.E202K,GPR161:NM_001267612:exon3:c.G157A:p.E53K,GPR161:NM_001349633:exon3:c.G553A:p.E185K,GPR161:NM_001267609:exon4:c.G613A:p.E205K,GPR161:NM_001267610:exon4:c.G553A:p.E185K,GPR161:NM_001349632:exon5:c.G553A:p.E185K,GPR161:NM_001349634:exon5:c.G553A:p.E185K,GPR161:NM_153832:exon5:c.G553A:p.E185K	0.02957929	0.960088859	0.010331851	.	0.15614	0.15387	-0.800872469	12.33191791	94.16225	2.08754	0.034	0.443	D	0.452	0.481	B	0.164	0.412	B	0.000	0.629	D	1.000	0.588	D	2.265	0.646	M	1.23	0.369	T	-1.67	0.457	N	0.513	0.572	-0.892	0.488	T	0.082	0.323	T	0.013	0.327	T	3.440	0.471	23.0	0.999	0.941	0.970	0.717	D	c	0.410	0.475	1.000	0.747	0.706	0.609	0	5.07	0.680	5.927	0.696	0.935	0.490	1.000	0.715	0.969	0.458	14.859	0.699	GPCR, rhodopsin-like, 7TM	.	.	0.5	103	153	chr1	168066292	chr1:168066292	C	T	103	PASS	AN=2;DP=153	GT	0/1
chr1	177001937	177001937	G	A	exonic	ASTN1	.	synonymous SNV	ASTN1:NM_001286164:exon3:c.C520T:p.L174L,ASTN1:NM_004319:exon3:c.C520T:p.L174L,ASTN1:NM_207108:exon3:c.C520T:p.L174L	0.999415997	0.000584003	9.68E-13	.	0.12514	0.11666	-1.095046929	6.97688134	570.07336	4.84399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	84	chr1	177001937	chr1:177001937	G	A	72	PASS	AN=2;DP=84	GT	0/1
chr1	198264408	198264408	A	-	intronic	NEK7	.	.	.	0.707657761	0.29219643	0.000145809	.	0.24935	0.11215	-0.029247611	51.40363293	55.39612	1.49342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	73	chr1	198264407	chr1:198264407	CA	C	54	PASS	AN=2;DP=73	GT	0/1
chr1	202527984	202527984	G	T	intronic	PPP1R12B	.	.	.	0.124454642	0.875545286	7.20E-08	.	0.39842	0.10794	-0.857930839	10.95187544	214.85888	3.16168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	120	chr1	202527984	chr1:202527984	G	T	91	PASS	AN=2;DP=120	GT	0/1
chr1	203278553	203278553	G	C	UTR3	BTG2	NM_006763:c.*1987G>C	.	.	0.048978487	0.685197566	0.265823946	.	0.59042	0.1111	-0.207437529	38.2814343	44.13231	1.26674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	45	chr1	203278553	chr1:203278553	G	C	56	PASS	AN=2;DP=45	GT	0/1
chr1	205901802	205901802	C	T	intronic	SLC26A9	.	.	.	0.002985459	0.996911146	0.000103395	.	0.17926	0.11651	-0.143334748	42.35079028	424.02635	4.30029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	63	chr1	205901802	chr1:205901802	C	T	71	PASS	AN=2;DP=63	GT	0/1
chr1	228248893	228248893	C	T	UTR3	WNT3A	NM_033131:c.*1727C>T	.	.	0.777794121	0.220637276	0.001568603	.	0.14918	0.58479	-0.205617011	38.57631517	18.81775	0.64982	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	154	chr1	228248893	chr1:228248893	C	T	84	PASS	AN=2;DP=154	GT	0/1
chr1	230974299	230974299	G	A	UTR3	C1orf198	NM_001136495:c.*1299C>T;NM_001136494:c.*1299C>T;NM_032800:c.*1299C>T	.	.	0.027375276	0.921047694	0.05157703	.	0.23574	.	0.194852702	67.03231894	31.69042	0.99734	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	80	chr1	230974299	chr1:230974299	G	A	64	PASS	AN=2;DP=80	GT	0/1
chr1	242540222	242540222	G	A	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	chr1	242540222	chr1:242540222	G	A	.	PASS	AN=0;DP=26	GT	0/1
chr1	242540223	242540223	G	T	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	38	chr1	242540223	chr1:242540223	G	T	71	PASS	AN=2;DP=38	GT	1/0
chr1	243218249	243218249	A	T	intergenic	PLD5;LINC01347	dist=530251;dist=1367	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	141	chr1	243218249	chr1:243218249	A	T	.	PASS	AN=0;DP=141	GT	0/1
chr2	1500507	1500507	G	T	exonic	TPO	.	stopgain	TPO:NM_175722:exon11:c.G1837T:p.G613X,TPO:NM_001206745:exon12:c.G2185T:p.G729X,TPO:NM_175719:exon12:c.G2185T:p.G729X,TPO:NM_175721:exon12:c.G2356T:p.G786X,TPO:NM_000547:exon13:c.G2356T:p.G786X,TPO:NM_001206744:exon13:c.G2356T:p.G786X	1.36E-07	0.988057948	0.011941916	DISEASE: Note=An alternative splicing in the thyroperoxidase mRNA can cause Graves' disease.; DISEASE: Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]: A disorder due to defective conversion of accumulated iodide to organically bound iodine. The iodide organification defect can be partial or complete. {ECO:0000269|PubMed:10084596, ECO:0000269|PubMed:10468986, ECO:0000269|PubMed:11061528, ECO:0000269|PubMed:11415848, ECO:0000269|PubMed:11874711, ECO:0000269|PubMed:11916616, ECO:0000269|PubMed:12213873, ECO:0000269|PubMed:12490071, ECO:0000269|PubMed:12843174, ECO:0000269|PubMed:12864797, ECO:0000269|PubMed:12938097, ECO:0000269|PubMed:16284446, ECO:0000269|PubMed:16684826, ECO:0000269|PubMed:7550241, ECO:0000269|PubMed:9024270, ECO:0000269|PubMed:9924196}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18628	0.48162	-0.14151689	42.36258552	2837.88244	10.06894	.	.	.	.	.	.	.	.	.	0.043	0.238	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.455	0.983	39	0.992	0.537	0.808	0.401	D	c	0.767	0.513	0.998	0.359	0.581	0.326	0	4.2	0.486	3.523	0.530	0.902	0.416	0.994	0.380	0.007	0.100	14.183	0.650	Sushi/SCR/CCP domain	.	.	0.5	.	67	chr2	1500507	chr2:1500507	G	T	.	PASS	AN=0;DP=67	GT	0/1
chr2	1680706	1680706	G	A	exonic	PXDN	.	stopgain	PXDN:NM_012293:exon8:c.C841T:p.R281X	2.04E-05	0.999934089	4.56E-05	DISEASE: Corneal opacification with other ocular anomalies (COPOA) [MIM:269400]: An ocular disease characterized by sclerocornea associated with other ocular anomalies, such as cataract, microcornea, microphthalmia, and anterior segment dysgenesis. Sclerocornea is a primary anomaly in which scleralization of a peripheral part of the cornea, or the entire corneal tissue, occurs. In the peripheral type of sclerocornea, the affected area is vascularized with regular arcades of superficial scleral vessels. In total sclerocornea, the entire cornea is opaque and vascularized. {ECO:0000269|PubMed:21907015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.44329	0.10322	-1.512251235	3.479594244	529.85594	4.69745	.	.	.	.	.	.	.	.	.	0.000	0.523	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.930	0.979	38	0.998	0.927	0.846	0.434	D	c	0.767	0.620	1.000	0.747	0.707	0.730	0	4.77	0.603	3.258	0.510	1.027	0.646	1.000	0.715	1.000	0.888	13.662	0.617	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	63	chr2	1680706	chr2:1680706	G	A	.	PASS	AN=0;DP=63	GT	0/1
chr2	1893021	1893021	C	G	exonic	MYT1L	.	nonsynonymous SNV	MYT1L:NM_001303052:exon16:c.G2512C:p.D838H,MYT1L:NM_001329845:exon16:c.G2512C:p.D838H,MYT1L:NM_001329846:exon16:c.G2506C:p.D836H,MYT1L:NM_001329847:exon16:c.G2506C:p.D836H,MYT1L:NM_001329848:exon16:c.G2506C:p.D836H,MYT1L:NM_001329849:exon16:c.G2506C:p.D836H,MYT1L:NM_001329851:exon16:c.G2512C:p.D838H,MYT1L:NM_001329852:exon16:c.G2506C:p.D836H,MYT1L:NM_015025:exon16:c.G2506C:p.D836H,MYT1L:NM_001329844:exon17:c.G2512C:p.D838H	0.999963989	3.60E-05	6.51E-13	.	0.30683	0.11638	-1.506435464	3.544468035	525.36937	4.67655	0.003	0.682	D	0.652	0.395	P	0.382	0.421	B	0.005	0.328	N	0.997	0.433	D	0.695	0.181	N	0.73	0.507	T	-1.15	0.295	N	0.245	0.355	-0.960	0.392	T	0.094	0.356	T	0.010	0.259	T	4.432	0.593	24.2	0.995	0.687	0.994	0.953	D	c	0.194	0.324	1.000	0.747	0.487	0.133	0	5.01	0.663	5.405	0.659	0.807	0.329	1.000	0.715	0.137	0.201	18.279	0.900	Myelin transcription factor 1	.	.	0.5	67	40	chr2	1893021	chr2:1893021	C	G	67	PASS	AN=2;DP=40	GT	0/1
chr2	9593028	9593028	T	-	intronic	CPSF3	.	.	.	3.46E-05	0.99741028	0.002555149	.	0.16707	.	-0.558357437	19.54470394	35.81924	1.07713	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	26	chr2	9593027	chr2:9593027	AT	A	51	PASS	AN=2;DP=26	GT	0/1
chr2	20240668	20240668	C	A	exonic	LAPTM4A	.	synonymous SNV	LAPTM4A:NM_014713:exon2:c.G216T:p.S72S	0.50380241	0.492021029	0.004176561	.	0.43282	0.10804	-0.139478553	43.29440906	119.75939	2.38284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	21	chr2	20240668	chr2:20240668	C	A	88	PASS	AN=2;DP=21	GT	1/0
chr2	23916368	23916368	G	A	exonic	KLHL29	.	stopgain	KLHL29:NM_052920:exon8:c.G1512A:p.W504X	.	.	.	.	0.74488	.	-0.53631094	20.53550366	164.66985	2.80262	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.568	0.984	39	0.996	0.732	0.967	0.705	D	c	1.229	1.082	1.000	0.747	0.672	0.522	0	5.24	0.728	9.928	0.988	1.048	0.713	1.000	0.715	1.000	0.888	19.215	0.937	BTB/Kelch-associated	.	.	0.5	.	42	chr2	23916368	chr2:23916368	G	A	.	PASS	AN=0;DP=42	GT	0/1
chr2	27529135	27529135	G	A	exonic	TRIM54	.	synonymous SNV	TRIM54:NM_187841:exon7:c.G921A:p.E307E,TRIM54:NM_032546:exon8:c.G1047A:p.E349E	8.25E-07	0.297899937	0.702099238	.	0.13331	0.13638	-0.756778259	13.44656759	59.43838	1.56351	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	124	chr2	27529135	chr2:27529135	G	A	86	PASS	AN=2;DP=124	GT	0/1
chr2	27693830	27693830	C	G	exonic	IFT172	.	nonsynonymous SNV	IFT172:NM_015662:exon16:c.G1657C:p.E553Q	2.29E-18	0.999993369	6.63E-06	DISEASE: Short-rib thoracic dysplasia 10 with or without polydactyly (SRTD10) [MIM:615630]: A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. {ECO:0000269|PubMed:24140113}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 71 (RP71) [MIM:616394]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:25168386}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25302	0.16159	-1.955181094	1.857749469	367.466	4.05229	0.005	0.632	D	0.374	0.414	B	0.334	0.476	B	0.000	0.843	D	1.000	0.537	D	1.545	0.392	L	1.64	0.278	T	-1.88	0.439	N	0.115	0.126	-1.002	0.294	T	0.116	0.409	T	0.012	0.311	T	4.410	0.590	24.1	0.997	0.785	0.992	0.921	D	c	0.452	0.538	1.000	0.747	0.706	0.609	0	5.36	0.765	7.209	0.773	0.847	0.346	1.000	0.715	0.997	0.653	17.646	0.880	WD40/YVTN repeat-like-containing domain	.	.	0.5	56	57	chr2	27693830	chr2:27693830	C	G	56	PASS	AN=2;DP=57	GT	0/1
chr2	44445605	44445605	T	-	intronic	PPM1B	.	.	.	0.109620711	0.884012724	0.006366565	.	0.99971	0.21173	-0.490397599	22.50530786	53.58105	1.456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	41	chr2	44445604	chr2:44445604	GT	G	74	PASS	AN=2;DP=41	GT	0/1
chr2	44559598	44559598	C	A	exonic	PREPL	.	nonsynonymous SNV	PREPL:NM_001042385:exon7:c.G1167T:p.K389N,PREPL:NM_001171613:exon8:c.G1086T:p.K362N,PREPL:NM_001171617:exon8:c.G1086T:p.K362N,PREPL:NM_006036:exon8:c.G1353T:p.K451N,PREPL:NM_001171603:exon9:c.G1353T:p.K451N,PREPL:NM_001171606:exon9:c.G1353T:p.K451N	2.43E-11	0.240558654	0.759441346	.	0.37424	0.10892	-0.835882558	11.47676339	281.52127	3.59257	0.005	0.632	D	0.996	0.670	D	0.99	0.774	D	0.000	0.463	D	1.000	0.810	D	1.955	0.530	M	.	.	.	-1.65	0.500	N	0.193	0.246	-0.291	0.752	T	0.394	0.748	T	0.016	0.371	T	4.514	0.604	24.3	0.998	0.924	0.937	0.587	D	c	0.516	0.477	0.631	0.220	0.732	0.924	0	4.67	0.579	3.472	0.526	0.935	0.490	1.000	0.715	0.996	0.625	14.182	0.650	Alpha/Beta hydrolase fold;Alpha/Beta hydrolase fold|Peptidase S9A, N-terminal domain;Peptidase S9A, N-terminal domain	.	.	0.5	.	27	chr2	44559598	chr2:44559598	C	A	.	PASS	AN=0;DP=27	GT	0/1
chr2	47389401	47389401	T	A	intronic	CALM2	.	.	.	0.856387219	0.141331344	0.002281437	DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 4 (CPVT4) [MIM:614916]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:23040497}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Long QT syndrome 14 (LQT14) [MIM:616247]: A form of long QT syndrome, a heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:24076290}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Long QT syndrome 15 (LQT15) [MIM:616249]: A form of long QT syndrome, a heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:23388215, ECO:0000269|PubMed:24917665}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69728	0.32162	0.12325821	62.38499646	8.57012	0.31396	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr2	47389401	chr2:47389401	T	A	.	PASS	AN=0;DP=55	GT	0/1
chr2	61411443	61411443	G	C	intronic	AHSA2	.	.	.	5.61E-06	0.140152678	0.859841708	.	0.05809	.	-0.339715008	30.06605331	275.26294	3.55364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	73	chr2	61411443	chr2:61411443	G	C	118	PASS	AN=2;DP=73	GT	1/0
chr2	65300138	65300138	G	T	intronic	CEP68	.	.	.	0.371622602	0.626025199	0.002352199	.	0.05976	0.09504	0.718303761	85.85161595	1991.18812	8.21944	0.018	0.506	D	0.0	0.026	B	0.001	0.040	B	.	.	.	1	0.090	N	.	.	.	1.85	0.245	T	-0.62	0.183	N	0.021	0.005	-0.986	0.335	T	0.034	0.146	T	0.003	0.081	T	-0.092	0.085	1.788	0.936	0.229	0.195	0.205	N	c	-1.120	-1.186	0.999	0.394	0.461	0.090	0	-0.517	0.113	-0.739	0.049	-0.918	0.026	0.000	0.063	0.000	0.016	8.567	0.325	.	.	.	0.5	.	36	chr2	65300138	chr2:65300138	G	T	.	PASS	AN=0;DP=36	GT	0/1
chr2	71209708	71209708	T	A	exonic	ANKRD53	.	nonsynonymous SNV	ANKRD53:NM_001115116:exon5:c.T784A:p.F262I,ANKRD53:NM_024933:exon5:c.T784A:p.F262I	0.000455608	0.867354929	0.132189463	.	0.06661	0.09362	1.26585432	93.59518754	1459.41609	7.12227	0.1	0.390	T	1.0	0.899	D	0.998	0.875	D	0.002	0.366	N	0.984	0.408	D	0.18	0.091	N	-0.11	0.706	T	-1.19	0.342	N	0.67	0.680	-0.280	0.756	T	0.335	0.702	T	0.036	0.572	D	5.365	0.727	25.9	0.992	0.539	0.898	0.502	D	c	0.426	0.478	1.000	0.747	0.554	0.283	0	5.57	0.840	1.972	0.399	0.964	0.580	1.000	0.715	0.995	0.604	13.988	0.637	Ankyrin repeat-containing domain	.	.	0.5	.	63	chr2	71209708	chr2:71209708	T	A	.	PASS	AN=0;DP=63	GT	0/1
chr2	71896341	71896341	G	A	intronic	DYSF	.	.	.	1.00E-15	0.999999362	6.38E-07	DISEASE: Limb-girdle muscular dystrophy 2B (LGMD2B) [MIM:253601]: An autosomal recessive degenerative myopathy characterized by weakness and atrophy starting in the proximal pelvifemoral muscles, with onset in the late teens or later, massive elevation of serum creatine kinase levels and slow progression. Scapular muscle involvement is minor and not present at onset. Upper limb girdle involvement follows some years after the onset in lower limbs. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:14678801, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:16705711, ECO:0000269|PubMed:16996541, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]: A late- onset muscular dystrophy involving the distal lower limb musculature. It is characterized by weakness that initially affects the gastrocnemius muscle during early adulthood. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:11468312, ECO:0000269|PubMed:12796534, ECO:0000269|PubMed:15116377, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:15477515, ECO:0000269|PubMed:15515206, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526, ECO:0000269|Ref.26}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Distal myopathy with anterior tibial onset (DMAT) [MIM:606768]: Onset of the disorder is between 14 and 28 years of age and the anterior tibial muscles are the first muscle group to be involved. Inheritance is autosomal recessive. {ECO:0000269|PubMed:11198284}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18661	0.30664	-1.309065031	4.853739089	1760.18248	7.74393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	49	chr2	71896341	chr2:71896341	G	A	72	PASS	AN=2;DP=49	GT	0/1
chr2	73496111	73496111	G	A	exonic	FBXO41	.	synonymous SNV	FBXO41:NM_001080410:exon1:c.C648T:p.D216D	0.951773201	0.048220951	5.85E-06	.	0.30259	0.1115	.	.	1132.93967	6.42282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	chr2	73496111	chr2:73496111	G	A	.	PASS	AN=0;DP=28	GT	0/1
chr2	89339848	89339848	C	G	intergenic	MIR4436A;NONE	dist=227880;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	192	chr2	89339848	chr2:89339848	C	G	88	PASS	AN=2;DP=192	GT	0/1
chr2	91777719	91777719	G	A	intergenic	NONE;LOC654342	dist=NONE;dist=46990	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	239	chr2	91777719	chr2:91777719	G	A	75	PASS	AN=2;DP=239	GT	0/1
chr2	95940557	95940557	A	T	exonic	PROM2	.	nonsynonymous SNV	PROM2:NM_001165977:exon1:c.A224T:p.Q75L,PROM2:NM_001165978:exon1:c.A224T:p.Q75L,PROM2:NM_144707:exon1:c.A224T:p.Q75L	7.90E-08	0.994662578	0.005337343	.	0.12478	0.0927	-0.369255208	28.25548478	1092.43407	6.32455	0.002	0.721	D	0.999	0.764	D	0.984	0.745	D	0.001	0.428	D	1.000	0.495	D	2.93	0.848	M	0.81	0.485	T	-5.55	0.862	D	0.527	0.674	-0.634	0.634	T	0.268	0.640	T	0.173	0.850	D	4.590	0.615	24.4	0.993	0.575	0.707	0.344	D	c	0.400	0.310	1.000	0.747	0.609	0.351	0	4.94	0.645	2.723	0.467	1.028	0.649	0.998	0.411	0.909	0.387	10.981	0.465	.	.	.	0.5	.	71	chr2	95940557	chr2:95940557	A	T	.	PASS	AN=0;DP=71	GT	0/1
chr2	96147352	96147352	G	A	exonic	TRIM43B	.	synonymous SNV	TRIM43B:NM_001164464:exon3:c.C498T:p.F166F	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	92	chr2	96147352	chr2:96147352	G	A	106	PASS	AN=2;DP=92	GT	1/0
chr2	96517502	96517502	A	C	exonic	ANKRD36C	.	nonsynonymous SNV	ANKRD36C:NM_001310154:exon87:c.T6351G:p.I2117M	.	.	.	.	.	.	.	.	2676.37542	9.72635	0.038	0.427	D	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	1.27	0.361	T	0.01	0.069	N	0.067	0.112	-1.027	0.214	T	0.037	0.162	T	.	.	.	-0.910	0.035	0.025	0.253	0.012	0.004	0.021	N	c	-1.567	-1.743	0.000	0.044	0.651	0.465	0	-3.59	0.043	-0.643	0.055	-1.236	0.015	0.000	0.063	0.000	0.016	0.308	0.003	Ankyrin repeat-containing domain	.	.	0.5	85	57	chr2	96517502	chr2:96517502	A	C	85	PASS	AN=2;DP=57	GT	0/1
chr2	96606914	96606914	C	-	exonic	ANKRD36C	.	frameshift deletion	ANKRD36C:NM_001310154:exon20:c.1525delG:p.A509Qfs*14	.	.	.	.	.	.	.	.	2676.37542	9.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	182	chr2	96606913	chr2:96606913	GC	G	51	PASS	AN=2;DP=182	GT	0/1
chr2	106498259	106498259	G	T	exonic	NCK2	.	nonsynonymous SNV	NCK2:NM_001004720:exon3:c.G702T:p.W234C,NCK2:NM_003581:exon4:c.G702T:p.W234C	0.702843118	0.293520718	0.003636164	.	0.24804	0.25902	-0.714505427	14.4019816	20.00595	0.68218	0.0	0.912	D	0.987	0.600	D	0.928	0.645	D	0.000	0.843	D	1	0.810	D	2.795	0.818	M	-5.51	0.992	D	-12.07	0.996	D	0.973	0.974	1.076	0.988	D	0.980	0.994	D	0.619	0.967	D	6.609	0.908	32	0.993	0.588	0.966	0.698	D	c	0.960	0.915	1.000	0.747	0.707	0.730	0	5.51	0.817	9.536	0.971	0.974	0.594	1.000	0.715	0.993	0.574	19.782	0.964	SH2 domain|SH3 domain	.	.	0.5	130	208	chr2	106498259	chr2:106498259	G	T	130	PASS	AN=2;DP=208	GT	0/1
chr2	106994488	106994488	G	C	intergenic	UXS1;PLGLA	dist=183693;dist=4082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	118	chr2	106994488	chr2:106994488	G	C	76	PASS	AN=2;DP=118	GT	0/1
chr2	106994545	106994545	C	T	intergenic	UXS1;PLGLA	dist=183750;dist=4025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	122	chr2	106994545	chr2:106994545	C	T	64	PASS	AN=2;DP=122	GT	0/1
chr2	110036009	110036009	G	T	exonic	SH3RF3	.	synonymous SNV	SH3RF3:NM_001099289:exon5:c.G1314T:p.S438S	0.981100872	0.018885189	1.39E-05	.	.	.	.	.	1390.76659	6.97706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	86	chr2	110036009	chr2:110036009	G	T	.	PASS	AN=0;DP=86	GT	0/1
chr2	119599910	119599910	C	A	UTR3	EN1	NM_001426:c.*604G>T	.	.	0.75193186	0.238255669	0.009812471	.	0.60781	0.26527	.	.	13.35248	0.48584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	chr2	119599910	chr2:119599910	C	A	.	PASS	AN=0;DP=49	GT	0/1
chr2	119599911	119599911	C	A	UTR3	EN1	NM_001426:c.*603G>T	.	.	0.75193186	0.238255669	0.009812471	.	0.60781	0.26527	.	.	13.35248	0.48584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	chr2	119599911	chr2:119599911	C	A	.	PASS	AN=0;DP=50	GT	0/1
chr2	125191997	125191997	A	C	intronic	CNTNAP5	.	.	.	0.097272924	0.902726965	1.10E-07	.	0.28988	0.10318	-0.986602472	8.645907054	325.79675	3.83698	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	13	chr2	125191997	chr2:125191997	A	C	44	PASS	AN=2;DP=13	GT	0/1
chr2	128370201	128370201	G	T	intronic	MYO7B	.	.	.	6.38E-16	0.999852793	0.000147207	.	0.11748	.	1.019668216	90.92356688	5040.89055	14.51846	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	74	chr2	128370201	chr2:128370201	G	T	76	PASS	AN=2;DP=74	GT	0/1
chr2	131414196	131414196	A	T	exonic	POTEJ	.	synonymous SNV	POTEJ:NM_001277083:exon15:c.A1863T:p.L621L	.	.	.	.	.	.	.	.	1579.22659	7.35384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	108	chr2	131414196	chr2:131414196	A	T	.	PASS	AN=0;DP=108	GT	0/1
chr2	131976061	131976061	G	T	exonic	POTEE	.	nonsynonymous SNV	POTEE:NM_001083538:exon1:c.G86T:p.C29F	.	.	.	.	.	.	.	.	513.98926	4.63955	0.12	0.279	T	0.676	0.394	P	0.308	0.396	B	.	.	.	1	0.090	N	0.55	0.145	N	-0.97	0.757	T	-0.37	0.132	N	0.421	0.478	-0.900	0.480	T	0.209	0.569	T	0.030	0.525	D	-0.368	0.064	0.461	0.652	0.075	0.010	0.039	N	c	-0.930	-1.136	0.000	0.012	0.554	0.246	0	0.1	0.138	0.059	0.141	0.303	0.270	0.004	0.165	0.007	0.100	.	.	.	.	.	0.5	.	109	chr2	131976061	chr2:131976061	G	T	.	PASS	AN=0;DP=109	GT	0/1
chr2	133426045	133426045	G	T	exonic	LYPD1	.	nonsynonymous SNV	LYPD1:NM_144586:exon2:c.C118A:p.P40T,LYPD1:NM_001321234:exon3:c.C166A:p.P56T	0.000238591	0.313658655	0.686102754	.	0.21654	.	0.3032669	72.009908	18.3074	0.63566	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1.000	0.810	D	2.045	0.562	M	-1.48	0.812	T	-2.85	0.600	D	0.724	0.723	0.127	0.847	D	0.525	0.823	D	0.092	0.758	D	5.793	0.792	27.1	0.998	0.897	0.972	0.733	D	c	0.730	0.775	1.0	0.983	0.652	0.477	0	5.43	0.789	8.986	0.930	1.048	0.713	1.000	0.715	0.999	0.750	17.605	0.879	Ly-6 antigen / uPA receptor -like	.	.	0.5	.	40	chr2	133426045	chr2:133426045	G	T	.	PASS	AN=0;DP=40	GT	0/1
chr2	136552282	136552282	G	A	exonic	LCT	.	synonymous SNV	LCT:NM_002299:exon14:c.C5040T:p.F1680F	0.064255017	0.935744974	8.95E-09	DISEASE: Congenital lactase deficiency (COLACD) [MIM:223000]: Autosomal recessive, rare and severe gastrointestinal disorder. It is characterized by watery diarrhea in infants fed with breast milk or other lactose-containing formulas. An almost total lack of LCT activity is found in jejunal biopsy material of patients with congenital lactase deficiency. Opposite to congenital lactase deficiency, also known as lactose intolerance, is the most common enzyme deficiency worldwide. It is caused by developmental down- regulation of lactase activity during childhood or early adulthood. The decline of lactase activity is a normal physiological phenomenon; however, the majority of Northern Europeans have the ability to maintain lactase activity and digest lactose throughout life (lactase persistence). The down-regulation of lactase activity operates at the transcriptional level and it is associated with a noncoding variation in the MCM6 gene, located in the upstream vicinity of LCT. {ECO:0000269|PubMed:16400612}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10638	0.66554	-1.335817967	4.659117716	3628.57927	11.68781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	chr2	136552282	chr2:136552282	G	A	.	PASS	AN=0;DP=40	GT	0/1
chr2	136872414	136872414	-	A	UTR3	CXCR4	NM_001348059:c.*24_*25insT;NM_001348056:c.*24_*25insT;NM_003467:c.*24_*25insT;NM_001348060:c.*24_*25insT;NM_001008540:c.*24_*25insT	.	.	0.42745098	0.539796705	0.032752315	DISEASE: WHIM syndrome (WHIMS) [MIM:193670]: Immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis. {ECO:0000269|PubMed:12692554}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.90261	0.79193	-0.295622497	32.61972163	7.8354	0.28802	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	25	chr2	136872414	chr2:136872414	T	TA	39	PASS	AN=2;DP=25	GT	1/0
chr2	144008050	144008050	C	G	intronic	ARHGAP15	.	.	.	5.25E-06	0.964756522	0.035238224	.	0.77364	0.12676	-0.624497208	17.16206653	736.83485	5.38892	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	34	chr2	144008050	chr2:144008050	C	G	41	PASS	AN=2;DP=34	GT	0/1
chr2	153476208	153476208	G	A	exonic	FMNL2	.	nonsynonymous SNV	FMNL2:NM_052905:exon15:c.G1813A:p.V605M	0.996999397	0.003000603	5.23E-11	.	0.37448	.	0.135991087	63.61759849	191.04411	2.99833	0.054	0.386	T	0.99	0.615	D	0.969	0.703	D	0.000	0.523	D	1	0.810	D	2.615	0.767	M	0.93	0.441	T	-0.71	0.202	N	0.683	0.690	-0.864	0.510	T	0.150	0.478	T	0.034	0.558	D	5.015	0.675	25.2	0.998	0.910	0.998	0.995	D	c	0.337	0.465	1.000	0.747	0.707	0.730	0	5.12	0.693	9.309	0.953	0.940	0.530	1.000	0.715	0.994	0.587	18.611	0.912	.	.	.	0.5	.	29	chr2	153476208	chr2:153476208	G	A	.	PASS	AN=0;DP=29	GT	0/1
chr2	162890134	162890134	G	C	exonic	DPP4	.	nonsynonymous SNV	DPP4:NM_001935:exon10:c.C804G:p.F268L	4.06E-10	0.983161288	0.016838711	.	0.31053	0.64989	-0.973616687	8.8995046	165.27236	2.81237	1.0	0.010	T	0.0	0.026	B	0.001	0.040	B	0.002	0.383	N	0.980	0.396	D	-1.215	0.008	N	2.1	0.200	T	2.09	0.004	N	0.206	0.253	-0.968	0.375	T	0.011	0.040	T	0.003	0.079	T	1.357	0.227	12.57	0.750	0.105	0.752	0.365	D	c	-0.799	-0.545	0.767	0.236	0.615	0.372	0	1.29	0.206	0.388	0.203	1.048	0.713	0.999	0.424	1.000	0.888	4.229	0.100	Dipeptidylpeptidase IV, N-terminal domain	.	.	0.5	79	64	chr2	162890134	chr2:162890134	G	C	79	PASS	AN=2;DP=64	GT	0/1
chr2	173341108	173341108	C	T	intronic	ITGA6	.	.	.	0.009913603	0.990086247	1.50E-07	DISEASE: Epidermolysis bullosa letalis, with pyloric atresia (EB- PA) [MIM:226730]: An autosomal recessive, frequently lethal, epidermolysis bullosa with variable involvement of skin, nails, mucosa, and with variable effects on the digestive system. It is characterized by mucocutaneous fragility, aplasia cutis congenita, and gastrointestinal atresia, which most commonly affects the pylorus. Pyloric atresia is a primary manifestation rather than a scarring process secondary to epidermolysis bullosa. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.61813	0.48979	0.249861693	69.66265629	3306.75309	10.97922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	43	chr2	173341108	chr2:173341108	C	T	60	PASS	AN=2;DP=43	GT	0/1
chr2	176965470	176965470	G	T	exonic	HOXD12	.	nonsynonymous SNV	HOXD12:NM_021193:exon2:c.G795T:p.Q265H	0.003345917	0.610026817	0.386627266	.	0.8886	0.19255	0.395088462	76.15003539	604.16052	4.97604	0.242	0.176	T	0.126	0.253	B	0.041	0.226	B	0.000	0.559	D	0.993	0.810	D	1.06	0.271	L	-3.25	0.935	D	-1.16	0.297	N	0.435	0.490	-0.329	0.742	T	0.587	0.852	D	0.064	0.693	D	2.791	0.396	21.3	0.991	0.526	0.903	0.511	D	c	-0.349	-0.215	0.941	0.274	0.598	0.340	0	1.68	0.231	1.051	0.298	-0.189	0.103	1.000	0.715	0.975	0.474	8.264	0.308	.	.	.	0.5	.	91	chr2	176965470	chr2:176965470	G	T	.	PASS	AN=0;DP=91	GT	0/1
chr2	190925148	190925148	C	A	exonic	MSTN	.	nonsynonymous SNV	MSTN:NM_005259:exon2:c.G387T:p.M129I	0.812914736	0.186112611	0.000972653	DISEASE: Muscle hypertrophy (MSLHP) [MIM:614160]: A condition characterized by increased muscle bulk and strength. Affected individuals are exceptionally strong. {ECO:0000269|PubMed:15215484}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.83937	0.74393	0.663285274	84.55414013	913.77022	5.87603	0.271	0.160	T	0.0	0.026	B	0.0	0.013	B	0.001	0.407	D	0.830	0.287	N	0	0.065	N	-0.1	0.643	T	0.39	0.035	N	0.159	0.191	-1.014	0.256	T	0.104	0.382	T	0.017	0.383	T	0.556	0.147	7.847	0.856	0.154	0.207	0.209	N	c	-0.737	-0.579	0.991	0.323	0.487	0.133	0	4.89	0.632	0.051	0.139	0.059	0.165	0.029	0.202	0.947	0.422	6.745	0.225	Transforming growth factor-beta, N-terminal	.	.	0.5	.	38	chr2	190925148	chr2:190925148	C	A	.	PASS	AN=0;DP=38	GT	0/1
chr2	204350859	204350859	G	A	intronic	RAPH1	.	.	.	0.957851233	0.042148732	3.46E-08	.	0.25984	0.27016	-2.607452819	0.807973579	124.99766	2.43194	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	63	chr2	204350859	chr2:204350859	G	A	39	PASS	AN=2;DP=63	GT	0/1
chr2	205989177	205989177	A	-	exonic	PARD3B	.	frameshift deletion	PARD3B:NM_001302769:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_057177:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_152526:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_205863:exon9:c.1292delA:p.D431Afs*5	8.65E-08	0.999805592	0.000194321	.	0.48627	0.09509	0.126687467	62.75064874	840.37721	5.67705	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	41	chr2	205989176	chr2:205989176	GA	G	82	PASS	AN=2;DP=41	GT	0/1
chr2	215851354	215851354	C	T	exonic	ABCA12	.	nonsynonymous SNV	ABCA12:NM_015657:exon20:c.G3121A:p.V1041I,ABCA12:NM_173076:exon28:c.G4075A:p.V1359I	2.02E-07	0.999999798	2.70E-13	DISEASE: Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]: A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. {ECO:0000269|PubMed:12915478, ECO:0000269|PubMed:17508018, ECO:0000269|PubMed:18284401, ECO:0000269|PubMed:19262603, ECO:0000269|PubMed:22257947}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ichthyosis, congenital, autosomal recessive 4B (ARCI4B) [MIM:242500]: A rare, very severe form of congenital ichthyosis, in which the neonate is born with a thick covering of armor-like scales. The skin dries out to form hard diamond-shaped plaques separated by fissures, resembling 'armor plating'. The normal facial features are severely affected, with distortion of the lips (eclabion), eyelids (ectropion), ears, and nostrils. Affected babies are often born prematurely and rarely survive the perinatal period. Babies who survive into infancy and beyond develop skin changes resembling severe non-bullous congenital ichthyosiform erythroderma. {ECO:0000269|PubMed:15756637, ECO:0000269|PubMed:16675967, ECO:0000269|PubMed:16902423}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16262	0.15786	-0.299763455	32.26586459	2992.15591	10.38229	0.413	0.100	T	0.0	0.067	B	0.001	0.093	B	0.358	0.137	N	0.999	0.213	N	0.225	0.096	N	-3.24	0.935	D	-0.7	0.199	N	0.061	0.077	-0.509	0.683	T	0.545	0.833	D	0.032	0.539	D	2.069	0.310	16.65	0.968	0.308	0.210	0.210	N	c	-0.677	-0.544	0.001	0.081	0.693	0.558	0	1.25	0.204	0.583	0.234	-0.170	0.106	0.415	0.261	0.862	0.360	7.885	0.286	ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	27	chr2	215851354	chr2:215851354	C	T	.	PASS	AN=0;DP=27	GT	0/1
chr2	219134766	219134766	G	-	exonic	AAMP	.	frameshift deletion	AAMP:NM_001087:exon1:c.44delC:p.P15Hfs*4,AAMP:NM_001302545:exon1:c.44delC:p.P15Hfs*4	0.531201269	0.468105025	0.000693706	.	0.49551	0.1223	0.040529541	57.15380986	343.13644	3.92709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	61	chr2	219134765	chr2:219134765	TG	T	42	PASS	AN=2;DP=61	GT	0/1
chr2	219745839	219745839	T	C	intronic	WNT10A	.	.	.	0.010169289	0.943911812	0.045918899	DISEASE: Note=Defects in WNT10A may be a cause of hypohidrotic/anhidrotic ectodermal dysplasia, a disorder characterized by sparse hair (atrichosis or hypotrichosis), abnormal or missing teeth and the inability to sweat due to the absence of sweat glands. Most patients carrying WNT10A mutations present with sweating anomalies. However, comparison with cases harboring mutations in the ectodysplasin pathway identifies some phenotypic differences. Dermatological features (anomalies of hair and sweat glands) are less severe in patients carrying WNT10A mutations and facial dysmorphism can be absent. The dental phenotype consists in microdontia, whereas teeth agenesis is more frequent in patients carrying mutations in the ectodysplasin pathway. {ECO:0000269|PubMed:20979233}.; DISEASE: Odonto-onycho-dermal dysplasia (OODD) [MIM:257980]: A rare autosomal recessive ectodermal dysplasia characterized by dry hair, severe hypodontia, smooth tongue with marked reduction of fungiform and filiform papillae, onychodysplasia, keratoderma and hyperhidrosis of palms and soles, and hyperkeratosis of the skin. {ECO:0000269|PubMed:17847007, ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Schopf-Schulz-Passarge syndrome (SSPS) [MIM:224750]: A rare ectodermal dysplasia, characterized chiefly by cysts of the eyelid margins, palmoplantar keratoderma, hypodontia, hypotrichosis and nail dystrophy. Multiple eyelid apocrine hidrocystomas are the hallmark of this condition, although they usually appear in adulthood. The concomitant presence of eccrine syringofibroadenoma in most patients and of other adnexal skin tumors in some affected subjects indicates that Schopf-Schulz- Passarge syndrome is a genodermatosis with skin appendage neoplasms. {ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tooth agenesis selective 4 (STHAG4) [MIM:150400]: A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). In STHAG4, the upper lateral incisors are absent or peg-shaped. {ECO:0000269|PubMed:21484994, ECO:0000269|PubMed:22581971}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24339	0.20297	.	.	263.26685	3.48077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	58	chr2	219745839	chr2:219745839	T	C	89	PASS	AN=2;DP=58	GT	0/1
chr2	219826587	219826587	G	T	UTR3	CDK5R2	NM_003936:c.*941G>T	.	.	.	.	.	.	0.44177	0.11161	.	.	35.94	1.07912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	117	chr2	219826587	chr2:219826587	G	T	.	PASS	AN=0;DP=117	GT	0/1
chr2	230931295	230931295	C	T	intronic	SLC16A14	.	.	.	0.215983364	0.775382473	0.008634163	.	0.12329	0.10389	-0.490397599	22.50530786	65.9738	1.67277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	chr2	230931295	chr2:230931295	C	T	.	PASS	AN=0;DP=69	GT	0/1
chr2	232321394	232321394	T	A	exonic	NCL	.	nonsynonymous SNV	NCL:NM_005381:exon11:c.A1653T:p.R551S	0.999106738	0.000893261	3.29E-10	.	0.98769	0.73546	-0.686998355	15.26893135	112.77476	2.30967	0.001	0.784	D	1.0	0.899	D	0.997	0.850	D	0.000	0.843	D	1	0.810	D	2.785	0.815	M	-1.22	0.924	T	-4.15	0.761	D	0.819	0.816	0.699	0.932	D	0.821	0.940	D	0.415	0.937	D	6.355	0.878	29.4	0.998	0.851	0.971	0.726	D	c	0.470	0.427	1.000	0.747	0.722	0.854	0	4.44	0.530	1.319	0.330	1.058	0.762	0.981	0.351	1.000	0.888	8.095	0.298	Nucleotide-binding alpha-beta plait domain|RNA recognition motif domain;Nucleotide-binding alpha-beta plait domain|RNA recognition motif domain|RNA recognition motif domain, eukaryote	.	.	0.5	.	29	chr2	232321394	chr2:232321394	T	A	.	PASS	AN=0;DP=29	GT	0/1
chr2	232577559	232577559	T	C	exonic	PTMA	.	stoploss	PTMA:NM_001099285:exon5:c.T334C:p.X112Q,PTMA:NM_002823:exon5:c.T331C:p.X111Q	0.377491926	0.576544202	0.045963872	.	.	.	-0.009020804	52.8544468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2.417	0.352	18.93	0.684	0.084	0.932	0.572	D	c	0.982	0.806	1.000	0.747	0.140	0.025	0	4.63	0.570	4.562	0.603	1.040	0.660	1.000	0.715	1.000	0.888	13.544	0.610	.	.	.	0.5	61	174	chr2	232577559	chr2:232577559	T	C	61	PASS	AN=2;DP=174	GT	0/1
chr2	234394236	234394236	-	T	exonic	USP40	.	frameshift insertion	USP40:NM_018218:exon29:c.3477dupA:p.Q1160Tfs*19	1.74E-14	0.764370206	0.235629794	.	0.06046	0.09101	0.501484965	79.67681057	7072.32994	18.02774	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	17	chr2	234394236	chr2:234394236	G	GT	41	PASS	AN=2;DP=17	GT	0/1
chr2	238274611	238274627	CTTCTGGGCCACAAAAA	-	exonic	COL6A3	.	frameshift deletion	COL6A3:NM_057166:exon9:c.3731_3747del:p.V1244Gfs*45,COL6A3:NM_057167:exon11:c.4934_4950del:p.V1645Gfs*45,COL6A3:NM_004369:exon12:c.5552_5568del:p.V1851Gfs*45	7.79E-11	1	1.79E-10	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:10399756, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:9536084}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dystonia 27 (DYT27) [MIM:616411]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT27 is an autosomal recessive form characterized by segmental isolated dystonia involving the face, neck, bulbar muscles, and upper limbs. {ECO:0000269|PubMed:26004199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93588	0.40359	-2.550505158	0.861052135	5032.39412	14.4934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	82	chr2	238274610	chr2:238274610	CCTTCTGGGCCACAAAAA	C	65	PASS	AN=2;DP=82	GT	0/1
chr2	241622318	241622318	C	A	upstream	AQP12B	dist=1	.	.	0.004358648	0.431917163	0.563724189	.	0.16011	.	.	.	3743.83383	11.95806	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	299	chr2	241622318	chr2:241622318	C	A	121	PASS	AN=2;DP=299	GT	0/1
chr2	242794725	242794725	C	G	intronic	PDCD1	.	.	.	0.017954048	0.894121848	0.087924104	DISEASE: Systemic lupus erythematosus 2 (SLEB2) [MIM:605218]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. {ECO:0000269|PubMed:12402038}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.14221	0.27803	-0.314027422	31.9297004	885.9353	5.79855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	chr2	242794725	chr2:242794725	C	G	.	PASS	AN=0;DP=40	GT	0/1
chr3	369955	369955	T	A	exonic	CHL1	.	synonymous SNV	CHL1:NM_001253388:exon3:c.T303A:p.S101S,CHL1:NM_001253387:exon5:c.T303A:p.S101S,CHL1:NM_006614:exon5:c.T303A:p.S101S	2.05E-06	0.999947701	5.02E-05	.	0.39224	0.09664	-0.158112528	41.92026421	1165.89885	6.49553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	chr3	369955	chr3:369955	T	A	.	PASS	AN=0;DP=32	GT	0/1
chr3	9730571	9730571	G	-	intronic	MTMR14	.	.	.	0.002939821	0.99695446	0.000105719	.	0.30998	0.11304	-0.911109353	9.961075725	98.92051	2.15158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	102	chr3	9730570	chr3:9730570	TG	T	91	PASS	AN=2;DP=102	GT	0/1
chr3	9912079	9912079	G	T	intronic	CIDEC	.	.	.	0.001416632	0.665901653	0.332681714	DISEASE: Note=In omental adipose tissue of obese patients matched for BMI, expression levels tend to correlate with insulin sensitivity. Expression is increased 2-3 fold in the group of patients with high insulin sensitivity, compared to the insulin- resistant group. This observation is consistent with the idea that triglyceride storage in adipocytes plays an important role in sequestering triglycerides and fatty acids away from the circulation and peripheral tissues, thus enhancing insulin sensitivity in liver and muscle. This effect is not significant in subcutaneous adipose tissue (PubMed:18509062). In subcutaneous adipose tissue of diabetic patients, tends to negatively correlate with body mass index and total fat mass, independently of insulin sensitivity (PubMed:18334488). {ECO:0000269|PubMed:18334488, ECO:0000269|PubMed:18509062}.; DISEASE: Lipodystrophy, familial partial, 5 (FPLD5) [MIM:615238]: A form of lipodystrophy characterized by loss of subcutaneous adipose tissue affecting limb, femorogluteal and subcutaneous abdominal fat, preservation of visceral, neck and axilliary fat, hepatomegaly, hepatic steatosis and insulin-resistant diabetes. {ECO:0000269|PubMed:20049731}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20849	.	0.262810045	70.43524416	157.22556	2.74041	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	chr3	9912079	chr3:9912079	G	T	.	PASS	AN=0;DP=33	GT	0/1
chr3	12574140	12574140	-	T	intronic	TSEN2	.	.	.	0.000104861	0.987514431	0.012380708	.	0.09274	0.08793	-0.753139731	13.67067705	284.29352	3.60987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	15	chr3	12574140	chr3:12574140	C	CT	41	PASS	AN=2;DP=15	GT	0/1
chr3	14520577	14520577	C	T	intronic	SLC6A6	.	.	.	0.98227565	0.017723862	4.88E-07	.	0.32797	.	-0.291981272	33.20358575	72.45796	1.77348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	45	chr3	14520577	chr3:14520577	C	T	51	PASS	AN=2;DP=45	GT	0/1
chr3	16216734	16216734	G	A	exonic	GALNT15	.	nonsynonymous SNV	GALNT15:NM_001319051:exon1:c.G76A:p.V26I,GALNT15:NM_054110:exon1:c.G76A:p.V26I	5.52E-10	0.376453241	0.623546758	.	0.30314	0.09703	-0.661316159	16.02382637	2902.69931	10.21345	0.04	0.437	D	0.203	0.281	B	0.01	0.139	B	0.259	0.037	N	1	0.090	N	1.21	0.306	L	0.58	0.580	T	-0.07	0.080	N	0.072	0.114	-1.059	0.120	T	0.075	0.303	T	0.039	0.588	D	-0.131	0.082	1.511	0.836	0.143	0.084	0.141	N	c	-1.094	-1.197	1.000	0.489	0.741	0.978	0	-4.59	0.031	-0.064	0.115	0.080	0.190	0.002	0.151	0.038	0.155	1.076	0.015	.	.	.	0.5	.	59	chr3	16216734	chr3:16216734	G	A	.	PASS	AN=0;DP=59	GT	0/1
chr3	16679458	16679458	G	A	intergenic	DAZL;PLCL2	dist=32452;dist=246994	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	15	chr3	16679458	chr3:16679458	G	A	50	PASS	AN=2;DP=15	GT	0/1
chr3	28364889	28364889	G	-	UTR3	AZI2	NM_022461:c.*644delC;NM_001271650:c.*644delC	.	.	0.185308909	0.812253432	0.002437659	.	0.47993	0.11092	-0.405853867	26.23260203	14.46843	0.52075	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	74	chr3	28364888	chr3:28364888	TG	T	42	PASS	AN=2;DP=74	GT	0/1
chr3	48684190	48684190	G	C	intronic	CELSR3	.	.	.	0.999656221	0.000343779	1.51E-19	.	.	0.2449	-4.265082462	0.11205473	3038.6677	10.47295	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	91	chr3	48684190	chr3:48684190	G	C	99	PASS	AN=2;DP=91	GT	0/1
chr3	50141668	50141668	-	T	intronic	RBM5	.	.	.	0.99999947	5.30E-07	2.25E-17	.	0.49937	0.11696	-1.111360919	6.717386176	14.39881	0.51975	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	19	chr3	50141668	chr3:50141668	C	CT	40	PASS	AN=2;DP=19	GT	0/1
chr3	53919752	53919752	C	A	intronic	SELENOK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	chr3	53919752	chr3:53919752	C	A	.	PASS	AN=0;DP=45	GT	0/1
chr3	58112428	58112428	C	T	exonic	FLNB	.	synonymous SNV	FLNB:NM_001164317:exon24:c.C4161T:p.Y1387Y,FLNB:NM_001164318:exon24:c.C4161T:p.Y1387Y,FLNB:NM_001164319:exon24:c.C4161T:p.Y1387Y,FLNB:NM_001457:exon24:c.C4161T:p.Y1387Y	0.00243124	0.99756876	3.24E-12	DISEASE: Note=Interaction with FLNA may compensate for dysfunctional FLNA homodimer in the periventricular nodular heterotopia (PVNH) disorder.; DISEASE: Atelosteogenesis 1 (AO1) [MIM:108720]: A lethal chondrodysplasia characterized by distal hypoplasia of the humeri and femurs, hypoplasia of the mid-thoracic spine, occasionally complete lack of ossification of single hand bones, and the finding in cartilage of multiple degenerated chondrocytes which are encapsulated in fibrous tissue. {ECO:0000269|PubMed:14991055}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atelosteogenesis 3 (AO3) [MIM:108721]: A short-limb lethal skeletal dysplasia with vertebral abnormalities, disharmonious skeletal maturation, poorly modeled long bones and joint dislocations. Recurrent respiratory insufficiency and/or infections usually result in early death. {ECO:0000269|PubMed:14991055}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Boomerang dysplasia (BOOMD) [MIM:112310]: A perinatal lethal osteochondrodysplasia characterized by absence or underossification of the limb bones and vertebrae. Patients manifest dwarfism with short, bowed, rigid limbs and characteristic facies. Boomerang dysplasia is distinguished from atelosteogenesis on the basis of a more severe defect in mineralization, with complete absence of ossification in some limb elements and vertebral segments. {ECO:0000269|PubMed:15994868}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Larsen syndrome (LRS) [MIM:150250]: An osteochondrodysplasia characterized by large-joint dislocations and characteristic craniofacial abnormalities. The cardinal features of the condition are dislocations of the hip, knee and elbow joints, with equinovarus or equinovalgus foot deformities. Spatula-shaped fingers, most marked in the thumb, are also present. Craniofacial anomalies include hypertelorism, prominence of the forehead, a depressed nasal bridge, and a flattened midface. Cleft palate and short stature are often associated features. Spinal anomalies include scoliosis and cervical kyphosis. Hearing loss is a well-recognized complication. {ECO:0000269|PubMed:14991055, ECO:0000269|PubMed:16801345}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spondylocarpotarsal synostosis syndrome (SCT) [MIM:272460]: Disorder characterized by short stature and vertebral, carpal and tarsal fusions. {ECO:0000269|PubMed:14991055}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.45177	0.2159	-1.444990676	3.939608398	1028.35714	6.16096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	chr3	58112428	chr3:58112428	C	T	.	PASS	AN=0;DP=20	GT	0/1
chr3	58368401	58368401	C	G	exonic	PXK	.	nonsynonymous SNV	PXK:NM_001289096:exon2:c.C263G:p.P88R,PXK:NM_001289100:exon2:c.C263G:p.P88R,PXK:NM_001349490:exon2:c.C263G:p.P88R,PXK:NM_001349500:exon2:c.C263G:p.P88R,PXK:NM_001349522:exon2:c.C263G:p.P88R,PXK:NM_001349524:exon2:c.C263G:p.P88R,PXK:NM_001289095:exon3:c.C311G:p.P104R,PXK:NM_001349494:exon3:c.C314G:p.P105R,PXK:NM_001349495:exon3:c.C314G:p.P105R,PXK:NM_001349496:exon3:c.C311G:p.P104R,PXK:NM_001349497:exon3:c.C311G:p.P104R,PXK:NM_001349501:exon3:c.C314G:p.P105R,PXK:NM_001349502:exon3:c.C311G:p.P104R,PXK:NM_001349510:exon3:c.C314G:p.P105R,PXK:NM_001349511:exon3:c.C314G:p.P105R,PXK:NM_001349512:exon3:c.C314G:p.P105R,PXK:NM_001349514:exon3:c.C311G:p.P104R,PXK:NM_001349515:exon3:c.C311G:p.P104R,PXK:NM_001349516:exon3:c.C314G:p.P105R,PXK:NM_001349517:exon3:c.C311G:p.P104R,PXK:NM_001349518:exon3:c.C311G:p.P104R,PXK:NM_001289098:exon4:c.C362G:p.P121R,PXK:NM_001289099:exon4:c.C113G:p.P38R,PXK:NM_001349488:exon4:c.C362G:p.P121R,PXK:NM_001349492:exon4:c.C362G:p.P121R,PXK:NM_001349493:exon4:c.C362G:p.P121R,PXK:NM_001349498:exon4:c.C302G:p.P101R,PXK:NM_001349499:exon4:c.C362G:p.P121R,PXK:NM_001349503:exon4:c.C362G:p.P121R,PXK:NM_001349504:exon4:c.C362G:p.P121R,PXK:NM_001349506:exon4:c.C362G:p.P121R,PXK:NM_001349507:exon4:c.C362G:p.P121R,PXK:NM_001349508:exon4:c.C362G:p.P121R,PXK:NM_001349509:exon4:c.C362G:p.P121R,PXK:NM_001349519:exon4:c.C362G:p.P121R,PXK:NM_001349520:exon4:c.C362G:p.P121R,PXK:NM_001349527:exon4:c.C362G:p.P121R,PXK:NM_017771:exon4:c.C362G:p.P121R,PXK:NM_001349489:exon5:c.C113G:p.P38R,PXK:NM_001349513:exon5:c.C113G:p.P38R,PXK:NM_001349521:exon5:c.C113G:p.P38R,PXK:NM_001349528:exon5:c.C113G:p.P38R,PXK:NM_001349529:exon5:c.C113G:p.P38R,PXK:NM_001349530:exon5:c.C113G:p.P38R,PXK:NM_001349531:exon5:c.C113G:p.P38R	0.932144256	0.06785563	1.15E-07	.	0.13995	0.09839	0.266447942	70.5826846	2672.1939	9.71802	0.045	0.784	D	0.751	0.487	P	0.327	0.479	B	0.000	0.843	D	1	0.810	D	3.1	0.878	M	1.06	0.398	T	-6.39	0.913	D	0.839	0.827	-0.699	0.605	T	0.203	0.561	T	0.028	0.508	D	5.715	0.780	26.8	0.996	0.710	0.986	0.847	D	c	0.610	0.657	1.000	0.747	0.732	0.924	0	5.57	0.840	7.347	0.784	0.935	0.490	1.000	0.715	1.000	0.888	19.545	0.953	Phox homologous domain;Phox homologous domain|Protein kinase domain	.	.	0.5	71	17	chr3	58368401	chr3:58368401	C	G	71	PASS	AN=2;DP=17	GT	0/1
chr3	59737880	59737880	C	A	UTR3	FHIT	NM_001320901:c.*72G>T;NM_001320900:c.*72G>T;NM_001320899:c.*72G>T	.	.	0.001391839	0.662104571	0.33650359	DISEASE: Note=A chromosomal aberration involving FHIT has been found in a lymphoblastoid cell line established from a family with renal cell carcinoma and thyroid carcinoma. Translocation t(3;8)(p14.2;q24.1) with RNF139. Although the 3p14.2 breakpoint has been shown to interrupt FHIT in its 5-prime non-coding region, it is unlikely that FHIT is causally related to renal or other malignancies. {ECO:0000269|PubMed:15007172}.; DISEASE: Note=Associated with digestive tract cancers. Numerous tumor types are found to have aberrant forms of FHIT protein due to deletions in a coding region of chromosome 3p14.2 including the fragile site locus FRA3B. {ECO:0000269|PubMed:15007172}.; 	0.25475	.	-0.560178693	19.30879925	49.36677	1.3751	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	chr3	59737880	chr3:59737880	C	A	.	PASS	AN=0;DP=25	GT	0/1
chr3	62535675	62535675	C	A	exonic	CADPS	.	synonymous SNV	CADPS:NM_003716:exon11:c.G1869T:p.T623T,CADPS:NM_183393:exon11:c.G1869T:p.T623T,CADPS:NM_183394:exon11:c.G1869T:p.T623T	0.052816468	0.94718353	2.47E-09	.	0.46523	.	-1.346642726	4.62962963	108.92082	2.26567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	88	chr3	62535675	chr3:62535675	C	A	88	PASS	AN=2;DP=88	GT	0/1
chr3	63820995	63820995	A	C	ncRNA_intronic	C3orf49	.	.	.	.	.	.	.	0.11088	.	.	.	1468.35326	7.14177	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	43	chr3	63820995	chr3:63820995	A	C	74	PASS	AN=2;DP=43	GT	0/1
chr3	63898180	63898180	G	T	intronic	ATXN7	.	.	.	0.928556028	0.071440779	3.19E-06	DISEASE: Spinocerebellar ataxia 7 (SCA7) [MIM:164500]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA7 belongs to the autosomal dominant cerebellar ataxias type II (ADCA II) which are characterized by cerebellar ataxia with retinal degeneration and pigmentary macular dystrophy. {ECO:0000269|PubMed:9288099}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40116	0.43982	0.205769367	67.49823071	3924.42931	12.38246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	133	chr3	63898180	chr3:63898180	G	T	109	PASS	AN=2;DP=133	GT	0/1
chr3	73432720	73432720	C	T	exonic	PDZRN3	.	synonymous SNV	PDZRN3:NM_001303139:exon8:c.G2091A:p.R697R,PDZRN3:NM_001303140:exon8:c.G1968A:p.R656R,PDZRN3:NM_001303141:exon8:c.G2163A:p.R721R,PDZRN3:NM_001303142:exon8:c.G2148A:p.R716R,PDZRN3:NM_015009:exon10:c.G2997A:p.R999R	0.908376144	0.091617814	6.04E-06	.	0.4722	0.13321	-0.990222991	8.634111819	1513.34426	7.23005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	113	chr3	73432720	chr3:73432720	C	T	95	PASS	AN=2;DP=113	GT	0/1
chr3	88101443	88101443	C	A	UTR3	CGGBP1	NM_003663:c.*3180G>T;NM_001195308:c.*3180G>T;NM_001008390:c.*3180G>T	.	.	0.777631518	0.215081104	0.007287378	.	0.22371	0.11109	0.013025609	54.62962963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	39	chr3	88101443	chr3:88101443	C	A	65	PASS	AN=2;DP=39	GT	0/1
chr3	100468103	100468103	-	TGAGTGATTTTCCTTCTCAGATAAAAGGTATAGTTGATT	downstream	ABI3BP;TFG	dist=76	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	48	chr3	100468103	chr3:100468103	G	GTGAGTGATTTTCCTTCTCAGATAAAAGGTATAGTTGATT	110	PASS	AN=2;DP=48	GT	0/1
chr3	101006886	101006886	C	A	intronic	IMPG2	.	.	.	1.47E-08	0.997551473	0.002448512	DISEASE: Retinitis pigmentosa 56 (RP56) [MIM:613581]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:20673862}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular dystrophy, vitelliform, 5 (VMD5) [MIM:616152]: A form of macular dystrophy, a retinal disease in which various forms of deposits, pigmentary changes, and atrophic lesions are observed in the macula lutea. Vitelliform macular dystrophies are characterized by yellow, lipofuscin-containing deposits, usually localized at the center of the macula. VMD5 features include late- onset moderate visual impairment and preservation of retinal pigment epithelium reflectivity. {ECO:0000269|PubMed:20673862, ECO:0000269|PubMed:25085631}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11371	0.11319	-0.837696902	11.45317292	209.43193	3.12459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	148	chr3	101006886	chr3:101006886	C	A	.	PASS	AN=0;DP=148	GT	0/1
chr3	105470244	105470244	C	G	intronic	CBLB	.	.	.	0.913125167	0.086874824	8.83E-09	.	0.48496	0.38173	-0.839512508	11.40009436	332.72726	3.87692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	24	chr3	105470244	chr3:105470244	C	G	56	PASS	AN=2;DP=24	GT	0/1
chr3	113236435	113236435	T	C	intergenic	SPICE1;SIDT1	dist=2401;dist=14783	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	106	chr3	113236435	chr3:113236435	T	C	71	PASS	AN=2;DP=106	GT	0/1
chr3	116163752	116163752	C	T	exonic	LSAMP	.	nonsynonymous SNV	LSAMP:NM_001318915:exon1:c.G127A:p.V43M,LSAMP:NM_002338:exon1:c.G127A:p.V43M	0.946283747	0.053678415	3.78E-05	.	0.72117	0.19389	0.03689118	56.64071715	22.84835	0.76216	0.001	0.912	D	0.984	0.899	D	0.738	0.774	P	0.004	0.344	N	0.832	0.355	D	3.89	0.961	H	-0.63	0.720	T	-1.81	0.473	N	0.461	0.525	0.552	0.913	D	0.597	0.856	D	0.105	0.780	D	6.619	0.909	32	0.999	0.966	0.862	0.451	D	c	0.768	0.692	1.000	0.747	0.652	0.477	0	4.47	0.536	5.574	0.669	0.932	0.445	1.000	0.715	1.000	0.888	16.369	0.831	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	111	chr3	116163752	chr3:116163752	C	T	.	PASS	AN=0;DP=111	GT	0/1
chr3	119533787	119533787	C	-	intronic	NR1I2	.	.	.	0.000129417	0.846347083	0.1535235	.	0.4518	0.65028	-0.552898813	19.86317528	99.56266	2.15923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	70	chr3	119533786	chr3:119533786	TC	T	102	PASS	AN=2;DP=70	GT	0/1
chr3	122255139	122255139	C	A	exonic	PARP9	.	nonsynonymous SNV	PARP9:NM_001146102:exon10:c.G2061T:p.K687N,PARP9:NM_001146103:exon10:c.G1956T:p.K652N,PARP9:NM_001146104:exon10:c.G1956T:p.K652N,PARP9:NM_001146105:exon10:c.G1956T:p.K652N,PARP9:NM_001146106:exon10:c.G1956T:p.K652N,PARP9:NM_031458:exon10:c.G2061T:p.K687N	5.14E-06	0.963727364	0.036267496	DISEASE: Note=Overexpressed at significantly higher levels in fatal high-risk diffuse large B-cell lymphomas (DLB-CL) compared to cured low-risk tumors. Overexpression in B-cell lymphoma transfectants may promote malignant B-cell migration. May therefore be involved in promoting B-cell migration and dissemination of high-risk DLB-CL tumors (PubMed:11110709). {ECO:0000269|PubMed:11110709}.; 	0.06342	0.08152	-0.394936437	27.02878037	529.88765	4.69811	0.004	0.682	D	1.0	0.899	D	0.992	0.971	D	0.002	0.370	N	0.965	0.408	D	3.75	0.951	H	2.05	0.315	T	-4.5	0.781	D	0.538	0.597	-0.690	0.610	T	0.202	0.560	T	0.014	0.346	T	6.051	0.833	28.0	0.998	0.900	0.875	0.467	D	c	0.597	0.494	0.999	0.392	0.707	0.730	0	5.37	0.769	1.494	0.350	0.935	0.490	0.995	0.385	0.999	0.750	9.963	0.407	Poly(ADP-ribose) polymerase, catalytic domain	.	.	0.5	.	38	chr3	122255139	chr3:122255139	C	A	.	PASS	AN=0;DP=38	GT	0/1
chr3	125648158	125648158	G	T	ncRNA_exonic	FAM86JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	145	chr3	125648158	chr3:125648158	G	T	.	PASS	AN=0;DP=145	GT	0/1
chr3	126229438	126229438	C	A	intronic	UROC1	.	.	.	3.36E-10	0.734541324	0.265458675	DISEASE: Urocanase deficiency (UROCD) [MIM:276880]: An inborn error of histidine metabolism resulting in urocanic aciduria and neurological manifestations including mental retardation, ataxia, episodic aggressive behavior or exaggerated affection-seeking. {ECO:0000269|PubMed:19304569}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10659	0.13811	0.319642692	72.82967681	647.41865	5.10863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	81	chr3	126229438	chr3:126229438	C	A	.	PASS	AN=0;DP=81	GT	0/1
chr3	127964353	127964353	G	A	intronic	EEFSEC	.	.	.	0.013115288	0.954167067	0.032717646	.	0.26555	0.26974	-0.376526807	28.10804435	263.47872	3.48275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	chr3	127964353	chr3:127964353	G	A	.	PASS	AN=0;DP=37	GT	0/1
chr3	131101931	131101931	C	G	intronic	NUDT16	.	.	.	0.001460676	0.436410802	0.562128522	.	0.22475	.	.	.	161.74115	2.77897	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	46	chr3	131101931	chr3:131101931	C	G	82	PASS	AN=2;DP=46	GT	1/0
chr3	133614314	133614314	G	T	UTR5	RAB6B	NM_016577:c.-4C>A	.	.	0.893311149	0.106470904	0.000217948	.	0.70633	0.14229	0.014844891	54.94810097	3.08689	0.1111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	102	chr3	133614314	chr3:133614314	G	T	.	PASS	AN=0;DP=102	GT	0/1
chr3	138362810	138362810	T	-	intergenic	FAIM;PIK3CB	dist=10597;dist=8730	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	137	chr3	138362809	chr3:138362809	CT	C	81	PASS	AN=2;DP=137	GT	0/1
chr3	142546542	142546543	GC	-	intronic	PCOLCE2	.	.	.	6.88E-07	0.700523665	0.299475647	.	0.14001	0.08463	0.066214104	58.95848077	517.122	4.64926	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	50	chr3	142546541	chr3:142546541	GGC	G	117	PASS	AN=2;DP=50	GT	0/1
chr3	145841052	145841052	C	G	intronic	PLOD2	.	.	.	0.00117484	0.998744975	8.02E-05	DISEASE: Note=PLOD2 mutations give rise to a broad variety of phenotypes with variable degrees of severity of bone fragility and joint contractures. Disease-associated mutations have been found in patients with autosomal recessive osteogenesis imperfecta (AR- OI) (PubMed:22689593). {ECO:0000269|PubMed:22689593}.; 	0.65048	0.12778	0.112125503	62.09601321	137.52121	2.55175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	88	chr3	145841052	chr3:145841052	C	G	109	PASS	AN=2;DP=88	GT	1/0
chr3	157213185	157213185	T	C	UTR5	VEPH1	NM_024621:c.-47A>G;NM_001167911:c.-47A>G;NM_001167912:c.-47A>G;NM_001167916:c.-47A>G;NM_001167915:c.-47A>G;NM_001167917:c.-47A>G	.	.	9.33E-12	0.260769387	0.739230613	.	0.16283	0.09703	1.071061453	91.69025714	3650.39187	11.74053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	16	chr3	157213185	chr3:157213185	T	C	.	PASS	AN=0;DP=16	GT	0/1
chr3	180559378	180559378	T	C	ncRNA_intronic	LOC101928882	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	56	chr3	180559378	chr3:180559378	T	C	95	PASS	AN=2;DP=56	GT	0/1
chr3	182897192	182897192	C	G	exonic	MCF2L2	.	synonymous SNV	MCF2L2:NM_015078:exon30:c.G3321C:p.P1107P	1.61E-12	0.999318945	0.000681055	.	0.57276	0.09212	0.854236942	88.51144138	3783.20077	12.04253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	66	chr3	182897192	chr3:182897192	C	G	92	PASS	AN=2;DP=66	GT	0/1
chr3	183210014	183210014	C	A	exonic	KLHL6	.	nonsynonymous SNV	KLHL6:NM_130446:exon7:c.G1567T:p.G523W	3.43E-06	0.797610641	0.202385932	.	0.22527	0.11012	-0.907472583	10.07313046	190.44155	2.99478	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.04	0.971	H	-3.47	0.945	D	-6.35	0.910	D	0.98	0.982	1.074	0.987	D	0.935	0.979	D	0.441	0.942	D	6.806	0.925	32	0.995	0.671	0.997	0.986	D	c	0.873	0.780	1.000	0.747	0.707	0.730	0	5.53	0.825	7.376	0.788	0.892	0.403	1.000	0.715	0.234	0.225	19.448	0.948	Kelch-type beta propeller	.	.	0.5	.	69	chr3	183210014	chr3:183210014	C	A	.	PASS	AN=0;DP=69	GT	0/1
chr3	183681309	183681309	T	C	exonic	ABCC5	.	nonsynonymous SNV	ABCC5:NM_001320032:exon15:c.A683G:p.Y228C,ABCC5:NM_005688:exon15:c.A2099G:p.Y700C	0.896205135	0.103794865	2.35E-11	.	0.38723	0.35905	-1.967739992	1.816466148	80.81009	1.89955	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.185	0.615	M	-1.93	0.849	D	-8.67	0.976	D	0.96	0.964	0.612	0.921	D	0.739	0.911	D	0.496	0.951	D	5.844	0.800	27.3	0.999	0.940	0.983	0.816	D	c	0.803	0.788	1.000	0.747	0.732	0.924	0	5.7	0.886	7.658	0.826	1.061	0.807	1.000	0.715	0.972	0.466	15.968	0.797	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	135	112	chr3	183681309	chr3:183681309	T	C	135	PASS	AN=2;DP=112	GT	1/0
chr3	183911026	183911026	A	T	intronic	ABCF3	.	.	.	0.004026166	0.995906699	6.71E-05	.	0.57953	0.15513	-0.771553417	13.15168672	319.46185	3.79528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	chr3	183911026	chr3:183911026	A	T	.	PASS	AN=0;DP=61	GT	0/1
chr3	186358318	186358318	G	T	exonic	FETUB	.	nonsynonymous SNV	FETUB:NM_001308077:exon1:c.G69T:p.Q23H,FETUB:NM_001308079:exon1:c.G69T:p.Q23H,FETUB:NM_014375:exon1:c.G69T:p.Q23H	6.88E-05	0.732564853	0.26736631	.	0.02716	.	0.621009802	83.41589998	583.45117	4.89852	0.226	0.245	T	0.641	0.385	P	0.275	0.383	B	0.000	0.003	N	1	0.090	N	0.805	0.203	L	0.93	0.441	T	-1.23	0.322	N	0.069	0.114	-1.064	0.109	T	0.071	0.289	T	0.010	0.262	T	-1.031	0.031	0.014	0.949	0.252	0.074	0.133	N	c	-1.190	-1.264	1.000	0.747	0.497	0.185	0	-0.705	0.106	-0.098	0.109	-0.443	0.057	0.000	0.063	0.000	0.016	2.956	0.055	Cystatin domain	.	.	0.5	.	48	chr3	186358318	chr3:186358318	G	T	.	PASS	AN=0;DP=48	GT	0/1
chr3	188592084	188592084	C	A	intronic	LPP	.	.	.	0.582399908	0.417507007	9.31E-05	DISEASE: Note=A chromosomal aberration involving LPP is associated with pulmonary chondroid hamartomas. Translocation t(3;12)(q27- q28;q14-q15) with HMGA2 is detected in pulmonary chondroid hamartomas.; DISEASE: Note=A chromosomal aberration involving LPP is associated with parosteal lipomas. Translocation t(3;12)(q28;q14) with HMGA2 is also shown in one parosteal lipoma.; DISEASE: Note=A chromosomal aberration involving LPP is associated with acute monoblastic leukemia. Translocation t(3;11)(q28;q23) with KMT2A/MLL1 is associated with acute monoblastic leukemia.; 	0.24469	0.15914	1.050838371	91.36588818	2291.9413	8.8632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	chr3	188592084	chr3:188592084	C	A	.	PASS	AN=0;DP=39	GT	0/1
chr3	195977188	195977188	T	C	intronic	PCYT1A	.	.	.	0.098300076	0.90012567	0.001574255	DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]: A disorder characterized by postnatal growth deficiency resulting in profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75481	.	-0.846787714	11.05803255	78.82184	1.87555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	116	chr3	195977188	chr3:195977188	T	C	92	PASS	AN=2;DP=116	GT	0/1
chr3	196529978	196529978	C	T	exonic	PAK2	.	synonymous SNV	PAK2:NM_002577:exon4:c.C379T:p.L127L	0.938688564	0.06130927	2.17E-06	.	0.8063	0.27444	-0.339715008	30.06605331	12.07124	0.43719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	27	chr3	196529978	chr3:196529978	C	T	65	PASS	AN=2;DP=27	GT	0/1
chr3	197610474	197610474	G	T	intergenic	LRCH3;IQCG	dist=12018;dist=5472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	85	chr3	197610474	chr3:197610474	G	T	86	PASS	AN=2;DP=85	GT	0/1
chr4	59454	59454	G	T	splicing	ZNF718	NM_001039127:exon2:c.133+2G>T;NM_001289931:exon2:c.37+2G>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	144	chr4	59454	chr4:59454	G	T	.	PASS	AN=0;DP=144	GT	0/1
chr4	7064140	7064140	C	T	exonic	GRPEL1	.	synonymous SNV	GRPEL1:NM_025196:exon3:c.G279A:p.Q93Q	0.896268186	0.102748808	0.000983006	.	0.19622	0.11034	0.170987912	65.5579146	184.97165	2.95207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	56	chr4	7064140	chr4:7064140	C	T	51	PASS	AN=2;DP=56	GT	0/1
chr4	13543752	13543752	G	T	exonic	NKX3-2	.	nonsynonymous SNV	NKX3-2:NM_001189:exon2:c.C867A:p.D289E	0.058492521	0.713863808	0.227643671	.	0.28515	0.14063	.	.	66.07302	1.67505	0.034	0.440	D	0.999	0.764	D	0.82	0.573	P	0.000	0.843	D	1.000	0.588	D	1.87	0.498	L	-2.77	0.909	D	-3.32	0.660	D	0.402	0.461	0.320	0.879	D	0.712	0.901	D	0.291	0.906	D	5.910	0.811	27.5	0.997	0.813	0.913	0.529	D	c	0.381	0.323	1.000	0.747	0.598	0.340	0	2.01	0.254	0.874	0.275	0.974	0.594	0.996	0.391	1.000	0.888	4.013	0.090	.	.	.	0.5	.	163	chr4	13543752	chr4:13543752	G	T	.	PASS	AN=0;DP=163	GT	0/1
chr4	17803853	17803853	G	A	UTR3	DCAF16	NM_017741:c.*1261C>T;NM_001345880:c.*1261C>T;NM_001345882:c.*1261C>T;NM_001345884:c.*1261C>T;NM_001345885:c.*1261C>T;NM_001345881:c.*1261C>T	.	.	0.00409866	0.653830628	0.342070712	.	0.21551	.	0.12689526	63.00424628	335.32468	3.8905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	98	chr4	17803853	chr4:17803853	G	A	70	PASS	AN=2;DP=98	GT	0/1
chr4	21305358	21305358	C	A	intronic	KCNIP4	.	.	.	0.967714667	0.032233051	5.23E-05	.	0.37064	.	-0.339715008	30.06605331	5.58554	0.20809	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	chr4	21305358	chr4:21305358	C	A	.	PASS	AN=0;DP=20	GT	0/1
chr4	25315698	25315698	A	-	exonic	ZCCHC4	.	frameshift deletion	ZCCHC4:NM_001318148:exon2:c.158delA:p.E56Kfs*56,ZCCHC4:NM_024936:exon2:c.158delA:p.E56Kfs*56	3.22E-05	0.986356163	0.013611642	.	0.1632	0.09095	1.798708763	96.91554612	690.84581	5.24094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.89	36	chr4	25315697	chr4:25315697	CA	C	11.89	PASS	AN=0;DP=36	GT	0/1
chr4	37974182	37974182	G	A	intronic	TBC1D1	.	.	.	3.94E-08	0.9998784	0.00012156	.	0.16285	0.20642	0.009173042	54.15782024	2012.94334	8.2609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	chr4	37974182	chr4:37974182	G	A	.	PASS	AN=0;DP=46	GT	0/1
chr4	38937317	38937317	T	-	intronic	FAM114A1	.	.	.	2.38E-08	0.457538177	0.542461799	.	0.11964	.	0.358272123	74.66383581	2541.88338	9.41853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	18	chr4	38937316	chr4:38937316	CT	C	44	PASS	AN=2;DP=18	GT	0/1
chr4	47706240	47706240	A	-	intronic	CORIN	.	.	.	6.35E-20	0.011817234	0.988182766	DISEASE: Pre-eclampsia/eclampsia 5 (PEE5) [MIM:614595]: A hypertensive disorder of pregnancy characterized by new hypertension (blood pressure 140/90 or greater) presenting after 20 weeks' gestation with clinically relevant proteinuria. It impacts 2 individuals, the mother and her child, both of whom can be severely affected. Preeclampsia is one of the causes of maternal mortality and morbidity worldwide. {ECO:0000269|PubMed:22437503}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12664	.	-0.145152788	42.33899505	519.7225	4.65704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	51	chr4	47706239	chr4:47706239	GA	G	54	PASS	AN=2;DP=51	GT	0/1
chr4	62410161	62410161	A	G	intronic	ADGRL3	.	.	.	.	.	.	.	0.16776	0.14106	-0.369255208	28.25548478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	48	chr4	62410161	chr4:62410161	A	G	70	PASS	AN=2;DP=48	GT	0/1
chr4	76787418	76787418	A	T	exonic	PPEF2	.	nonsynonymous SNV	PPEF2:NM_006239:exon15:c.T1844A:p.V615E	7.34E-10	0.869787638	0.130212361	.	0.37944	0.08962	1.164733225	92.65746638	2139.83122	8.51045	0.005	0.632	D	0.963	0.537	D	0.642	0.503	P	0.000	0.537	D	0.924	0.368	D	2.95	0.852	M	0.84	0.475	T	-4.43	0.775	D	0.788	0.779	-0.589	0.653	T	0.195	0.549	T	0.054	0.659	D	5.948	0.817	27.6	0.984	0.409	0.927	0.561	D	c	0.451	0.424	0.988	0.314	0.554	0.246	0	4.67	0.579	3.858	0.554	1.140	0.893	1.000	0.715	0.987	0.523	12.130	0.531	EF-hand domain pair	.	.	0.5	86	70	chr4	76787418	chr4:76787418	A	T	86	PASS	AN=2;DP=70	GT	0/1
chr4	79754716	79754716	-	T	intronic	BMP2K	.	.	.	0.001916525	0.99804383	3.96E-05	.	0.78082	.	0.273728691	70.74781788	1787.12697	7.80244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	23	chr4	79754716	chr4:79754716	A	AT	60	PASS	AN=2;DP=23	GT	0/1
chr4	82377924	82377924	-	A	exonic	RASGEF1B	.	frameshift insertion	RASGEF1B:NM_001300736:exon3:c.195dupT:p.A66Cfs*17,RASGEF1B:NM_001300735:exon4:c.318dupT:p.A107Cfs*17,RASGEF1B:NM_152545:exon4:c.318dupT:p.A107Cfs*17	0.488529662	0.511430599	3.97E-05	.	0.62004	0.10842	-0.514264485	21.41424864	73.40783	1.79055	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	32.17	26	chr4	82377924	chr4:82377924	C	CA	32.17	PASS	AN=0;DP=26	GT	0/1
chr4	85166011	85166011	C	A	ncRNA_intronic	LOC101928978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	57	chr4	85166011	chr4:85166011	C	A	64	PASS	AN=2;DP=57	GT	0/1
chr4	103534741	103534741	A	-	intronic	NFKB1	.	.	.	0.994260375	0.005739624	1.26E-09	.	0.93844	0.94648	-0.483123186	22.78249587	84.42133	1.95667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	44	chr4	103534740	chr4:103534740	TA	T	39	PASS	AN=2;DP=44	GT	0/1
chr4	111482530	111482530	G	T	intronic	ENPEP	.	.	.	3.58E-19	0.016944416	0.983055584	.	0.21927	0.47886	0.385781814	75.678226	422.73046	4.29372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	chr4	111482530	chr4:111482530	G	T	.	PASS	AN=0;DP=23	GT	0/1
chr4	120986916	120986916	G	A	exonic	MAD2L1	.	nonsynonymous SNV	MAD2L1:NM_002358:exon2:c.C131T:p.T44I	0.013167455	0.861483837	0.125348708	.	0.99211	0.15588	0.03689118	56.64071715	19.38659	0.66662	0.017	0.512	D	0.986	0.657	D	0.951	0.672	D	0.000	0.843	D	1	0.810	D	2.405	0.698	M	.	.	.	-3.54	0.686	D	0.789	0.784	-0.373	0.729	T	0.381	0.738	T	0.010	0.267	T	3.706	0.502	23.3	0.998	0.854	0.942	0.603	D	c	0.749	0.729	1.000	0.747	0.628	0.401	0	4.78	0.605	9.498	0.969	1.048	0.713	1.000	0.715	0.995	0.604	18.181	0.897	HORMA domain	.	.	0.5	.	31	chr4	120986916	chr4:120986916	G	A	.	PASS	AN=0;DP=31	GT	0/1
chr4	140036425	140036425	-	G	intronic	ELF2	.	.	.	0.985385387	0.014613112	1.50E-06	.	0.19471	0.14089	0.52918614	80.81505072	355.52103	3.99118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	73	chr4	140036425	chr4:140036425	C	CG	42	PASS	AN=2;DP=73	GT	0/1
chr4	141383166	141383166	T	A	intronic	MGAT4D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	chr4	141383166	chr4:141383166	T	A	.	PASS	AN=0;DP=69	GT	0/1
chr4	143000716	143000716	G	T	intronic	INPP4B	.	.	.	0.99861101	0.00138899	8.00E-12	.	0.04918	0.1047	-0.440847477	24.59896202	99.84144	2.16508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	chr4	143000716	chr4:143000716	G	T	.	PASS	AN=0;DP=52	GT	0/1
chr4	143011461	143011461	T	-	intronic	INPP4B	.	.	.	0.99861101	0.00138899	8.00E-12	.	0.04918	0.1047	-0.440847477	24.59896202	99.84144	2.16508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	74	chr4	143011460	chr4:143011460	AT	A	59	PASS	AN=2;DP=74	GT	0/1
chr4	144465944	144465944	G	T	exonic	SMARCA5	.	nonsynonymous SNV	SMARCA5:NM_003601:exon17:c.G2227T:p.A743S	0.999999855	1.45E-07	9.54E-19	.	0.97888	0.36004	-0.979072682	8.752064166	9.86498	0.36124	1.0	0.010	T	0.06	0.217	B	0.101	0.292	B	0.000	0.843	D	1	0.810	D	0.75	0.191	N	-2.62	0.900	D	-0.64	0.187	N	0.685	0.692	-0.260	0.761	T	0.522	0.822	D	0.160	0.841	D	2.152	0.320	17.19	0.990	0.500	0.995	0.966	D	c	-0.020	0.238	1.000	0.747	0.707	0.730	0	5.8	0.921	9.896	0.986	1.048	0.713	1.000	0.715	0.997	0.653	20.058	0.977	ISWI, HAND domain	.	.	0.5	71	32	chr4	144465944	chr4:144465944	G	T	71	PASS	AN=2;DP=32	GT	1/0
chr4	146026683	146026683	A	G	intronic	ABCE1	.	.	.	0.999982597	1.74E-05	5.48E-13	.	0.54899	0.31462	-0.251530012	35.42108988	5.45332	0.20296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	46	chr4	146026683	chr4:146026683	A	G	60	PASS	AN=2;DP=46	GT	0/1
chr4	169315628	169315628	T	-	exonic	DDX60L	.	frameshift deletion	DDX60L:NM_001012967:exon28:c.3798delA:p.I1269Lfs*2,DDX60L:NM_001291510:exon28:c.3801delA:p.I1270Lfs*2,DDX60L:NM_001345927:exon28:c.3801delA:p.I1270Lfs*2	8.17E-30	0.000634233	0.999365767	.	0.07164	0.0727	2.618410593	98.77919321	7052.9357	17.9578	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	63	chr4	169315627	chr4:169315627	CT	C	88	PASS	AN=2;DP=63	GT	0/1
chr4	169315633	169315633	C	A	exonic	DDX60L	.	nonsynonymous SNV	DDX60L:NM_001012967:exon28:c.G3793T:p.V1265L,DDX60L:NM_001291510:exon28:c.G3796T:p.V1266L,DDX60L:NM_001345927:exon28:c.G3796T:p.V1266L	8.17E-30	0.000634233	0.999365767	.	0.07164	0.0727	2.618410593	98.77919321	7052.9357	17.9578	0.016	0.518	D	0.011	0.276	B	0.002	0.272	B	0.573	0.055	U	1	0.090	N	-0.5	0.026	N	1.01	0.411	T	0.58	0.026	N	0.103	0.195	-0.987	0.335	T	0.042	0.182	T	0.010	0.272	T	2.202	0.326	17.52	0.903	0.190	0.017	0.053	N	c	-1.307	-1.384	0.996	0.344	0.732	0.924	0	-5.29	0.025	-0.051	0.117	-0.340	0.072	0.012	0.185	0.002	0.062	7.514	0.266	Helicase, C-terminal|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	79	62	chr4	169315633	chr4:169315633	C	A	79	PASS	AN=2;DP=62	GT	0/1
chr5	10390429	10390429	T	-	intronic	MARCH6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	132	chr5	10390428	chr5:10390428	CT	C	70	PASS	AN=2;DP=132	GT	0/1
chr5	10397474	10397474	T	-	intronic	MARCH6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	61	chr5	10397473	chr5:10397473	CT	C	92	PASS	AN=2;DP=61	GT	0/1
chr5	24511520	24511520	G	T	exonic	CDH10	.	stopgain	CDH10:NM_001317224:exon5:c.C918A:p.Y306X,CDH10:NM_006727:exon6:c.C918A:p.Y306X	0.309152977	0.690814761	3.23E-05	.	0.42021	0.11113	-0.800872469	12.33191791	34.27199	1.04877	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.073	0.972	37	0.996	0.746	0.858	0.447	D	c	0.454	0.253	0.003	0.102	0.554	0.246	0	-0.294	0.121	1.501	0.351	0.067	0.174	1.000	0.715	0.999	0.750	10.529	0.440	Cadherin|Cadherin-like	.	.	0.5	.	54	chr5	24511520	chr5:24511520	G	T	.	PASS	AN=0;DP=54	GT	0/1
chr5	34930047	34930047	C	T	intronic	DNAJC21	.	.	.	1.45E-05	0.991233393	0.008752095	.	0.13651	0.10368	-0.154246007	42.22694032	118.51193	2.36941	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	301	chr5	34930047	chr5:34930047	C	T	.	PASS	AN=0;DP=301	GT	0/1
chr5	55042105	55042105	G	T	intronic	DDX4	.	.	.	0.998516038	0.001483962	4.64E-11	.	0.68619	0.10786	-0.310388054	32.14791224	861.19729	5.72325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	chr5	55042105	chr5:55042105	G	T	.	PASS	AN=0;DP=21	GT	0/1
chr5	61857068	61857068	C	G	exonic	IPO11	.	nonsynonymous SNV	IPO11:NM_001134779:exon27:c.C2686G:p.L896V,IPO11:NM_016338:exon27:c.C2566G:p.L856V	0.996456955	0.003543045	3.21E-12	.	0.69666	0.11055	-0.529034136	20.85987261	87.81015	2.0015	0.006	0.614	D	0.994	0.670	D	0.929	0.667	D	0.000	0.843	D	1.000	0.588	D	2.36	0.681	M	-0.92	0.751	T	-2.2	0.495	N	0.838	0.855	0.030	0.829	D	0.516	0.819	D	0.075	0.722	D	5.909	0.811	27.5	0.998	0.898	0.927	0.560	D	c	0.547	0.515	0.918	0.265	0.732	0.924	0	4.44	0.530	2.886	0.480	0.069	0.176	1.000	0.715	1.000	0.888	13.177	0.589	Armadillo-like helical|Armadillo-type fold;Armadillo-type fold	.	.	0.5	93	30	chr5	61857068	chr5:61857068	C	G	93	PASS	AN=2;DP=30	GT	0/1
chr5	64756006	64756006	C	T	exonic	ADAMTS6	.	nonsynonymous SNV	ADAMTS6:NM_197941:exon4:c.G622A:p.G208R	0.998800473	0.001199527	1.13E-12	.	0.4309	0.11953	-0.574945567	18.90186365	218.20018	3.19214	0.021	0.491	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	2.455	0.715	M	0.14	0.609	T	-3.74	0.710	D	0.864	0.858	-0.396	0.722	T	0.368	0.728	T	0.067	0.701	D	6.838	0.927	33	0.999	0.997	0.988	0.872	D	c	0.759	0.797	1.000	0.747	0.707	0.730	0	6.06	0.983	7.435	0.794	0.935	0.490	1.000	0.715	1.000	0.888	20.640	0.995	.	.	.	0.5	.	23	chr5	64756006	chr5:64756006	C	T	.	PASS	AN=0;DP=23	GT	0/1
chr5	65029420	65029420	G	T	intronic	NLN	.	.	.	3.60E-07	0.985541392	0.014458248	.	0.39163	0.14364	-0.354480518	29.42911064	1132.42209	6.4199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	112	chr5	65029420	chr5:65029420	G	T	93	PASS	AN=2;DP=112	GT	0/1
chr5	83402467	83402467	C	A	exonic	EDIL3	.	nonsynonymous SNV	EDIL3:NM_001278642:exon5:c.G621T:p.Q207H,EDIL3:NM_005711:exon6:c.G651T:p.Q217H	4.09E-05	0.990205567	0.009753556	.	0.47277	0.13726	-0.426079032	25.36565228	65.31372	1.66299	0.0	0.912	D	0.998	0.899	D	0.994	0.875	D	0.000	0.843	D	1	0.810	D	4.515	0.990	H	-5.16	0.988	D	-4.34	0.768	D	0.936	0.930	1.038	0.979	D	0.983	0.995	D	0.648	0.970	D	6.752	0.921	32	0.998	0.856	0.980	0.788	D	c	1.011	0.915	1.000	0.747	0.706	0.609	0	5.37	0.769	7.357	0.785	0.852	0.362	1.000	0.715	0.998	0.697	19.114	0.933	Coagulation factor 5/8 C-terminal domain|Galactose-binding domain-like	.	.	0.5	.	25	chr5	83402467	chr5:83402467	C	A	.	PASS	AN=0;DP=25	GT	0/1
chr5	86564459	86564459	G	T	exonic	RASA1	.	nonsynonymous SNV	RASA1:NM_002890:exon1:c.G191T:p.G64V	0.999998286	1.71E-06	7.92E-17	DISEASE: Note=Mutations in the SH2 domain of RASA seem to be oncogenic and cause basal cell carcinomas.; DISEASE: Capillary malformation-arteriovenous malformation (CMAVM) [MIM:608354]: A disorder characterized by atypical capillary malformations that are multiple, small, round to oval in shape and pinkish red in color. These capillary malformations are associated with either arteriovenous malformation, arteriovenous fistula, or Parkes Weber syndrome. {ECO:0000269|PubMed:14639529, ECO:0000269|PubMed:24038909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Parkes Weber syndrome (PKWS) [MIM:608355]: Disorder characterized by a cutaneous flush with underlying multiple micro- arteriovenous fistulas, in association with soft tissue and skeletal hypertrophy of the affected limb. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.71615	0.1353	-0.821100135	11.88369899	144.431	2.61738	0.01	0.564	D	0.889	0.469	P	0.238	0.368	B	0.239	0.036	N	0.995	0.426	D	0.695	0.181	N	-0.67	0.725	T	-0.43	0.144	N	0.453	0.511	-0.828	0.534	T	0.184	0.533	T	0.144	0.827	D	4.731	0.634	24.6	0.983	0.397	0.127	0.172	N	c	-0.132	-0.054	1.000	0.747	0.442	0.072	0	3.7	0.414	0.568	0.232	0.877	0.384	0.902	0.312	0.983	0.502	12.682	0.561	.	.	.	0.5	.	34	chr5	86564459	chr5:86564459	G	T	.	PASS	AN=0;DP=34	GT	0/1
chr5	89999592	89999592	G	T	exonic	ADGRV1	.	stopgain	ADGRV1:NM_032119:exon35:c.G8266T:p.G2756X	.	.	.	DISEASE: Usher syndrome 2C (USH2C) [MIM:605472]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:14740321, ECO:0000269|PubMed:22147658}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Febrile seizures, familial, 4 (FEB4) [MIM:604352]: Seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.07741	0.17025	8.124040712	99.95281906	.	.	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.580	0.999	51	0.990	0.505	0.994	0.960	D	c	1.211	1.057	1.000	0.747	0.554	0.246	0	5.15	0.702	9.222	0.943	1.048	0.713	1.000	0.715	0.877	0.367	18.825	0.920	Na-Ca exchanger/integrin-beta4	.	.	0.5	.	26	chr5	89999592	chr5:89999592	G	T	.	PASS	AN=0;DP=26	GT	0/1
chr5	118309599	118309599	G	A	intronic	DTWD2	.	.	.	2.16E-05	0.484452633	0.515525762	.	0.17158	0.1149	-0.448125345	24.19202642	92.81718	2.06998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	142	chr5	118309599	chr5:118309599	G	A	113	PASS	AN=2;DP=142	GT	0/1
chr5	122522921	122522921	G	C	UTR3	PRDM6	NM_001136239:c.*26G>C	.	.	.	.	.	.	0.32166	0.09864	.	.	3796.30099	12.08898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	97	chr5	122522921	chr5:122522921	G	C	72	PASS	AN=2;DP=97	GT	0/1
chr5	127872118	127872118	G	T	exonic	FBN2	.	nonsynonymous SNV	FBN2:NM_001999:exon2:c.C314A:p.P105H	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	0.001	0.784	D	0.999	0.764	D	0.935	0.653	D	0.000	0.629	D	1.000	0.810	D	1.78	0.463	L	-1.96	0.869	D	-4.83	0.925	D	0.729	0.731	0.262	0.869	D	0.632	0.871	D	0.066	0.699	D	5.064	0.682	25.2	0.997	0.831	0.959	0.665	D	c	0.540	0.639	1.0	0.983	0.726	0.872	0	5.32	0.753	9.898	0.986	1.048	0.713	1.000	0.715	0.999	0.750	19.186	0.936	.	.	.	0.5	.	84	chr5	127872118	chr5:127872118	G	T	.	PASS	AN=0;DP=84	GT	0/1
chr5	127872119	127872119	G	T	exonic	FBN2	.	nonsynonymous SNV	FBN2:NM_001999:exon2:c.C313A:p.P105T	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	0.066	0.365	T	0.208	0.282	B	0.068	0.262	B	0.000	0.629	D	1.000	0.588	D	1.32	0.331	L	-1.91	0.865	D	-4.1	0.860	D	0.708	0.716	-0.381	0.726	T	0.382	0.739	T	0.040	0.595	D	3.058	0.427	22.4	0.998	0.861	0.821	0.411	D	c	-0.104	0.122	1.000	0.747	0.726	0.872	0	5.32	0.753	2.895	0.481	1.048	0.713	1.000	0.715	0.998	0.697	13.803	0.625	.	.	.	0.5	.	84	chr5	127872119	chr5:127872119	G	T	.	PASS	AN=0;DP=84	GT	0/1
chr5	133307751	133307751	A	-	UTR3	VDAC1	NM_003374:c.*711delT	.	.	0.975595138	0.024378689	2.62E-05	.	.	.	-0.295622497	32.61972163	24.73819	0.81167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	14	chr5	133307750	chr5:133307750	GA	G	42	PASS	AN=2;DP=14	GT	0/1
chr5	133640116	133640199	TTTGACTGTATTGTGACAGGCAATTCTGGAAAATGGAATTCTTTCCTGTCAGATCTGGAAAAATTCAGCTTCCTTTTGTTCTCA	-	exonic	CDKL3	.	nonframeshift deletion	CDKL3:NM_001349366:exon6:c.633_716del:p.N211_S238del,CDKL3:NM_001349364:exon7:c.633_716del:p.N211_S238del,CDKL3:NM_001349365:exon7:c.633_716del:p.N211_S238del,CDKL3:NM_001349363:exon8:c.951_1034del:p.N317_S344del,CDKL3:NM_001300853:exon10:c.951_1034del:p.N317_S344del,CDKL3:NM_001113575:exon11:c.1518_1601del:p.N506_S533del	4.33E-07	0.600309182	0.399690385	.	0.18586	0.10438	0.328949044	73.41354093	99.29071	2.15668	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	17	chr5	133640115	chr5:133640115	TTTTGACTGTATTGTGACAGGCAATTCTGGAAAATGGAATTCTTTCCTGTCAGATCTGGAAAAATTCAGCTTCCTTTTGTTCTCA	T	40	PASS	AN=2;DP=17	GT	0/1
chr5	138718897	138718897	C	T	intronic	SLC23A1	.	.	.	0.024322306	0.972818626	0.002859068	.	0.15514	0.14852	0.266447942	70.5826846	399.62426	4.19635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	84	chr5	138718897	chr5:138718897	C	T	67	PASS	AN=2;DP=84	GT	0/1
chr5	140080299	140080299	G	T	intronic	ZMAT2	.	.	.	0.97143376	0.028527624	3.86E-05	.	0.64216	0.11262	-0.031067188	51.03798066	2.53643	0.09383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	chr5	140080299	chr5:140080299	G	T	.	PASS	AN=0;DP=36	GT	0/1
chr5	140201593	140201593	T	A	exonic	PCDHA5	.	nonsynonymous SNV	PCDHA5:NM_018908:exon1:c.T233A:p.L78Q,PCDHA5:NM_031501:exon1:c.T233A:p.L78Q	0.003538248	0.986919756	0.009541996	.	0.09837	.	0.100999032	60.76315169	773.98299	5.50488	0.037	0.430	D	0.899	0.475	P	0.59	0.486	P	.	.	.	1	0.810	D	1.725	0.447	L	1.17	0.379	T	-4.49	0.780	D	0.207	0.479	-0.972	0.369	T	0.107	0.389	T	0.053	0.654	D	4.407	0.590	24.1	0.992	0.538	0.397	0.260	N	c	-0.293	-0.357	0.374	0.199	0.517	0.208	0	2.83	0.320	-0.729	0.050	0.908	0.420	0.000	0.063	1.000	0.888	3.128	0.060	Cadherin|Cadherin, N-terminal|Cadherin-like	.	.	0.5	.	216	chr5	140201593	chr5:140201593	T	A	.	PASS	AN=0;DP=216	GT	0/1
chr5	147162132	147162132	-	T	UTR5	JAKMIP2	NM_014790:c.-110764_-110763insA;NM_001270934:c.-110764_-110763insA;NM_001282282:c.-112_-111insA;NM_001270941:c.-110764_-110763insA	.	.	0.999936528	6.35E-05	1.06E-13	.	0.66287	0.12537	-1.199555187	5.761972163	105.04961	2.21693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	120	chr5	147162132	chr5:147162132	G	GT	66	PASS	AN=2;DP=120	GT	0/1
chr5	148579955	148579955	G	A	exonic	ABLIM3	.	nonsynonymous SNV	ABLIM3:NM_001301015:exon4:c.G412A:p.A138T,ABLIM3:NM_001301028:exon4:c.G412A:p.A138T,ABLIM3:NM_001345861:exon4:c.G412A:p.A138T,ABLIM3:NM_001301018:exon5:c.G412A:p.A138T,ABLIM3:NM_001301027:exon5:c.G436A:p.A146T,ABLIM3:NM_001345858:exon5:c.G412A:p.A138T,ABLIM3:NM_001345859:exon5:c.G412A:p.A138T,ABLIM3:NM_001345860:exon5:c.G412A:p.A138T,ABLIM3:NM_014945:exon5:c.G412A:p.A138T	0.016025349	0.983972836	1.82E-06	.	0.44749	0.10843	-1.150005948	6.286860109	169.47144	2.84089	0.42	0.098	T	0.0	0.026	B	0.0	0.063	B	0.002	0.382	N	0.997	0.228	N	-0.41	0.029	N	1.01	0.411	T	-0.03	0.095	N	0.019	0.080	-1.024	0.224	T	0.032	0.139	T	0.005	0.112	T	1.796	0.277	14.96	0.946	0.246	0.611	0.311	D	c	-0.602	-0.377	1.000	0.458	0.646	0.442	0	2.54	0.295	2.231	0.424	-0.513	0.050	1.000	0.715	0.995	0.604	4.614	0.117	Zinc finger, LIM-type	.	.	0.5	.	48	chr5	148579955	chr5:148579955	G	A	.	PASS	AN=0;DP=48	GT	0/1
chr5	149678006	149678006	G	T	exonic	ARSI	.	nonsynonymous SNV	ARSI:NM_001012301:exon2:c.C481A:p.R161S	1.05E-09	0.089882668	0.910117331	.	0.1223	0.15805	-1.03976177	7.802547771	156.19896	2.73165	0.162	0.248	T	0.26	0.298	B	0.233	0.367	B	0.000	0.843	D	1	0.810	D	0.73	0.189	N	-3.93	0.961	D	-2.07	0.563	N	0.903	0.909	0.380	0.888	D	0.743	0.912	D	0.099	0.772	D	3.232	0.448	22.8	0.992	0.537	0.953	0.641	D	c	-0.022	0.130	1.000	0.747	0.615	0.372	0	4.58	0.559	4.886	0.626	0.953	0.551	1.000	0.715	0.998	0.697	17.591	0.878	Alkaline phosphatase-like, alpha/beta/alpha|Alkaline-phosphatase-like, core domain|Sulfatase, N-terminal	.	.	0.5	.	90	chr5	149678006	chr5:149678006	G	T	.	PASS	AN=0;DP=90	GT	0/1
chr5	154169883	154169883	A	G	splicing	LARP1	NM_015315:exon2:c.206-2A>G	.	.	0.999952189	4.78E-05	5.32E-14	.	0.27569	0.0905	-1.350267166	4.600141543	57.4938	1.52959	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.357	0.583	24.1	0.995	0.685	0.998	0.994	D	c	1.065	0.893	1.000	0.747	0.257	0.036	0	5.39	0.775	7.727	0.837	1.199	0.960	1.000	0.715	0.907	0.385	15.442	0.748	.	.	.	0.5	65	58	chr5	154169883	chr5:154169883	A	G	65	PASS	AN=2;DP=58	GT	0/1
chr5	167545508	167545508	C	T	intronic	TENM2	.	.	.	0.99995109	4.89E-05	9.42E-17	.	0.25516	.	.	.	688.9914	5.23649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	82	chr5	167545508	chr5:167545508	C	T	.	PASS	AN=0;DP=82	GT	0/1
chr5	168137995	168137995	C	A	exonic	SLIT3	.	nonsynonymous SNV	SLIT3:NM_001271946:exon25:c.G2624T:p.G875V,SLIT3:NM_003062:exon25:c.G2624T:p.G875V	0.991788384	0.008211616	4.20E-14	.	0.82846	0.13042	-2.196075097	1.374144845	779.81909	5.52544	0.015	0.546	D	0.981	0.577	D	0.938	0.656	D	0.000	0.843	D	1	0.810	D	2.075	0.572	M	-0.99	0.759	T	-5.58	0.867	D	0.854	0.888	0.185	0.857	D	0.561	0.841	D	0.097	0.767	D	6.759	0.922	32	0.998	0.882	0.975	0.747	D	c	0.699	0.649	0.999	0.399	0.554	0.283	0	4.8	0.610	4.939	0.630	0.935	0.490	1.000	0.715	0.986	0.517	18.416	0.905	Cysteine-rich flanking region, C-terminal|Leucine-rich repeat domain, L domain-like	.	.	0.5	.	113	chr5	168137995	chr5:168137995	C	A	.	PASS	AN=0;DP=113	GT	0/1
chr5	168201337	168201337	G	C	exonic	SLIT3	.	nonsynonymous SNV	SLIT3:NM_001271946:exon13:c.C1198G:p.Q400E,SLIT3:NM_003062:exon13:c.C1198G:p.Q400E	0.991788384	0.008211616	4.20E-14	.	0.82846	0.13042	-2.196075097	1.374144845	779.81909	5.52544	0.01	0.564	D	0.238	0.362	B	0.102	0.380	B	0.000	0.843	D	1.000	0.588	D	0.67	0.164	N	1.87	0.241	T	-1.46	0.358	N	0.54	0.701	-1.094	0.049	T	0.066	0.272	T	0.011	0.283	T	2.479	0.359	19.33	0.987	0.441	0.982	0.804	D	c	0.275	0.425	1.000	0.439	0.554	0.246	0	5.5	0.813	7.813	0.845	1.048	0.713	1.000	0.715	0.913	0.390	19.431	0.947	Leucine-rich repeat domain, L domain-like	.	.	0.5	96	81	chr5	168201337	chr5:168201337	G	C	96	PASS	AN=2;DP=81	GT	0/1
chr5	172578610	172578610	-	T	exonic	BNIP1	.	frameshift insertion	BNIP1:NM_013979:exon3:c.220dupT:p.K77fs*0,BNIP1:NM_013980:exon3:c.220dupT:p.K77fs*0	0.001436928	0.871526967	0.127036106	.	0.26308	0.14515	-0.115612493	45.12856806	26.59592	0.86174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	21	chr5	172578610	chr5:172578610	A	AT	41	PASS	AN=2;DP=21	GT	0/1
chr5	175957157	175957157	C	T	exonic	RNF44	.	synonymous SNV	RNF44:NM_014901:exon7:c.G852A:p.L284L	0.567929658	0.431553355	0.000516987	.	0.35919	.	-0.179930907	40.35739561	104.3157	2.20769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	chr5	175957157	chr5:175957157	C	T	.	PASS	AN=0;DP=51	GT	0/1
chr5	176636550	176636550	-	A	intronic	NSD1	.	.	.	0.999999999	8.21E-10	2.66E-26	DISEASE: Beckwith-Wiedemann syndrome (BWS) [MIM:130650]: A disorder characterized by anterior abdominal wall defects including exomphalos (omphalocele), pre- and postnatal overgrowth, and macroglossia. Additional less frequent complications include specific developmental defects and a predisposition to embryonal tumors. {ECO:0000269|PubMed:14997421}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving NSD1 is found in childhood acute myeloid leukemia. Translocation t(5;11)(q35;p15.5) with NUP98.; DISEASE: Note=A chromosomal aberration involving NSD1 is found in an adult form of myelodysplastic syndrome (MDS). Insertion of NUP98 into NSD1 generates a NUP98-NSD1 fusion product. {ECO:0000269|PubMed:15382262}.; 	0.66088	0.2415	-1.552781294	3.237791932	2326.46017	8.93558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	80	chr5	176636550	chr5:176636550	T	TA	58	PASS	AN=2;DP=80	GT	0/1
chr6	7410735	7410735	-	T	intronic	RIOK1	.	.	.	8.14E-07	0.909984901	0.090014285	.	0.07427	0.09451	0.778977686	87.21396556	153.59995	2.71046	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	15	chr6	7410735	chr6:7410735	G	GT	51	PASS	AN=2;DP=15	GT	0/1
chr6	25114003	25114003	T	C	ncRNA_exonic	CMAHP	.	.	.	.	.	.	.	0.1819	0.13388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	47	chr6	25114003	chr6:25114003	T	C	64	PASS	AN=2;DP=47	GT	0/1
chr6	27834598	27834598	C	A	UTR3	HIST1H1B	NM_005322:c.*29G>T	.	.	0.509138756	0.421807909	0.069053335	.	0.27585	0.20571	0.575097644	82.1656051	458.1171	4.44431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	chr6	27834598	chr6:27834598	C	A	.	PASS	AN=0;DP=43	GT	0/1
chr6	35263513	35263513	C	G	UTR3	ZNF76	NM_003427:c.*488C>G;NM_001292032:c.*488C>G	.	.	5.07E-16	0.006453546	0.993546454	.	0.26454	0.10496	0.404185162	76.48619958	1199.49311	6.56948	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	166	chr6	35263513	chr6:35263513	C	G	101	PASS	AN=2;DP=166	GT	0/1
chr6	42176568	42176568	C	A	intronic	MRPS10	.	.	.	0.028212146	0.922237701	0.049550153	.	0.19668	0.10229	-0.0274281	51.65723048	31.89637	1.00349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	chr6	42176568	chr6:42176568	C	A	.	PASS	AN=0;DP=45	GT	0/1
chr6	42625963	42625963	-	T	intronic	UBR2	.	.	.	0.99999988	1.20E-07	8.34E-24	.	0.72806	0.25871	-1.365077992	4.5175749	3342.51324	11.07201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	17	chr6	42625963	chr6:42625963	C	CT	41	PASS	AN=2;DP=17	GT	0/1
chr6	57393144	57393144	A	T	exonic	PRIM2	.	unknown	UNKNOWN	5.15E-08	0.39171957	0.608280379	.	0.89222	0.08308	.	.	55.84911	1.50063	.	.	.	0.134	0.257	B	0.091	0.284	B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.391	0.451	.	.	.	.	.	.	.	.	.	2.510	0.363	19.53	0.889	0.178	0.926	0.558	D	n	1.419	0.069	1.000	0.747	0.258	0.037	0	4.7	0.586	5.569	0.669	1.093	0.878	1.000	0.715	0.948	0.423	10.683	0.448	.	.	.	0.5	86	31	chr6	57393144	chr6:57393144	A	T	86	PASS	AN=2;DP=31	GT	0/1
chr6	71508548	71508548	C	G	intronic	SMAP1	.	.	.	0.983689233	0.016308801	1.97E-06	.	0.25151	.	-0.071520315	48.34866714	1636.02834	7.47505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	35	chr6	71508548	chr6:71508548	C	G	70	PASS	AN=2;DP=35	GT	1/0
chr6	102247559	102247559	G	A	exonic	GRIK2	.	nonsynonymous SNV	GRIK2:NM_001166247:exon7:c.G988A:p.V330M,GRIK2:NM_021956:exon7:c.G988A:p.V330M,GRIK2:NM_175768:exon7:c.G988A:p.V330M	0.994567954	0.005432045	1.10E-09	DISEASE: Mental retardation, autosomal recessive 6 (MRT6) [MIM:611092]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. In contrast to syndromic or specific mental retardation which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only primary symptom of non-syndromic mental retardation. MRT6 patients display mild to severe mental retardation and psychomotor development delay in early childhood. Patients do not have neurologic problems, congenital malformations, or facial dysmorphism. Body height, weight, and head circumference are normal. {ECO:0000269|PubMed:17847003}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.53627	.	-1.131590109	6.481481481	129.48869	2.48041	0.043	0.473	D	0.998	0.715	D	0.936	0.654	D	0.000	0.843	D	1.000	0.588	D	2.27	0.647	M	-1.63	0.825	D	-0.74	0.383	N	0.671	0.710	0.230	0.864	D	0.594	0.855	D	0.101	0.774	D	6.493	0.895	31	0.999	0.982	0.991	0.912	D	c	0.794	0.811	1.000	0.747	0.554	0.283	0	5.44	0.793	9.602	0.976	1.048	0.713	1.000	0.715	1.000	0.888	19.253	0.939	Periplasmic binding protein-like I|Receptor, ligand binding region	.	.	0.5	.	48	chr6	102247559	chr6:102247559	G	A	.	PASS	AN=0;DP=48	GT	0/1
chr6	111696681	111696681	G	C	exonic	REV3L	.	synonymous SNV	REV3L:NM_002912:exon14:c.C2877G:p.L959L,REV3L:NM_001286432:exon15:c.C2643G:p.L881L,REV3L:NM_001286431:exon16:c.C2643G:p.L881L	1	6.81E-14	7.45E-35	.	0.85968	0.1947	-2.097226344	1.551073366	1709.50934	7.62408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	39	chr6	111696681	chr6:111696681	G	C	53	PASS	AN=2;DP=39	GT	0/1
chr6	123696766	123696766	G	C	exonic	TRDN	.	nonsynonymous SNV	TRDN:NM_001251987:exon19:c.C1260G:p.D420E,TRDN:NM_006073:exon19:c.C1257G:p.D419E	1.82E-10	0.82694144	0.17305856	DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness (CPVT5) [MIM:615441]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, or sudden death after physical activity or emotional stress. Some patients have muscle weakness. {ECO:0000269|PubMed:22422768}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18235	0.15914	1.976952171	97.61146497	4408.1144	13.27537	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.327	0.142	N	1.000	0.090	P	-0.805	0.016	N	2.57	0.136	T	0.22	0.047	N	0.027	0.009	-0.910	0.469	T	0.004	0.012	T	0.018	0.402	T	0.655	0.156	8.529	0.298	0.016	0.425	0.267	N	c	-1.057	-0.785	0.000	0.052	0.487	0.133	0	4.14	0.477	0.616	0.239	-0.339	0.072	1.000	0.715	0.987	0.523	9.685	0.391	.	.	.	0.5	75	34	chr6	123696766	chr6:123696766	G	C	75	PASS	AN=2;DP=34	GT	1/0
chr6	124721526	124721526	C	A	intronic	NKAIN2	.	.	.	0.007832385	0.928062091	0.064105523	.	0.35628	.	-0.163345027	41.24793583	15.60658	0.55645	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	chr6	124721526	chr6:124721526	C	A	.	PASS	AN=0;DP=28	GT	0/1
chr6	144081696	144081696	A	-	exonic	PHACTR2	.	frameshift deletion	PHACTR2:NM_001100164:exon5:c.613delA:p.N207Ifs*79,PHACTR2:NM_014721:exon5:c.580delA:p.N196Ifs*79	0.007389423	0.992472999	0.000137578	.	0.7271	0.09166	-0.045835247	50.34206181	1505.57685	7.21249	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	41	chr6	144081695	chr6:144081695	TA	T	39	PASS	AN=2;DP=41	GT	0/1
chr6	152422082	152422082	C	T	UTR3	ESR1	NM_001122742:c.*1981C>T;NM_001291230:c.*1981C>T;NM_001122741:c.*1981C>T;NM_001291241:c.*1981C>T;NM_001122740:c.*1981C>T;NM_000125:c.*1981C>T	.	.	0.987167021	0.012831888	1.09E-06	DISEASE: Estrogen resistance (ESTRR) [MIM:615363]: A disorder characterized by partial or complete resistance to estrogens, in the presence of elevated estrogen serum levels. Clinical features include absence of the pubertal growth spurt, delayed bone maturation, unfused epiphyses, reduced bone mineral density, osteoporosis, continued growth into adulthood and very tall adult stature. Glucose intolerance, hyperinsulinemia and lipid abnormalities may also be present. {ECO:0000269|PubMed:23841731, ECO:0000269|PubMed:8961262}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99765	0.95064	0.242582624	69.45623968	148.46269	2.6565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	17	chr6	152422082	chr6:152422082	C	T	41	PASS	AN=2;DP=17	GT	0/1
chr6	168355107	168355107	-	T	intronic	AFDN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	28	chr6	168355107	chr6:168355107	C	CT	40	PASS	AN=2;DP=28	GT	0/1
chr7	3991295	3991295	T	G	intronic	SDK1	.	.	.	0.005015997	0.994984003	2.78E-11	.	0.23874	0.11227	-4.629838752	0.076669026	1933.799	8.09023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	chr7	3991295	chr7:3991295	T	G	.	PASS	AN=0;DP=24	GT	0/1
chr7	4843227	4843227	C	A	exonic	RADIL	.	nonsynonymous SNV	RADIL:NM_018059:exon11:c.G2449T:p.G817C	1.31E-12	0.089137837	0.910862163	.	.	.	0.236922632	68.73083274	3259.52862	10.87748	0.016	0.518	D	0.989	0.637	D	0.584	0.559	P	0.736	0.064	N	1	0.090	N	0.69	0.170	N	3.33	0.062	T	-1.68	0.401	N	0.25	0.305	-1.030	0.203	T	0.019	0.080	T	0.045	0.621	D	4.241	0.568	23.9	0.988	0.468	0.022	0.064	N	c	-0.880	-1.102	0.005	0.108	0.646	0.450	0	-1.01	0.096	-1.559	0.022	-0.823	0.031	0.000	0.063	0.016	0.126	2.796	0.050	.	.	.	0.5	.	79	chr7	4843227	chr7:4843227	C	A	.	PASS	AN=0;DP=79	GT	0/1
chr7	5662432	5662432	C	T	UTR3	RNF216	NM_207116:c.*59G>A;NM_207111:c.*59G>A	.	.	0.409334345	0.590665052	6.03E-07	DISEASE: Gordon Holmes syndrome (GDHS) [MIM:212840]: A disease characterized by cerebellar symptoms and signs of sex steroid deficiency. Clinical features include cerebellar and brain stem atrophy, cerebellar ataxia, hypothalamic LHRH deficiency, hypogonadotrophic hypogonadism, lack of secondary sexual characteristics, and infertility. {ECO:0000269|PubMed:23656588}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12144	0.08992	-1.188670131	5.891719745	131.90997	2.5009	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	113	chr7	5662432	chr7:5662432	C	T	86	PASS	AN=2;DP=113	GT	0/1
chr7	11091407	11091407	G	A	exonic	PHF14	.	synonymous SNV	PHF14:NM_014660:exon14:c.G2481A:p.T827T	0.20653924	0.793444436	1.63E-05	.	0.53698	0.10653	-0.532670911	20.78320359	132.45351	2.50445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	63	chr7	11091407	chr7:11091407	G	A	71	PASS	AN=2;DP=63	GT	0/1
chr7	19748658	19748658	C	A	UTR5	TWISTNB	NM_001002926:c.-19G>T	.	.	0.309424388	0.672567774	0.018007838	.	0.14338	0.12628	-0.404032746	26.53338051	60.1892	1.57562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	100	chr7	19748658	chr7:19748658	C	A	.	PASS	AN=0;DP=100	GT	0/1
chr7	29771637	29771637	C	A	intergenic	DPY19L2P3;WIPF3	dist=43778;dist=74533	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	chr7	29771637	chr7:29771637	C	A	.	PASS	AN=0;DP=49	GT	0/1
chr7	30795291	30795291	G	T	exonic	INMT	.	nonsynonymous SNV	INMT:NM_001199219:exon3:c.G613T:p.V205L,INMT:NM_006774:exon3:c.G616T:p.V206L	0.000120278	0.385695	0.614184722	.	0.10895	0.11082	1.976952171	97.61146497	4681.43934	13.79634	0.009	0.574	D	0.986	0.596	D	0.874	0.603	P	0.003	0.355	N	0.909	0.364	D	1.91	0.513	L	3.92	0.035	T	-2.07	0.473	N	0.284	0.420	-1.073	0.088	T	0.023	0.100	T	0.002	0.050	T	4.535	0.607	24.3	0.994	0.604	0.773	0.377	D	c	0.333	0.248	1.000	0.747	0.625	0.395	0	2.78	0.316	2.354	0.435	0.857	0.375	1.000	0.715	0.905	0.384	8.857	0.342	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	75	84	chr7	30795291	chr7:30795291	G	T	75	PASS	AN=2;DP=84	GT	0/1
chr7	32529874	32529874	C	T	intronic	LSM5	.	.	.	0.018231933	0.725921529	0.255846538	.	0.68416	0.11388	-0.031067188	51.03798066	5.18241	0.19274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	chr7	32529874	chr7:32529874	C	T	.	PASS	AN=0;DP=69	GT	0/1
chr7	32861170	32861171	AT	-	intergenic	LINC00997;DPY19L1P2	dist=58634;dist=4743	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	28	chr7	32861169	chr7:32861169	CAT	C	72	PASS	AN=2;DP=28	GT	0/1
chr7	42007149	42007149	-	A	intronic	GLI3	.	.	.	0.999994739	5.26E-06	6.01E-15	DISEASE: Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]: Autosomal dominant disorder affecting limb and craniofacial development. It is characterized by pre- and postaxial polydactyly, syndactyly of fingers and toes, macrocephaly and hypertelorism. {ECO:0000269|PubMed:10441342, ECO:0000269|PubMed:12414818, ECO:0000269|PubMed:12794692, ECO:0000269|PubMed:9302279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pallister-Hall syndrome (PHS) [MIM:146510]: An autosomal dominant disorder characterized by a wide range of clinical manifestations. Clinical features include hypothalamic hamartoma, pituitary dysfunction, central or postaxial polydactyly, and syndactyly. Malformations are frequent in the viscera, e.g. anal atresia, bifid uvula, congenital heart malformations, pulmonary or renal dysplasia. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial A1 (PAPA1) [MIM:174200]: A condition characterized by the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type A, the extra digit is well-formed and articulates with the fifth or a sixth metacarpal/metatarsal. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial B (PAPB) [MIM:174200]: A condition characterized by an extra digit in the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type B the extra digit is not well formed and is frequently in the form of a skin. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly preaxial 4 (POP4) [MIM:174700]: Preaxial polydactyly (i.e., polydactyly on the radial/tibial side of the hand/foot) covers a heterogeneous group of entities. In preaxial polydactyly type IV, the thumb shows only the mildest degree of duplication, and syndactyly of various degrees affects fingers 3 and 4. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.9964	0.10708	-1.310171316	4.83014862	2831.41391	10.04419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	37	chr7	42007149	chr7:42007149	G	GA	39	PASS	AN=2;DP=37	GT	0/1
chr7	44097842	44097842	C	G	exonic	DBNL	.	nonsynonymous SNV	DBNL:NM_001284313:exon5:c.C358G:p.R120G,DBNL:NM_001284315:exon5:c.C382G:p.R128G,DBNL:NM_001014436:exon7:c.C667G:p.R223G,DBNL:NM_001122956:exon7:c.C667G:p.R223G,DBNL:NM_014063:exon7:c.C667G:p.R223G	0.070981914	0.926323701	0.002694385	.	0.20108	0.72014	-0.023789244	52.09365416	77.70496	1.85644	0.015	0.574	D	0.799	0.577	P	0.401	0.585	B	0.001	0.393	N	0.999	0.506	D	3.4	0.918	M	1.8	0.338	T	-3.83	0.790	D	0.238	0.523	-1.076	0.082	T	0.092	0.352	T	0.079	0.733	D	6.393	0.883	29.6	0.996	0.729	0.519	0.288	D	c	-0.122	-0.110	1.000	0.747	0.722	0.854	0	4.05	0.462	-0.098	0.109	0.935	0.490	0.008	0.178	0.996	0.625	7.320	0.255	ADF-H/Gelsolin-like domain|Actin-depolymerising factor homology domain	.	.	0.5	90	76	chr7	44097842	chr7:44097842	C	G	90	PASS	AN=2;DP=76	GT	0/1
chr7	44282825	44282825	G	T	intronic	CAMK2B	.	.	.	0.468620194	0.531370436	9.37E-06	.	0.30429	0.29938	-0.624497208	17.16206653	1301.92267	6.78858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	70	chr7	44282825	chr7:44282825	G	T	71	PASS	AN=2;DP=70	GT	0/1
chr7	45956171	45956171	C	T	exonic	IGFBP3	.	synonymous SNV	IGFBP3:NM_000598:exon3:c.G726A:p.K242K,IGFBP3:NM_001013398:exon3:c.G744A:p.K248K	0.362251902	0.586835044	0.050913054	.	0.28872	0.82225	.	.	2102.84042	8.44477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	chr7	45956171	chr7:45956171	C	T	.	PASS	AN=0;DP=29	GT	0/1
chr7	65219668	65219668	G	T	ncRNA_intronic	CCT6P1;LOC441242	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	29	chr7	65219668	chr7:65219668	G	T	59	PASS	AN=2;DP=29	GT	0/1
chr7	73513337	73513337	C	-	intronic	LIMK1	.	.	.	0.990896287	0.009103618	9.51E-08	DISEASE: Note=LIMK1 is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.; 	0.30864	0.32739	-0.821100135	11.88369899	175.30019	2.8795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	240	chr7	73513336	chr7:73513336	TC	T	122	PASS	AN=2;DP=240	GT	0/1
chr7	73530070	73530070	G	T	intronic	LIMK1	.	.	.	0.990896287	0.009103618	9.51E-08	DISEASE: Note=LIMK1 is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.; 	0.30864	0.32739	-0.821100135	11.88369899	175.30019	2.8795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	chr7	73530070	chr7:73530070	G	T	.	PASS	AN=0;DP=59	GT	0/1
chr7	75684340	75684340	G	T	intronic	MDH2	.	.	.	0.177605136	0.809688717	0.012706147	.	0.32327	0.90548	-0.334253673	30.70299599	208.93323	3.11958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	chr7	75684340	chr7:75684340	G	T	.	PASS	AN=0;DP=37	GT	0/1
chr7	88389357	88389357	G	A	exonic	ZNF804B	.	nonsynonymous SNV	ZNF804B:NM_181646:exon1:c.G67A:p.V23I	4.78E-14	0.047962738	0.952037262	.	0.09352	.	3.374093349	99.43972635	2368.37941	9.03579	0.007	0.599	D	0.639	0.385	P	0.159	0.330	B	0.049	0.232	N	0.506	0.318	D	0.805	0.203	L	3.22	0.070	T	-0.73	0.206	N	0.276	0.334	-1.071	0.092	T	0.017	0.071	T	0.005	0.121	T	4.557	0.610	24.4	0.998	0.928	0.883	0.478	D	c	0.259	0.385	1.000	0.517	0.455	0.088	0	5.08	0.682	5.290	0.652	0.998	0.613	1.000	0.715	1.000	0.888	12.998	0.579	.	.	.	0.5	.	96	chr7	88389357	chr7:88389357	G	A	.	PASS	AN=0;DP=96	GT	0/1
chr7	99924207	99924208	CT	-	ncRNA_intronic	PMS2P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	182	chr7	99924206	chr7:99924206	CCT	C	44	PASS	AN=2;DP=182	GT	0/1
chr7	101575395	101575395	A	T	intronic	CUX1	.	.	.	0.999988878	1.11E-05	3.08E-16	.	0.78386	0.44868	-1.868734056	2.011087521	217.29988	3.18613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	chr7	101575395	chr7:101575395	A	T	.	PASS	AN=0;DP=32	GT	0/1
chr7	127326714	127326714	G	A	exonic	SND1	.	synonymous SNV	SND1:NM_014390:exon2:c.G126A:p.G42G	0.999917089	8.29E-05	4.11E-14	.	0.73895	0.12655	-1.063626766	7.484076433	188.34653	2.98065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	chr7	127326714	chr7:127326714	G	A	.	PASS	AN=0;DP=67	GT	0/1
chr7	132174174	132174174	G	T	exonic	PLXNA4	.	synonymous SNV	PLXNA4:NM_001105543:exon3:c.C1248A:p.S416S,PLXNA4:NM_020911:exon3:c.C1248A:p.S416S,PLXNA4:NM_181775:exon4:c.C1248A:p.S416S	0.999999702	2.98E-07	4.57E-20	.	0.16772	0.11298	-0.194946553	39.21325784	462.81286	4.45854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	chr7	132174174	chr7:132174174	G	T	.	PASS	AN=0;DP=46	GT	0/1
chr7	133201567	133201567	T	C	intronic	EXOC4	.	.	.	0.000726958	0.99924068	3.24E-05	.	0.45903	.	-1.280491183	5.16631281	159.10541	2.75629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	75	chr7	133201567	chr7:133201567	T	C	65	PASS	AN=2;DP=75	GT	0/1
chr7	141671685	141671685	A	G	downstream	TAS2R38	dist=746	.	.	0.065390402	0.729870734	0.204738864	.	0.1324	0.10729	1.196071381	92.92285916	1623.12511	7.45029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	37	chr7	141671685	chr7:141671685	A	G	81	PASS	AN=2;DP=37	GT	0/1
chr7	141987184	141987184	C	T	intergenic	TRY2P;MTRNR2L6	dist=15116;dist=386947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	42	chr7	141987184	chr7:141987184	C	T	81	PASS	AN=2;DP=42	GT	1/0
chr7	142032275	142032275	C	A	intergenic	TRY2P;MTRNR2L6	dist=60207;dist=341856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	44	chr7	142032275	chr7:142032275	C	A	70	PASS	AN=2;DP=44	GT	0/1
chr7	142458878	142458878	G	C	intronic	PRSS1	.	.	.	0.001220295	0.848354593	0.150425112	DISEASE: Pancreatitis, hereditary (PCTT) [MIM:167800]: A disease characterized by pancreas inflammation, permanent destruction of the pancreatic parenchyma, maldigestion, and severe abdominal pain attacks. {ECO:0000269|PubMed:10204851, ECO:0000269|PubMed:10381903, ECO:0000269|PubMed:10930381, ECO:0000269|PubMed:11073545, ECO:0000269|PubMed:11788572, ECO:0000269|PubMed:11866271, ECO:0000269|PubMed:14695529, ECO:0000269|PubMed:15776435, ECO:0000269|PubMed:8841182, ECO:0000269|PubMed:9322498, ECO:0000269|PubMed:9633818}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.47806	0.78094	-0.117432389	44.89266336	35.65715	1.07286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	56	chr7	142458878	chr7:142458878	G	C	63	PASS	AN=2;DP=56	GT	0/1
chr7	142983878	142983878	G	T	exonic	TMEM139	.	nonsynonymous SNV	TMEM139:NM_001282876:exon3:c.G607T:p.D203Y,TMEM139:NM_153345:exon3:c.G607T:p.D203Y,TMEM139:NM_001242773:exon4:c.G607T:p.D203Y,TMEM139:NM_001242775:exon4:c.G607T:p.D203Y,TMEM139:NM_001282877:exon4:c.G607T:p.D203Y,TMEM139:NM_001242774:exon5:c.G607T:p.D203Y	0.018754136	0.731195381	0.250050483	.	0.00814	0.04021	0.703746784	85.42108988	71.67324	1.7618	0.002	0.721	D	0.952	0.522	P	0.785	0.557	P	0.009	0.305	N	1	0.090	N	1.545	0.392	L	.	.	.	-5.56	0.863	D	0.472	0.522	-0.966	0.380	T	0.158	0.491	T	0.003	0.053	T	4.025	0.541	23.6	0.990	0.497	0.206	0.209	N	c	-0.127	-0.328	1.000	0.454	0.625	0.396	0	2.62	0.302	1.672	0.369	0.065	0.171	0.011	0.184	0.020	0.134	6.974	0.237	.	.	.	0.5	.	53	chr7	142983878	chr7:142983878	G	T	.	PASS	AN=0;DP=53	GT	0/1
chr7	149518641	149518641	G	T	intronic	SSPO	.	.	.	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	chr7	149518641	chr7:149518641	G	T	.	PASS	AN=0;DP=68	GT	0/1
chr7	151878157	151878157	C	A	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon36:c.G6788T:p.G2263V	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.092	0.329	T	0.014	0.156	B	0.011	0.145	B	0.002	0.385	N	0.999	0.459	D	2.32	0.666	M	-1.81	0.840	D	-4.03	0.749	D	0.408	0.466	-0.401	0.720	T	0.405	0.755	T	0.072	0.715	D	1.809	0.278	15.04	0.985	0.420	0.913	0.531	D	c	-0.373	-0.280	0.542	0.212	0.707	0.730	0	2.91	0.328	1.520	0.353	0.870	0.379	1.000	0.715	0.958	0.437	10.289	0.426	.	.	.	0.5	.	51	chr7	151878157	chr7:151878157	C	A	.	PASS	AN=0;DP=51	GT	0/1
chr7	155473484	155473484	G	T	exonic	RBM33	.	nonsynonymous SNV	RBM33:NM_053043:exon5:c.G449T:p.G150V	0.999967325	3.27E-05	5.14E-13	.	0.15099	.	-1.144569759	6.363529134	1720.69538	7.64985	0.011	0.682	D	0.082	0.899	B	0.058	0.971	B	.	.	.	1	0.810	D	1.935	0.520	L	1.39	0.338	T	-6.03	0.898	D	0.4	0.581	-0.852	0.519	T	0.163	0.499	T	0.029	0.519	D	5.092	0.686	25.3	0.997	0.801	0.926	0.558	D	c	0.211	0.281	1.000	0.747	0.707	0.730	0	4.46	0.534	4.814	0.621	0.953	0.551	1.000	0.715	0.995	0.604	13.798	0.625	.	.	.	0.5	83	23	chr7	155473484	chr7:155473484	G	T	83	PASS	AN=2;DP=23	GT	0/1
chr7	155567837	155567837	G	T	UTR3	RBM33	NM_053043:c.*102G>T	.	.	0.999967325	3.27E-05	5.14E-13	.	0.15099	.	-1.144569759	6.363529134	1720.69538	7.64985	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	98	chr7	155567837	chr7:155567837	G	T	.	PASS	AN=0;DP=98	GT	0/1
chr8	2044268	2044268	C	T	exonic	MYOM2	.	synonymous SNV	MYOM2:NM_003970:exon18:c.C2307T:p.I769I	1.49E-55	7.78E-11	1	.	0.22436	0.11601	-0.500487825	21.84477471	8300.21663	19.71178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	chr8	2044268	chr8:2044268	C	T	.	PASS	AN=0;DP=38	GT	0/1
chr8	6616271	6616271	G	T	UTR3	AGPAT5	NM_018361:c.*1362G>T	.	.	0.005794953	0.971837733	0.022367313	.	0.55788	0.12279	-0.512444034	21.55579146	130.88869	2.49182	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	25	chr8	6616271	chr8:6616271	G	T	51	PASS	AN=2;DP=25	GT	1/0
chr8	52321066	52321066	C	T	exonic	PXDNL	.	nonsynonymous SNV	PXDNL:NM_144651:exon17:c.G3118A:p.V1040M	1.94E-27	0.000599486	0.999400514	.	.	.	2.732433216	98.95022411	6585.72871	17.14983	0.004	0.654	D	0.998	0.715	D	0.95	0.671	D	0.000	0.469	D	0.541	0.320	D	2.84	0.828	M	-0.74	0.732	T	-2.12	0.481	N	0.208	0.398	0.565	0.914	D	0.615	0.864	D	0.006	0.165	T	4.884	0.656	24.9	0.997	0.809	0.111	0.162	N	c	0.087	-0.190	0.475	0.207	0.646	0.450	0	3.82	0.430	0.328	0.193	0.700	0.299	0.001	0.137	0.001	0.043	13.168	0.588	.	.	.	0.5	.	38	chr8	52321066	chr8:52321066	C	T	.	PASS	AN=0;DP=38	GT	0/1
chr8	92365183	92365183	C	A	exonic	SLC26A7	.	synonymous SNV	SLC26A7:NM_001282357:exon11:c.C370A:p.R124R,SLC26A7:NM_052832:exon11:c.C1273A:p.R425R,SLC26A7:NM_134266:exon11:c.C1273A:p.R425R,SLC26A7:NM_001282356:exon12:c.C1273A:p.R425R	3.32E-08	0.923716211	0.076283756	.	0.50174	0.12722	0.112125503	62.09601321	242.55786	3.36166	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	62	chr8	92365183	chr8:92365183	C	A	67	PASS	AN=2;DP=62	GT	0/1
chr8	97307359	97307359	G	T	exonic	PTDSS1	.	stopgain	PTDSS1:NM_001290225:exon3:c.G37T:p.E13X,PTDSS1:NM_014754:exon5:c.G475T:p.E159X	0.857749192	0.142246932	3.88E-06	DISEASE: Lenz-Majewski hyperostotic dwarfism (LMHD) [MIM:151050]: A syndrome of intellectual disability and multiple congenital anomalies that features generalized craniotubular hyperostosis. LMHD is characterized by the combination of sclerosing bone dysplasia, intellectual disability and distinct craniofacial, dental, cutaneous and distal limb anomalies. The progressive generalized hyperostosis associated with this syndrome affects the cranium, the vertebrae and the diaphyses of tubular bones, leading to severe growth restriction. {ECO:0000269|PubMed:24241535}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26928	0.12774	-0.359940251	28.93371078	145.442	2.62713	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.049	0.988	41	0.998	0.846	0.986	0.848	D	c	1.097	0.934	1.000	0.747	0.706	0.609	0	4.68	0.582	8.049	0.891	0.953	0.551	1.000	0.715	1.000	0.888	16.130	0.811	.	.	.	0.5	.	37	chr8	97307359	chr8:97307359	G	T	.	PASS	AN=0;DP=37	GT	0/1
chr8	103665675	103665675	-	A	intronic	KLF10	.	.	.	0.003421767	0.834210438	0.162367795	.	0.62417	0.17296	0.374860183	75.43052607	239.0998	3.341	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.46	48	chr8	103665675	chr8:103665675	T	TA	11.46	PASS	AN=0;DP=48	GT	0/1
chr8	105501568	105501568	C	A	UTR3	LRP12	NM_013437:c.*1333G>T;NM_001135703:c.*1333G>T	.	.	0.969751549	0.030248081	3.70E-07	.	0.82964	0.19728	-0.596992387	18.18825195	240.40002	3.34916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	chr8	105501568	chr8:105501568	C	A	.	PASS	AN=0;DP=27	GT	0/1
chr8	113275776	113275776	A	T	intronic	CSMD3	.	.	.	0.999999996	4.08E-09	1.04E-35	.	0.39932	0.10693	-3.486527925	0.347959424	4750.0149	13.94247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	24	chr8	113275776	chr8:113275776	A	T	75	PASS	AN=2;DP=24	GT	0/1
chr8	113871300	113871300	G	A	intronic	CSMD3	.	.	.	0.999999996	4.08E-09	1.04E-35	.	0.39932	0.10693	-3.486527925	0.347959424	4750.0149	13.94247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	chr8	113871300	chr8:113871300	G	A	.	PASS	AN=0;DP=30	GT	0/1
chr8	128428591	128428591	G	A	exonic	POU5F1B	.	synonymous SNV	POU5F1B:NM_001159542:exon1:c.G480A:p.L160L	7.27E-07	0.154902824	0.845096449	.	0.06534	.	.	.	6077.10056	16.28567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	138	chr8	128428591	chr8:128428591	G	A	84	PASS	AN=2;DP=138	GT	0/1
chr8	131408987	131408987	C	T	intronic	ASAP1	.	.	.	0.999983091	1.69E-05	8.56E-16	.	0.41578	0.17656	-1.240018202	5.461193678	937.06285	5.93485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	chr8	131408987	chr8:131408987	C	T	.	PASS	AN=0;DP=34	GT	0/1
chr8	139145002	139145002	G	T	exonic	FAM135B	.	nonsynonymous SNV	FAM135B:NM_015912:exon20:c.C4055A:p.P1352H	0.999998682	1.32E-06	2.06E-16	.	0.08052	0.09691	-1.425829947	4.051663128	148.31692	2.65323	0.0	0.912	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	2.85	0.831	M	2.3	0.170	T	-8.44	0.972	D	0.811	0.800	-0.912	0.466	T	0.145	0.469	T	0.051	0.647	D	6.407	0.884	29.6	0.997	0.789	0.993	0.943	D	c	0.971	0.946	1.000	0.747	0.487	0.133	0	5.74	0.900	9.754	0.981	1.048	0.713	1.000	0.715	0.996	0.625	18.906	0.924	.	.	.	0.5	.	46	chr8	139145002	chr8:139145002	G	T	.	PASS	AN=0;DP=46	GT	0/1
chr8	145559866	145559866	G	A	UTR5	SCRT1	NM_031309:c.-35C>T	.	.	0.294251147	0.62556547	0.080183384	.	0.21303	.	.	.	10.3722	0.37768	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	92	chr8	145559866	chr8:145559866	G	A	.	PASS	AN=0;DP=92	GT	0/1
chr9	18706829	18706829	G	T	exonic	ADAMTSL1	.	synonymous SNV	ADAMTSL1:NM_001040272:exon14:c.G1659T:p.L553L	8.83E-05	0.999911689	4.59E-08	.	.	.	-0.860112269	10.89879689	3092.36494	10.5706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	66	chr9	18706829	chr9:18706829	G	T	110	PASS	AN=2;DP=66	GT	1/0
chr9	19350926	19350926	-	T	intronic	DENND4C	.	.	.	0.406967594	0.593032405	1.03E-09	.	0.38649	.	-0.957327604	9.017456947	1816.18274	7.85903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	21	chr9	19350926	chr9:19350926	C	CT	52	PASS	AN=2;DP=21	GT	0/1
chr9	33364821	33364821	-	A	intronic	NFX1	.	.	.	0.386441239	0.613558732	2.94E-08	.	0.44031	.	-1.591018721	3.084453881	335.711	3.89158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	18	chr9	33364821	chr9:33364821	G	GA	39	PASS	AN=2;DP=18	GT	0/1
chr9	37708421	37708421	C	-	exonic	FRMPD1	.	frameshift deletion	FRMPD1:NM_014907:exon4:c.285delC:p.P96Lfs*7	3.53E-10	0.995711787	0.004288213	.	0.15661	0.09359	1.70862952	96.44373673	4200.93656	12.88726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	18	chr9	37708420	chr9:37708420	TC	T	96	PASS	AN=2;DP=18	GT	1/0
chr9	66457299	66457299	G	T	ncRNA_exonic	LINC01410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	chr9	66457299	chr9:66457299	G	T	.	PASS	AN=0;DP=69	GT	0/1
chr9	94877628	94877628	C	A	exonic	SPTLC1	.	nonsynonymous SNV	SPTLC1:NM_001281303:exon1:c.G25T:p.V9F,SPTLC1:NM_006415:exon1:c.G25T:p.V9F,SPTLC1:NM_178324:exon1:c.G25T:p.V9F	2.78E-07	0.914098573	0.085901148	DISEASE: Neuropathy, hereditary sensory and autonomic, 1A (HSAN1A) [MIM:162400]: A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by prominent sensory abnormalities with a variable degree of motor and autonomic dysfunction. The neurological phenotype is often complicated by severe infections, osteomyelitis, and amputations. HSAN1A is an autosomal dominant axonal form with onset in the second or third decades. Initial symptoms are loss of pain, touch, heat, and cold sensation over the feet, followed by distal muscle wasting and weakness. Loss of pain sensation leads to chronic skin ulcers and distal amputations. {ECO:0000269|PubMed:11242114, ECO:0000269|PubMed:19651702, ECO:0000269|PubMed:21618344, ECO:0000269|PubMed:22302274, ECO:0000269|PubMed:24247255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=SPTLC1 mutations at Ser-331 are responsible for severe hereditary motor and sensory neuropathy (HMSN) forms, whose core features are severe, diffuse muscle wasting and hypotonia, motor and sensory disturbances, foot ulcers, amputations and/or burns, joint hypermobility, cataracts and considerable growth retardation. {ECO:0000269|PubMed:23454272}.; 	0.38002	0.22508	-0.247889024	35.98726115	180.38129	2.91802	0.204	0.506	T	0.686	0.511	P	0.235	0.465	B	0.000	0.843	D	1	0.810	D	2.67	0.784	M	-3.77	0.956	D	-1.22	0.309	N	0.822	0.810	0.727	0.935	D	0.825	0.941	D	0.465	0.946	D	4.047	0.544	23.7	0.986	0.431	0.917	0.538	D	c	0.237	0.328	1.0	0.983	0.025	0.001	3	4.81	0.613	4.084	0.571	0.674	0.295	1.000	0.715	0.996	0.625	16.789	0.854	.	.	.	0.5	.	277	chr9	94877628	chr9:94877628	C	A	.	PASS	AN=0;DP=277	GT	0/1
chr9	104309195	104309195	A	G	exonic	RNF20	.	nonsynonymous SNV	RNF20:NM_019592:exon7:c.A841G:p.I281V	0.000923365	0.999076445	1.90E-07	.	0.15368	0.12971	-0.598810865	18.13517339	121.63796	2.40133	0.539	0.068	T	0.803	0.432	P	0.785	0.557	P	0.000	0.843	D	1	0.810	D	1.12	0.289	L	-1.14	0.779	T	-0.3	0.119	N	0.33	0.391	-0.261	0.761	T	0.441	0.779	T	0.029	0.521	D	1.742	0.270	14.65	0.968	0.306	0.986	0.847	D	c	0.439	0.510	1.000	0.747	0.707	0.730	0	5.53	0.825	5.900	0.694	1.088	0.866	1.000	0.715	1.000	0.888	15.630	0.765	.	.	.	0.5	88	54	chr9	104309195	chr9:104309195	A	G	88	PASS	AN=2;DP=54	GT	1/0
chr9	108072082	108072082	C	G	exonic	SLC44A1	.	nonsynonymous SNV	SLC44A1:NM_001286730:exon3:c.C204G:p.I68M,SLC44A1:NM_001330731:exon3:c.C204G:p.I68M,SLC44A1:NM_080546:exon3:c.C204G:p.I68M	0.999253571	0.000746428	1.05E-09	.	0.2337	0.13691	-0.534490515	20.70063694	1596.58474	7.39509	0.16	0.241	T	0.202	0.461	B	0.193	0.446	B	0.000	0.843	D	0.978	0.394	D	2.2	0.622	M	-1.27	0.793	T	-1.49	0.364	N	0.456	0.508	-0.600	0.648	T	0.313	0.683	T	0.054	0.659	D	3.617	0.492	23.2	0.973	0.326	0.737	0.358	D	c	-0.116	-0.024	1.000	0.747	0.781	0.997	0	2.89	0.326	0.799	0.265	0.065	0.171	1.000	0.715	1.000	0.888	6.856	0.231	.	.	.	0.5	52	31	chr9	108072082	chr9:108072082	C	G	52	PASS	AN=2;DP=31	GT	0/1
chr9	115480313	115480313	C	G	UTR5	INIP	NM_021218:c.-1548G>C;NM_001329588:c.-23865G>C;NM_001329590:c.-23865G>C;NM_001329589:c.-23865G>C;NM_001329585:c.-20579G>C;NM_001329587:c.-1548G>C;NM_001329586:c.-1548G>C	.	.	0.017451553	0.717632071	0.264916376	.	0.26262	.	0.057118534	57.99716914	1.19806	0.03523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	428	chr9	115480313	chr9:115480313	C	G	147	PASS	AN=2;DP=428	GT	0/1
chr9	116359453	116359453	-	G	UTR3	RGS3	NM_144488:c.*220_*221insG;NM_001282923:c.*220_*221insG;NM_130795:c.*220_*221insG;NM_001276261:c.*220_*221insG;NM_001276260:c.*220_*221insG;NM_134427:c.*220_*221insG;NM_001322215:c.*220_*221insG;NM_001351526:c.*220_*221insG;NM_001282922:c.*220_*221insG;NM_144489:c.*220_*221insG;NM_001276262:c.*220_*221insG	.	.	9.68E-05	0.999879192	2.40E-05	.	0.27528	.	-0.356550349	29.16961548	669.24526	5.17392	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	206	chr9	116359453	chr9:116359453	A	AG	123	PASS	AN=2;DP=206	GT	0/1
chr9	130652978	130652978	G	A	exonic	ST6GALNAC6	.	synonymous SNV	ST6GALNAC6:NM_001287000:exon4:c.C540T:p.A180A,ST6GALNAC6:NM_001287001:exon4:c.C540T:p.A180A,ST6GALNAC6:NM_001287002:exon4:c.C540T:p.A180A,ST6GALNAC6:NM_001286999:exon5:c.C642T:p.A214A,ST6GALNAC6:NM_013443:exon5:c.C642T:p.A214A	0.00205356	0.912791919	0.085154521	.	0.14025	0.09314	-1.023168368	7.944090587	40.49297	1.1878	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	304	chr9	130652978	chr9:130652978	G	A	116	PASS	AN=2;DP=304	GT	0/1
chr9	132935066	132935066	C	-	intronic	NCS1	.	.	.	0.947220876	0.052601383	0.000177741	.	0.18713	0.18619	-0.141298762	42.87567823	2.47706	0.0911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	78	chr9	132935065	chr9:132935065	GC	G	52	PASS	AN=2;DP=78	GT	0/1
chr9	133251913	133251913	C	T	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	chr9	133251913	chr9:133251913	C	T	.	PASS	AN=0;DP=56	GT	0/1
chr9	135779074	135779074	G	C	exonic	TSC1	.	nonsynonymous SNV	TSC1:NM_001162427:exon16:c.C2019G:p.I673M,TSC1:NM_000368:exon17:c.C2172G:p.I724M,TSC1:NM_001162426:exon17:c.C2169G:p.I723M	0.999978334	2.17E-05	3.82E-14	DISEASE: Tuberous sclerosis 1 (TSC1) [MIM:191100]: An autosomal dominant multi-system disorder that affects especially the brain, kidneys, heart, and skin. It is characterized by hamartomas (benign overgrowths predominantly of a cell or tissue type that occurs normally in the organ) and hamartias (developmental abnormalities of tissue combination). Clinical manifestations include epilepsy, learning difficulties, behavioral problems, and skin lesions. Seizures can be intractable and premature death can occur from a variety of disease-associated causes. {ECO:0000269|PubMed:10227394, ECO:0000269|PubMed:10533069, ECO:0000269|PubMed:10570911, ECO:0000269|PubMed:10874311, ECO:0000269|PubMed:18830229, ECO:0000269|PubMed:22161988, ECO:0000269|PubMed:9328481}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Focal cortical dysplasia of Taylor balloon cell type (FCDBC) [MIM:607341]: Subtype of cortical dysplasias linked to chronic intractable epilepsy. Cortical dysplasias display a broad spectrum of structural changes, which appear to result from changes in proliferation, migration, differentiation, and apoptosis of neuronal precursors and neurons during cortical development. {ECO:0000269|PubMed:12112044}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.77672	0.4222	-1.03794674	7.832035858	754.82235	5.44924	0.07	0.377	T	1.0	0.899	D	0.981	0.736	D	0.000	0.843	D	0.998	0.810	D	2.015	0.552	M	-1.7	0.831	D	-0.28	0.121	N	0.413	0.471	0.011	0.825	D	0.565	0.842	D	0.101	0.775	D	4.308	0.577	24.0	0.997	0.810	0.994	0.960	D	c	0.542	0.559	1.000	0.747	0.731	0.878	0	5.32	0.753	5.002	0.635	1.048	0.713	1.000	0.715	0.960	0.441	13.394	0.601	.	.	.	0.5	82	100	chr9	135779074	chr9:135779074	G	C	82	PASS	AN=2;DP=100	GT	0/1
chr9	135779219	135779219	G	T	intronic	TSC1	.	.	.	0.999978334	2.17E-05	3.82E-14	DISEASE: Tuberous sclerosis 1 (TSC1) [MIM:191100]: An autosomal dominant multi-system disorder that affects especially the brain, kidneys, heart, and skin. It is characterized by hamartomas (benign overgrowths predominantly of a cell or tissue type that occurs normally in the organ) and hamartias (developmental abnormalities of tissue combination). Clinical manifestations include epilepsy, learning difficulties, behavioral problems, and skin lesions. Seizures can be intractable and premature death can occur from a variety of disease-associated causes. {ECO:0000269|PubMed:10227394, ECO:0000269|PubMed:10533069, ECO:0000269|PubMed:10570911, ECO:0000269|PubMed:10874311, ECO:0000269|PubMed:18830229, ECO:0000269|PubMed:22161988, ECO:0000269|PubMed:9328481}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Focal cortical dysplasia of Taylor balloon cell type (FCDBC) [MIM:607341]: Subtype of cortical dysplasias linked to chronic intractable epilepsy. Cortical dysplasias display a broad spectrum of structural changes, which appear to result from changes in proliferation, migration, differentiation, and apoptosis of neuronal precursors and neurons during cortical development. {ECO:0000269|PubMed:12112044}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.77672	0.4222	-1.03794674	7.832035858	754.82235	5.44924	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	chr9	135779219	chr9:135779219	G	T	.	PASS	AN=0;DP=34	GT	0/1
chr9	137702206	137702206	G	A	intronic	COL5A1	.	.	.	1	2.48E-13	8.59E-33	DISEASE: Ehlers-Danlos syndrome, classic type (EDS) [MIM:130000]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. {ECO:0000269|PubMed:10602121, ECO:0000269|PubMed:11992482, ECO:0000269|PubMed:15580559, ECO:0000269|PubMed:18972565, ECO:0000269|PubMed:9042913}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69297	.	-3.009169053	0.524887945	863.84203	5.72906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	65	chr9	137702206	chr9:137702206	G	A	.	PASS	AN=0;DP=65	GT	0/1
chr9	139402402	139402402	C	A	intronic	NOTCH1	.	.	.	0.999999994	5.68E-09	7.22E-23	DISEASE: Aortic valve disease 1 (AOVD1) [MIM:109730]: A common defect in the aortic valve in which two rather than three leaflets are present. It is often associated with aortic valve calcification, stenosis and insufficiency. In extreme cases, the blood flow may be so restricted that the left ventricle fails to grow, resulting in hypoplastic left heart syndrome. {ECO:0000269|PubMed:16025100}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Adams-Oliver syndrome 5 (AOS5) [MIM:616028]: A form of Adams-Oliver syndrome, a disorder characterized by the congenital absence of skin (aplasia cutis congenita) in combination with transverse limb defects. Aplasia cutis congenita can be located anywhere on the body, but in the vast majority of the cases, it is present on the posterior parietal region where it is often associated with an underlying defect of the parietal bones. Limb abnormalities are typically limb truncation defects affecting the distal phalanges or entire digits (true ectrodactyly). Only rarely, metatarsals/metacarpals or more proximal limb structures are also affected. Apart from transverse limb defects, syndactyly, most commonly of second and third toes, can also be observed. The clinical features are highly variable and can also include cardiovascular malformations, brain abnormalities and vascular defects such as cutis marmorata and dilated scalp veins. {ECO:0000269|PubMed:25132448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94531	0.91608	-3.510304589	0.330266572	576.67829	4.86776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	197	chr9	139402402	chr9:139402402	C	A	.	PASS	AN=0;DP=197	GT	0/1
chr9	140177108	140177108	G	A	downstream	TOR4A	dist=15	.	.	0.215534136	0.647904223	0.136561641	.	0.09004	0.12134	.	.	186.39911	2.9648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	chr9	140177108	chr9:140177108	G	A	.	PASS	AN=0;DP=51	GT	0/1
chr10	16957998	16957998	A	T	exonic	CUBN	.	nonsynonymous SNV	CUBN:NM_001081:exon46:c.T7032A:p.S2344R	3.03E-28	0.999999978	2.24E-08	DISEASE: Recessive hereditary megaloblastic anemia 1 (RH-MGA1) [MIM:261100]: Due to selective malabsorption of vitamin B12. Defects in vitamin B12 absorption lead to impaired function of thymidine synthase. As a consequence DNA synthesis is interrupted. Rapidly dividing cells involved in erythropoiesis are particularly affected. {ECO:0000269|PubMed:10080186, ECO:0000269|PubMed:10887099}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16009	0.3163	1.257700362	93.49492805	6532.49526	17.0026	0.059	0.375	T	0.569	0.366	P	0.21	0.356	B	0.073	0.214	N	0.998	0.446	D	2.345	0.676	M	2.13	0.196	T	-2.33	0.516	N	0.127	0.144	-1.108	0.032	T	0.043	0.187	T	0.014	0.336	T	2.972	0.417	22.1	0.966	0.298	0.293	0.236	N	c	-0.419	-0.465	0.024	0.136	0.516	0.203	0	1.92	0.248	-0.304	0.082	-0.114	0.115	0.002	0.151	0.024	0.140	8.923	0.346	CUB domain	.	.	0.5	.	56	chr10	16957998	chr10:16957998	A	T	.	PASS	AN=0;DP=56	GT	0/1
chr10	17256638	17256638	C	A	ncRNA_exonic	VIM-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	19	chr10	17256638	chr10:17256638	C	A	.	PASS	AN=0;DP=19	GT	0/1
chr10	18430127	18430127	C	A	exonic	CACNB2	.	nonsynonymous SNV	CACNB2:NM_001167945:exon1:c.C19A:p.L7M,CACNB2:NM_201571:exon1:c.C19A:p.L7M,CACNB2:NM_201572:exon1:c.C19A:p.L7M	0.001820338	0.997139378	0.001040285	DISEASE: Brugada syndrome 4 (BRGDA4) [MIM:611876]: A heart disease characterized by the association of Brugada syndrome with shortened QT intervals. Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:17224476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18213	0.15589	-0.705410796	14.77942911	766.55161	5.48442	0.141	0.330	T	0.742	0.442	P	0.047	0.293	B	.	.	.	1.000	0.516	D	.	.	.	-1.74	0.836	D	0.49	0.031	N	0.096	0.100	-0.844	0.524	T	0.163	0.500	T	0.098	0.770	D	2.148	0.319	17.17	0.967	0.301	0.340	0.247	N	c	-0.354	-0.239	1.000	0.405	0.598	0.340	0	2.63	0.303	1.396	0.339	0.739	0.307	1.000	0.715	1.000	0.888	6.157	0.194	.	.	.	0.5	.	30	chr10	18430127	chr10:18430127	C	A	.	PASS	AN=0;DP=30	GT	0/1
chr10	20432280	20432280	G	T	exonic	PLXDC2	.	nonsynonymous SNV	PLXDC2:NM_001282736:exon4:c.G451T:p.A151S,PLXDC2:NM_032812:exon5:c.G598T:p.A200S	0.613047817	0.386937644	1.45E-05	.	0.46149	0.10853	0.531004228	80.87992451	87.18855	1.99411	0.0	0.912	D	0.957	0.528	D	0.769	0.549	P	0.000	0.843	D	1	0.810	D	3.195	0.893	M	-1.41	0.806	T	-2.97	0.623	D	0.868	0.858	0.352	0.884	D	0.649	0.878	D	0.172	0.849	D	6.217	0.858	28.8	0.998	0.860	0.992	0.927	D	c	0.852	0.866	1.000	0.747	0.706	0.609	0	5.82	0.927	9.958	0.990	1.047	0.674	1.000	0.715	1.000	0.888	20.109	0.979	.	.	.	0.5	.	40	chr10	20432280	chr10:20432280	G	T	.	PASS	AN=0;DP=40	GT	0/1
chr10	21177143	21177143	-	A	intronic	NEBL	.	.	.	5.77E-24	0.009320316	0.990679684	.	0.56868	0.10631	0.567625503	81.74687426	2561.02103	9.45167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.55	39	chr10	21177143	chr10:21177143	G	GA	10.55	PASS	AN=0;DP=39	GT	0/1
chr10	21803522	21803522	A	G	UTR3	SKIDA1	NM_207371:c.*503T>C	.	.	.	.	.	.	0.891	.	.	.	438.2434	4.36472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	161	chr10	21803522	chr10:21803522	A	G	119	PASS	AN=2;DP=161	GT	0/1
chr10	30901795	30901795	G	A	exonic	LYZL2	.	synonymous SNV	LYZL2:NM_183058:exon4:c.C471T:p.I157I	3.26E-06	0.191157736	0.808839004	.	0.10712	0.11669	0.084621747	60.31493277	217.1399	3.1852	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	chr10	30901795	chr10:30901795	G	A	.	PASS	AN=0;DP=35	GT	0/1
chr10	35930412	35930412	-	G	upstream	FZD8;MIR4683	dist=50	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	19	chr10	35930412	chr10:35930412	C	CG	74	PASS	AN=2;DP=19	GT	0/1
chr10	37442560	37442560	G	A	exonic	ANKRD30A	.	nonsynonymous SNV	ANKRD30A:NM_052997:exon13:c.G1600A:p.E534K	1.26E-23	0.003987679	0.996012321	.	0.05405	.	2.702925512	98.90304317	3097.8543	10.58328	0.0	0.912	D	0.963	0.537	D	0.424	0.434	B	.	.	.	1	0.090	N	0.695	0.181	N	3.4	0.057	T	-0.76	0.295	N	0.111	0.120	-0.965	0.381	T	0.014	0.058	T	0.001	0.014	T	2.209	0.327	17.57	0.989	0.471	0.017	0.054	N	c	-0.569	-0.769	0.060	0.152	0.487	0.133	0	1.47	0.217	1.040	0.297	0.636	0.291	0.041	0.208	0.006	0.095	6.435	0.209	.	.	.	0.5	.	53	chr10	37442560	chr10:37442560	G	A	.	PASS	AN=0;DP=53	GT	0/1
chr10	45488707	45488707	C	G	intronic	RASSF4	.	.	.	2.05E-11	0.01752444	0.98247556	.	0.0992	0.09317	0.733063566	86.27034678	1210.23369	6.58766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	236	chr10	45488707	chr10:45488707	C	G	124	PASS	AN=2;DP=236	GT	0/1
chr10	45644255	45644255	C	A	ncRNA_intronic	RSU1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	chr10	45644255	chr10:45644255	C	A	.	PASS	AN=0;DP=56	GT	0/1
chr10	59997532	59997532	T	C	exonic	IPMK	.	synonymous SNV	IPMK:NM_152230:exon2:c.A234G:p.Q78Q	0.426106182	0.572340293	0.001553525	.	0.50963	0.09415	0.062575634	58.74026893	1147.67485	6.45706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	21	chr10	59997532	chr10:59997532	T	C	65	PASS	AN=2;DP=21	GT	0/1
chr10	61549576	61549576	C	A	UTR3	CCDC6	NM_005436:c.*3099G>T	.	.	0.967799856	0.03219801	2.13E-06	DISEASE: Note=A chromosomal aberration involving CCDC6 is found in papillary thyroid carcinomas (PTCs). Inversion inv(10)(q11.2;q21) generates the RET/CCDC6 (PTC1) oncogene. {ECO:0000269|PubMed:2406025}.; 	0.4367	0.16675	-0.137658575	43.57159707	4670.49647	13.75925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	chr10	61549576	chr10:61549576	C	A	.	PASS	AN=0;DP=50	GT	0/1
chr10	71267367	71267367	C	T	UTR3	TSPAN15	NM_001351263:c.*633C>T;NM_012339:c.*633C>T	.	.	0.001855808	0.902378587	0.095765605	.	0.29157	0.11343	0.350995466	74.37485256	209.06557	3.1214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr10	71267367	chr10:71267367	C	T	.	PASS	AN=0;DP=55	GT	0/1
chr10	84625104	84625104	G	C	intronic	NRG3	.	.	.	0.21033799	0.789584348	7.77E-05	.	0.1568	0.1028	-0.464712395	23.5727766	868.61501	5.74237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	55	chr10	84625104	chr10:84625104	G	C	90	PASS	AN=2;DP=55	GT	0/1
chr10	92656136	92656136	G	T	exonic	RPP30	.	synonymous SNV	RPP30:NM_001104546:exon10:c.G684T:p.A228A,RPP30:NM_006413:exon10:c.G684T:p.A228A	2.35E-05	0.912665745	0.08731072	.	0.25392	0.24934	0.106667882	61.73036093	95.28898	2.10698	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	chr10	92656136	chr10:92656136	G	T	.	PASS	AN=0;DP=30	GT	0/1
chr10	105049273	105049273	T	A	UTR3	INA	NM_032727:c.*847T>A	.	.	0.292917015	0.686595637	0.020487348	.	0.30146	0.26304	-0.095386216	46.48502005	174.52967	2.8739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	chr10	105049273	chr10:105049273	T	A	.	PASS	AN=0;DP=30	GT	0/1
chr10	122348917	122348917	G	T	exonic	PLPP4	.	nonsynonymous SNV	PLPP4:NM_001318169:exon3:c.G268T:p.V90F,PLPP4:NM_001318167:exon5:c.G530T:p.S177I,PLPP4:NM_001030059:exon7:c.G719T:p.S240I	.	.	.	.	0.18611	0.10773	-0.249709319	35.74545883	.	.	0.17	0.250	T	0.763	0.417	P	0.293	0.390	B	0.000	0.445	D	1.000	0.588	D	0.695	0.181	N	0.87	0.464	T	-1.89	0.441	N	0.659	0.678	-0.882	0.496	T	0.121	0.421	T	0.020	0.429	T	2.990	0.420	22.2	0.984	0.404	0.987	0.852	D	c	0.391	0.492	0.981	0.302	0.707	0.730	0	4.45	0.532	7.580	0.817	1.044	0.665	1.000	0.715	0.965	0.450	14.435	0.667	.	.	.	0.5	71	46	chr10	122348917	chr10:122348917	G	T	71	PASS	AN=2;DP=46	GT	0/1
chr10	123233234	123233235	AC	-	intergenic	WDR11;FGFR2	dist=564196;dist=4609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	71	chr10	123233233	chr10:123233233	AAC	A	50	PASS	AN=2;DP=71	GT	0/1
chr10	124377617	124377617	G	T	exonic	DMBT1	.	nonsynonymous SNV	DMBT1:NM_004406:exon25:c.G2705T:p.W902L,DMBT1:NM_017579:exon37:c.G4559T:p.W1520L,DMBT1:NM_001320644:exon38:c.G4589T:p.W1530L,DMBT1:NM_007329:exon38:c.G4589T:p.W1530L	7.36E-32	0.326788431	0.673211569	DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. Note=The gene represented in this entry is involved in disease pathogenesis. Homozygous deletions may be the predominant mechanism of DMBT1 inactivation playing a role in carcinogenesis. DMBT1 is deleted in medulloblastoma and glioblastoma cell lines; point mutations have also been reported in patients with glioma. A loss or reduction of DMBT1 expression has been seen in esophageal, gastric, lung and colorectal carcinomas as well.; 	0.25445	.	4.221416241	99.71691437	3210.34948	10.79937	0.004	0.654	D	0.95	0.899	P	0.378	0.971	B	0.107	0.026	N	0.668	0.346	D	4.23	0.980	H	0.61	0.535	T	-11.76	0.995	D	0.392	0.514	-0.603	0.647	T	0.515	0.818	D	0.052	0.652	D	6.347	0.876	29.3	0.989	0.471	0.963	0.681	D	c	0.706	0.559	0.990	0.318	0.487	0.133	0	3.2	0.357	6.260	0.723	0.957	0.564	1.000	0.715	0.984	0.507	10.728	0.451	SRCR domain|SRCR-like domain	.	.	0.5	.	209	chr10	124377617	chr10:124377617	G	T	.	PASS	AN=0;DP=209	GT	0/1
chr10	124640270	124640270	G	T	ncRNA_exonic	LOC399815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr10	124640270	chr10:124640270	G	T	.	PASS	AN=0;DP=42	GT	0/1
chr10	126138397	126138397	A	G	exonic	NKX1-2	.	nonsynonymous SNV	NKX1-2:NM_001146340:exon1:c.T116C:p.V39A	.	.	.	.	.	.	.	.	1240.59153	6.64779	0.097	0.309	T	0.006	0.126	B	0.003	0.080	B	.	.	.	1	0.090	N	0.55	0.145	N	-2.48	0.891	D	0.01	0.069	N	0.062	0.061	-0.620	0.640	T	0.488	0.805	T	0.123	0.804	D	1.805	0.278	15.01	0.962	0.286	0.068	0.127	N	c	-0.807	-0.796	1.000	0.747	0.767	0.994	0	0.062	0.136	-0.310	0.081	0.164	0.245	0.000	0.063	0.190	0.215	5.108	0.140	.	.	.	0.5	139	241	chr10	126138397	chr10:126138397	A	G	139	PASS	AN=2;DP=241	GT	0/1
chr11	822463	822463	-	C	exonic	PNPLA2	.	frameshift insertion	PNPLA2:NM_020376:exon5:c.554dupC:p.F187Lfs*5	0.001141193	0.838081873	0.160776935	DISEASE: Note=Genetic variations in PNPLA2 may be associated with risk of diabetes mellitus type 2. {ECO:0000269|PubMed:16644682}.; DISEASE: Neutral lipid storage disease with myopathy (NLSDM) [MIM:610717]: Neutral lipid storage disorder (NLSD) with myopathy but without ichthyosis. NLSDs are characterized by the presence of triglyceride-containing cytoplasmic droplets in leukocytes and in other tissues, including bone marrow, skin, and muscle. Individuals with NLSDM did not show obesity, in spite of a defect in triglyceride degradation in fibroblasts and in marked triglyceride storage in liver, muscles, and other visceral cells. {ECO:0000269|PubMed:17187067}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40021	0.21702	0.042348793	57.31304553	136.13585	2.535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	49.15	86	chr11	822463	chr11:822463	T	TC	49.15	PASS	AN=0;DP=86	GT	0/1
chr11	1093551	1093551	G	C	exonic	MUC2	.	synonymous SNV	MUC2:NM_002457:exon31:c.G5370C:p.V1790V	4.55E-05	0.999954537	2.00E-10	.	0.12651	.	.	.	13226.52773	24.78411	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	796	chr11	1093551	chr11:1093551	G	C	77	PASS	AN=2;DP=796	GT	0/1
chr11	1269651	1269651	C	G	exonic	MUC5B	.	synonymous SNV	MUC5B:NM_002458:exon31:c.C11541G:p.T3847T	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	499	chr11	1269651	chr11:1269651	C	G	147	PASS	AN=2;DP=499	GT	0/1
chr11	1457389	1457389	G	A	intronic	BRSK2	.	.	.	0.779570081	0.220416998	1.29E-05	.	0.16676	0.10676	-1.506435464	3.544468035	64.45039	1.64641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	144	chr11	1457389	chr11:1457389	G	A	64	PASS	AN=2;DP=144	GT	0/1
chr11	1481963	1481963	C	-	UTR3	BRSK2	NM_001256627:c.*10delC;NM_001256630:c.*10delC	.	.	0.779570081	0.220416998	1.29E-05	.	0.16676	0.10676	-1.506435464	3.544468035	64.45039	1.64641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	18	chr11	1481962	chr11:1481962	GC	G	56	PASS	AN=2;DP=18	GT	0/1
chr11	2975961	2975961	C	T	intronic	NAP1L4	.	.	.	0.99573103	0.004268896	7.38E-08	.	0.45495	0.10887	-0.159704656	41.90846898	741.74824	5.40816	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr11	2975961	chr11:2975961	C	T	.	PASS	AN=0;DP=55	GT	0/1
chr11	3047792	3047792	T	C	intronic	CARS	.	.	.	2.96E-06	0.999273135	0.000723902	DISEASE: Note=A chromosomal aberration involving CARS is associated with inflammatory myofibroblastic tumors (IMTs). Translocation t(2;11)(p23;p15) with ALK.; 	0.17352	0.23298	-0.394936437	27.02878037	1461.59792	7.13029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	120	chr11	3047792	chr11:3047792	T	C	119	PASS	AN=2;DP=120	GT	0/1
chr11	3845201	3845201	C	T	exonic	PGAP2	.	nonsynonymous SNV	PGAP2:NM_001256239:exon3:c.C254T:p.S85L,PGAP2:NM_001256240:exon3:c.C254T:p.S85L,PGAP2:NM_001145438:exon4:c.C425T:p.S142L,PGAP2:NM_001256237:exon4:c.C425T:p.S142L,PGAP2:NM_001256238:exon4:c.C254T:p.S85L,PGAP2:NM_001283038:exon4:c.C425T:p.S142L,PGAP2:NM_001346397:exon4:c.C407T:p.S136L,PGAP2:NM_001346398:exon4:c.C254T:p.S85L,PGAP2:NM_001346400:exon4:c.C254T:p.S85L,PGAP2:NM_001346404:exon4:c.C254T:p.S85L,PGAP2:NM_001346405:exon4:c.C254T:p.S85L,PGAP2:NM_014489:exon4:c.C437T:p.S146L,PGAP2:NM_001256235:exon5:c.C308T:p.S103L,PGAP2:NM_001256236:exon5:c.C608T:p.S203L,PGAP2:NM_001346402:exon5:c.C374T:p.S125L,PGAP2:NM_001346403:exon5:c.C437T:p.S146L	0.15222416	0.830890196	0.016885643	.	.	.	-0.291981272	33.20358575	.	.	0.18	0.721	T	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	1.76	0.459	L	1.04	0.402	T	-3.6	0.726	D	0.949	0.945	-0.886	0.493	T	0.219	0.582	T	0.018	0.406	T	5.634	0.768	26.6	0.999	0.976	0.933	0.577	D	c	0.719	0.737	1.000	0.747	0.719	0.830	0	5.86	0.939	7.090	0.764	0.935	0.490	1.000	0.715	0.930	0.404	15.677	0.770	.	.	.	0.5	.	102	chr11	3845201	chr11:3845201	C	T	.	PASS	AN=0;DP=102	GT	0/1
chr11	5510245	5510245	G	C	exonic	OR52D1	.	nonsynonymous SNV	OR52D1:NM_001005163:exon1:c.G309C:p.Q103H	0.003674386	0.630310019	0.366015595	.	0.2152	.	0.553050905	81.54635527	3127.66018	10.64209	0.006	0.614	D	1.0	0.899	D	0.998	0.875	D	0.000	0.629	D	1	0.810	D	4.25	0.981	H	7.2	0.005	T	-4.87	0.812	D	0.79	0.780	-1.093	0.050	T	0.010	0.039	T	0.005	0.126	T	3.717	0.504	23.3	0.997	0.789	0.968	0.711	D	c	0.631	0.414	1.000	0.747	0.487	0.133	0	2.62	0.302	1.456	0.346	1.048	0.713	0.994	0.380	0.624	0.293	10.999	0.466	GPCR, rhodopsin-like, 7TM	.	.	0.5	65	58	chr11	5510245	chr11:5510245	G	C	65	PASS	AN=2;DP=58	GT	0/1
chr11	7673080	7673080	G	C	intronic	PPFIBP2	.	.	.	1.42E-18	0.07197208	0.92802792	.	0.12626	0.10279	-0.279250919	33.56923803	1831.97955	7.88761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	196	chr11	7673080	chr11:7673080	G	C	56	PASS	AN=2;DP=196	GT	0/1
chr11	8934008	8934008	G	C	exonic	AKIP1	.	nonsynonymous SNV	AKIP1:NM_001206647:exon3:c.G231C:p.E77D,AKIP1:NM_020642:exon3:c.G231C:p.E77D	1.86E-05	0.265853082	0.734128348	.	0.03648	0.0643	1.060147109	91.46614768	910.85343	5.87002	0.241	0.200	T	0.044	0.203	B	0.041	0.226	B	0.076	0.212	N	1.000	0.286	N	1.64	0.420	L	1.2	0.386	T	-0.88	0.287	N	0.115	0.163	-1.048	0.149	T	0.058	0.244	T	0.005	0.137	T	0.925	0.182	10.23	0.949	0.252	0.015	0.050	N	c	-0.914	-0.944	1.000	0.517	0.660	0.490	0	-3.52	0.044	-0.596	0.058	-0.010	0.132	0.034	0.205	0.974	0.471	1.336	0.020	.	.	.	0.5	70	63	chr11	8934008	chr11:8934008	G	C	70	PASS	AN=2;DP=63	GT	0/1
chr11	17519742	17519742	C	G	exonic	USH1C	.	nonsynonymous SNV	USH1C:NM_001297764:exon18:c.G1500C:p.E500D,USH1C:NM_005709:exon19:c.G1557C:p.E519D,USH1C:NM_153676:exon24:c.G2457C:p.E819D	2.72E-12	0.964484478	0.035515522	DISEASE: Usher syndrome 1C (USH1C) [MIM:276904]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:10973247}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 18A (DFNB18A) [MIM:602092]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12107438}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07835	0.169	-0.40608828	25.86694975	3991.78955	12.49143	0.089	0.486	T	0.006	0.205	B	0.016	0.254	B	0.000	0.629	D	0.998	0.281	P	0.345	0.112	N	1.69	0.270	T	-1.43	0.356	N	0.128	0.202	-0.959	0.394	T	0.000	0.000	T	.	.	.	4.604	0.617	24.4	0.996	0.763	0.694	0.339	D	c	-0.392	-0.193	1.000	0.747	0.696	0.573	0	3.37	0.375	0.448	0.213	0.935	0.490	0.999	0.424	0.992	0.562	11.099	0.472	PDZ domain	.	.	0.5	86	15	chr11	17519742	chr11:17519742	C	G	86	PASS	AN=2;DP=15	GT	1/0
chr11	18291388	18291388	C	T	exonic	SAA1	.	nonsynonymous SNV	SAA1:NM_000331:exon4:c.C355T:p.P119S,SAA1:NM_199161:exon4:c.C355T:p.P119S,SAA1:NM_001178006:exon5:c.C355T:p.P119S	0.181814611	0.765265056	0.052920333	DISEASE: Note=Reactive, secondary amyloidosis is characterized by the extracellular accumulation in various tissues of the SAA1 protein. These deposits are highly insoluble and resistant to proteolysis; they disrupt tissue structure and compromise function. {ECO:0000269|PubMed:1463770}.; DISEASE: Note=Elevated serum SAA1 protein levels may be associated with lung cancer. {ECO:0000269|PubMed:1463770}.; 	0.07473	0.51812	0.103030231	61.2762444	286.88113	3.62775	0.05	0.395	D	0.999	0.764	D	0.996	0.832	D	0.000	0.477	D	0.997	0.437	D	2.925	0.847	M	2.78	0.113	T	-5.76	0.878	D	0.536	0.591	-0.884	0.495	T	0.107	0.390	T	0.004	0.093	T	5.605	0.763	26.5	0.998	0.926	0.843	0.431	D	c	0.630	0.481	1.000	0.517	0.581	0.326	0	3.55	0.396	3.416	0.522	0.932	0.445	1.000	0.715	0.989	0.536	12.917	0.574	.	.	.	0.5	.	57	chr11	18291388	chr11:18291388	C	T	.	PASS	AN=0;DP=57	GT	0/1
chr11	45275989	45275989	A	T	intronic	SYT13	.	.	.	0.220165779	0.771535728	0.008298494	.	0.15386	0.125	-0.534490515	20.70063694	43.04749	1.24539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	54	chr11	45275989	chr11:45275989	A	T	65	PASS	AN=2;DP=54	GT	0/1
chr11	49071098	49071098	C	A	intergenic	TRIM49B;TRIM64C	dist=11569;dist=4168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	chr11	49071098	chr11:49071098	C	A	.	PASS	AN=0;DP=57	GT	0/1
chr11	57070189	57070189	G	A	exonic	TNKS1BP1	.	nonsynonymous SNV	TNKS1BP1:NM_033396:exon7:c.C4427T:p.S1476L	0.02971088	0.970285547	3.57E-06	.	0.31646	0.09844	1.91638269	97.43453645	1715.46291	7.63566	0.606	0.055	T	0.054	0.212	B	0.013	0.154	B	0.449	0.125	N	1	0.090	N	1.545	0.392	L	1.25	0.365	T	-2.85	0.600	D	0.165	0.199	-1.036	0.185	T	0.054	0.228	T	0.018	0.399	T	0.512	0.143	7.519	0.379	0.025	0.046	0.101	N	c	-1.327	-1.331	0.986	0.309	0.707	0.730	0	1.4	0.213	0.211	0.171	0.134	0.217	0.000	0.063	0.002	0.062	9.581	0.385	.	.	.	0.5	.	27	chr11	57070189	chr11:57070189	G	A	.	PASS	AN=0;DP=27	GT	0/1
chr11	63256434	63256434	A	T	exonic	HRASLS5	.	nonsynonymous SNV	HRASLS5:NM_001146728:exon3:c.T284A:p.V95D,HRASLS5:NM_001146729:exon3:c.T254A:p.V85D,HRASLS5:NM_054108:exon3:c.T284A:p.V95D	0.00012337	0.619627423	0.380249207	.	0.04664	0.06022	1.484536216	95.31729181	289.40446	3.63903	0.0	0.912	D	0.828	0.441	P	0.372	0.418	B	0.000	0.004	N	1	0.090	N	0.805	0.203	L	1.41	0.334	T	-1.38	0.399	N	0.189	0.466	-1.038	0.179	T	0.055	0.233	T	0.002	0.043	T	1.656	0.260	14.16	0.858	0.156	0.056	0.114	N	c	-0.827	-0.986	1.000	0.416	0.706	0.609	0	-1.01	0.096	0.074	0.144	0.196	0.251	0.000	0.063	0.006	0.095	4.370	0.106	.	.	.	0.5	77	68	chr11	63256434	chr11:63256434	A	T	77	PASS	AN=2;DP=68	GT	0/1
chr11	63970809	63970809	C	T	intronic	STIP1	.	.	.	0.999887764	0.000112236	1.04E-11	.	0.65119	0.18755	-0.558357437	19.54470394	25.94299	0.8431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	25	chr11	63970809	chr11:63970809	C	T	66	PASS	AN=2;DP=25	GT	0/1
chr11	64693059	64693059	-	G	UTR5	PPP2R5B	NM_006244:c.-148_-147insG	.	.	0.932458812	0.06752751	1.37E-05	.	0.16145	0.10681	-0.538132194	20.26421326	15.72909	0.56074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	27	chr11	64693059	chr11:64693059	T	TG	42	PASS	AN=2;DP=27	GT	0/1
chr11	66249674	66249674	G	T	exonic	DPP3	.	nonsynonymous SNV	DPP3:NM_001256670:exon2:c.G3T:p.M1I,DPP3:NM_005700:exon2:c.G3T:p.M1I,DPP3:NM_130443:exon2:c.G3T:p.M1I	4.36E-09	0.939852021	0.060147975	.	.	0.29988	0.874458024	88.88888889	4443.48457	13.35156	0.034	0.538	D	0.225	0.342	B	0.047	0.264	B	0.000	0.843	D	1	0.810	D	.	.	.	1.98	0.433	T	-1.86	0.452	N	0.944	0.939	-1.010	0.269	T	0.093	0.355	T	0.050	0.642	D	4.266	0.571	23.9	0.996	0.722	0.995	0.970	D	c	0.323	0.476	1.000	0.747	0.742	0.980	0	5.71	0.890	7.961	0.874	0.948	0.535	1.000	0.715	1.000	0.888	15.355	0.740	.	.	.	0.5	.	65	chr11	66249674	chr11:66249674	G	T	.	PASS	AN=0;DP=65	GT	0/1
chr11	66512290	66512290	-	GGC	exonic	C11orf80	.	nonframeshift insertion	C11orf80:NM_024650:exon1:c.77_78insGGC:p.A34_G35insA	0.008462596	0.978338462	0.013198942	.	0.03682	.	0.106667882	61.73036093	116.69248	2.34991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	28	chr11	66512290	chr11:66512290	G	GGGC	80	PASS	AN=2;DP=28	GT	0/1
chr11	74336608	74336608	-	A	exonic	POLD3	.	frameshift insertion	POLD3:NM_006591:exon8:c.890dupA:p.R300Kfs*8	0.991394247	0.00860567	8.29E-08	.	0.60979	0.21476	0.575097644	82.1656051	193.7509	3.02008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	40	chr11	74336608	chr11:74336608	G	GA	39	PASS	AN=2;DP=40	GT	0/1
chr11	82996972	82996972	C	G	exonic	CCDC90B	.	nonsynonymous SNV	CCDC90B:NM_021825:exon1:c.G44C:p.R15T	0.009063821	0.937639502	0.053296678	.	0.14281	0.09698	0.549415813	81.38122199	88.38564	2.01561	0.585	0.062	T	0.0	0.026	B	0.0	0.013	B	0.540	0.053	N	1	0.194	N	0.345	0.112	N	1.57	0.304	T	0.43	0.044	N	0.125	0.433	-1.016	0.249	T	0.046	0.198	T	0.004	0.108	T	-0.211	0.075	1.040	0.507	0.044	0.066	0.124	N	c	-0.980	-1.011	1.000	0.747	0.442	0.072	0	0.705	0.172	-0.555	0.060	-0.328	0.075	0.000	0.063	0.000	0.016	1.445	0.022	.	.	.	0.5	136	211	chr11	82996972	chr11:82996972	C	G	136	PASS	AN=2;DP=211	GT	1/0
chr11	86111856	86111856	-	T	intronic	CCDC81	.	.	.	2.79E-09	0.897689748	0.102310249	.	0.06368	.	1.155610133	92.59259259	889.04414	5.80784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	16	chr11	86111856	chr11:86111856	C	CT	41	PASS	AN=2;DP=16	GT	0/1
chr11	90017138	90017138	A	T	ncRNA_intronic	DISC1FP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	chr11	90017138	chr11:90017138	A	T	.	PASS	AN=0;DP=41	GT	0/1
chr11	100211936	100211936	A	G	exonic	CNTN5	.	nonsynonymous SNV	CNTN5:NM_175566:exon20:c.A2807G:p.K936R,CNTN5:NM_001243270:exon22:c.A3029G:p.K1010R,CNTN5:NM_014361:exon23:c.A3029G:p.K1010R	0.001354061	0.998643262	2.68E-06	.	0.29361	0.20972	-0.080831688	47.22222222	849.40801	5.69596	0.038	0.427	D	0.986	0.609	D	0.689	0.600	P	0.000	0.843	D	1.000	0.548	D	2.16	0.606	M	0.73	0.507	T	-1.83	0.429	N	0.602	0.670	-0.617	0.641	T	0.255	0.626	T	0.026	0.488	D	4.222	0.566	23.9	0.999	0.941	0.920	0.544	D	c	0.629	0.611	0.998	0.360	0.487	0.133	0	5.46	0.799	6.232	0.721	1.199	0.960	1.000	0.715	0.985	0.512	14.709	0.687	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	79	79	chr11	100211936	chr11:100211936	A	G	79	PASS	AN=2;DP=79	GT	0/1
chr11	119509432	119509432	C	G	intronic	NECTIN1	.	.	.	.	.	.	DISEASE: Ectodermal dysplasia, Margarita Island type (EDMI) [MIM:225060]: An autosomal recessive form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. It is a syndrome characterized by the association of cleft lip/palate, ectodermal dysplasia (sparse short and dry scalp hair, sparse eyebrows and eyelashes), and partial syndactyly of the fingers and/or toes. Two thirds of the patients do not manifest oral cleft but present with abnormal teeth and nails. {ECO:0000269|PubMed:10932188}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Non-syndromic orofacial cleft 7 (OFC7) [MIM:225060]: A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum. {ECO:0000269|PubMed:10932188}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16543	0.24625	-0.238793231	36.3116301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	70	chr11	119509432	chr11:119509432	C	G	82	PASS	AN=2;DP=70	GT	0/1
chr11	120979889	120979889	C	A	intronic	TECTA	.	.	.	1.06E-12	0.999989746	1.03E-05	DISEASE: Deafness, autosomal dominant, 12 (DFNA12) [MIM:601543]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:10196713, ECO:0000269|PubMed:10987647, ECO:0000269|PubMed:12162770, ECO:0000269|PubMed:15319541, ECO:0000269|PubMed:16718611, ECO:0000269|PubMed:17661817, ECO:0000269|PubMed:20947814, ECO:0000269|PubMed:21520338, ECO:0000269|PubMed:9590290}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 21 (DFNB21) [MIM:603629]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12746400, ECO:0000269|PubMed:9949200}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.64735	0.20702	-2.430013277	1.032083038	4846.67098	14.13953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	chr11	120979889	chr11:120979889	C	A	.	PASS	AN=0;DP=23	GT	0/1
chr11	124619690	124619690	C	T	exonic	VSIG2	.	nonsynonymous SNV	VSIG2:NM_001329920:exon4:c.G500A:p.S167N,VSIG2:NM_014312:exon4:c.G500A:p.S167N	0.000163566	0.680813504	0.31902293	.	0.10318	0.0917	-0.025608647	51.91672564	322.84124	3.81715	0.309	0.140	T	0.008	0.135	B	0.026	0.195	B	0.491	0.120	N	1	0.090	N	0.855	0.214	L	-0.23	0.667	T	-1.11	0.287	N	0.081	0.074	-0.956	0.400	T	0.189	0.541	T	0.012	0.299	T	0.576	0.149	7.987	0.896	0.184	0.268	0.229	N	c	-0.751	-0.708	1.000	0.473	0.490	0.173	0	1.08	0.194	0.375	0.201	0.059	0.165	0.997	0.399	0.510	0.273	4.931	0.132	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	34	chr11	124619690	chr11:124619690	C	T	.	PASS	AN=0;DP=34	GT	0/1
chr11	124951303	124951303	-	T	intronic	SLC37A2	.	.	.	5.01E-10	0.581719585	0.418280414	.	0.10703	0.11611	0.04598748	57.47817882	1459.43023	7.12342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	70	chr11	124951303	chr11:124951303	A	AT	40	PASS	AN=2;DP=70	GT	0/1
chr12	5155256	5155256	A	T	UTR3	KCNA5	NM_002234:c.*101A>T	.	.	0.000687392	0.747420322	0.251892286	DISEASE: Atrial fibrillation, familial, 7 (ATFB7) [MIM:612240]: A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. {ECO:0000269|PubMed:16772329}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24009	0.20636	0.799205007	87.58551545	249.24831	3.40181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr12	5155256	chr12:5155256	A	T	.	PASS	AN=0;DP=42	GT	0/1
chr12	11546856	11546858	AGA	-	exonic	PRB2	.	nonframeshift deletion	PRB2:NM_006248:exon3:c.154_156del:p.S52del	2.88E-14	0.009733594	0.990266406	.	.	.	1.932845308	97.48171739	718.49848	5.3211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	157	chr12	11546855	chr12:11546855	GAGA	G	70	PASS	AN=2;DP=157	GT	0/1
chr12	11546875	11546875	T	C	exonic	PRB2	.	nonsynonymous SNV	PRB2:NM_006248:exon3:c.A137G:p.K46R	2.88E-14	0.009733594	0.990266406	.	.	.	1.932845308	97.48171739	718.49848	5.3211	.	.	.	0.938	0.506	P	0.188	0.346	B	.	.	.	1	0.090	N	1.1	0.281	L	3.61	0.045	T	-0.44	0.146	N	0.064	0.049	-0.945	0.418	T	0.005	0.018	T	0.000	0.002	T	-1.470	0.018	0.003	0.544	0.050	0.006	0.026	N	c	-1.017	-1.168	0.000	0.012	0.554	0.246	0	0.037	0.134	0.495	0.220	-0.566	0.046	0.001	0.137	0.000	0.016	5.784	0.175	.	.	.	0.5	42	127	chr12	11546875	chr12:11546875	T	C	42	PASS	AN=2;DP=127	GT	0/1
chr12	14930344	14930344	G	C	UTR3	H2AFJ	NM_177925:c.*2550G>C	.	.	0.765927442	0.225697347	0.008375211	.	0.87835	0.13522	0.147123112	64.11299835	3.65353	0.13509	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	49	chr12	14930344	chr12:14930344	G	C	82	PASS	AN=2;DP=49	GT	0/1
chr12	14952533	14952533	T	C	intronic	WBP11	.	.	.	0.999928146	7.19E-05	1.73E-11	.	0.58677	0.11579	-0.137658575	43.57159707	100.52915	2.1724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	60	chr12	14952533	chr12:14952533	T	C	58	PASS	AN=2;DP=60	GT	0/1
chr12	15702158	15702158	T	A	exonic	PTPRO	.	nonsynonymous SNV	PTPRO:NM_030668:exon2:c.T2A:p.M1K,PTPRO:NM_030669:exon2:c.T2A:p.M1K,PTPRO:NM_030670:exon2:c.T2A:p.M1K,PTPRO:NM_030671:exon2:c.T2A:p.M1K,PTPRO:NM_002848:exon14:c.T2435A:p.M812K,PTPRO:NM_030667:exon14:c.T2435A:p.M812K	0.30462609	0.695373854	5.61E-08	DISEASE: Nephrotic syndrome 6 (NPHS6) [MIM:614196]: A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. {ECO:0000269|PubMed:21722858}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.57353	.	-1.965936983	1.828261382	172.96294	2.86316	0.008	0.912	D	0.118	0.392	B	0.01	0.331	B	0.000	0.629	D	0.759	0.367	D	1.5	0.380	L	3.86	0.041	T	-1.22	0.543	N	0.809	0.798	-0.940	0.427	T	0.009	0.031	T	0.009	0.240	T	4.555	0.610	24.4	0.963	0.287	0.982	0.801	D	c	-0.019	0.148	0.999	0.372	0.706	0.609	0	4.63	0.570	3.957	0.562	1.061	0.807	1.000	0.715	1.000	0.888	14.514	0.673	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	75	39	chr12	15702158	chr12:15702158	T	A	75	PASS	AN=2;DP=39	GT	1/0
chr12	21661377	21661377	T	C	exonic	GOLT1B	.	nonsynonymous SNV	GOLT1B:NM_016072:exon3:c.T178C:p.F60L	0.79838372	0.196019029	0.005597252	.	0.20274	0.11262	0.501689326	79.7888653	47.70445	1.342	0.08	0.501	T	0.127	0.254	B	0.241	0.369	B	0.000	0.843	D	1	0.810	D	1.585	0.400	L	0.9	0.453	T	-5.3	0.844	D	0.814	0.802	-0.890	0.489	T	0.155	0.487	T	0.012	0.312	T	6.079	0.837	28.2	0.999	0.984	0.987	0.862	D	c	0.316	0.464	1.000	0.747	0.719	0.830	0	5.9	0.949	7.972	0.875	1.042	0.661	1.000	0.715	0.998	0.697	16.332	0.828	.	.	.	0.5	107	44	chr12	21661377	chr12:21661377	T	C	107	PASS	AN=2;DP=44	GT	0/1
chr12	21958999	21958999	A	-	intronic	ABCC9	.	.	.	0.000700543	0.999299455	2.34E-09	DISEASE: Cardiomyopathy, dilated 1O (CMD1O) [MIM:608569]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:15034580}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atrial fibrillation, familial, 12 (ATFB12) [MIM:614050]: A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. {ECO:0000269|PubMed:17245405}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hypertrichotic osteochondrodysplasia (HTOCD) [MIM:239850]: A rare disorder characterized by congenital hypertrichosis, neonatal macrosomia, a distinct osteochondrodysplasia, and cardiomegaly. The hypertrichosis leads to thick scalp hair, which extends onto the forehead, and a general increase in body hair. In addition, macrocephaly and coarse facial features, including a broad nasal bridge, epicanthal folds, a wide mouth, and full lips, can be suggestive of a storage disorder. About half of affected individuals are macrosomic and edematous at birth, whereas in childhood they usually have a muscular appearance with little subcutaneous fat. Thickened calvarium, narrow thorax, wide ribs, flattened or ovoid vertebral bodies, coxa valga, osteopenia, enlarged medullary canals, and metaphyseal widening of long bones have been reported. Cardiac manifestations such as patent ductus arteriosus, ventricular hypertrophy, pulmonary hypertension, and pericardial effusions are present in approximately 80% of cases. Motor development is usually delayed due to hypotonia. Most patients have a mild speech delay, and a small percentage have learning difficulties or intellectual disability. {ECO:0000269|PubMed:22608503, ECO:0000269|PubMed:22610116}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11236	0.15685	-1.967739992	1.816466148	117.11773	2.35297	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	16	chr12	21958998	chr12:21958998	CA	C	50	PASS	AN=2;DP=16	GT	0/1
chr12	25361440	25361440	A	-	UTR3	KRAS	NM_033360:c.*1410delT;NM_004985:c.*1289delT	.	.	0.001061193	0.603148256	0.395790551	DISEASE: Leukemia, acute myelogenous (AML) [MIM:601626]: A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes. {ECO:0000269|PubMed:8955068}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. {ECO:0000269|PubMed:17332249}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Noonan syndrome 3 (NS3) [MIM:609942]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. {ECO:0000269|PubMed:16474405, ECO:0000269|PubMed:16773572, ECO:0000269|PubMed:17056636, ECO:0000269|PubMed:17468812, ECO:0000269|PubMed:19396835}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. {ECO:0000269|PubMed:14534542, ECO:0000269|PubMed:3034404, ECO:0000269|PubMed:7773929}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in KRAS are a cause of pylocytic astrocytoma (PA). Pylocytic astrocytomas are neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. {ECO:0000269|PubMed:16247081}.; DISEASE: Cardiofaciocutaneous syndrome 2 (CFC2) [MIM:615278]: A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. CFC2 patients often do not have the skin abnormalities, such as ichthyosis, hyperkeratosis, and hemangioma observed in CFC1. {ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:16474405, ECO:0000269|PubMed:17056636, ECO:0000269|PubMed:21797849}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=KRAS mutations are involved in cancer development. {ECO:0000269|PubMed:14534542, ECO:0000269|PubMed:1553789, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:3034404, ECO:0000269|PubMed:3627975, ECO:0000269|PubMed:6092920, ECO:0000269|PubMed:6695174, ECO:0000269|PubMed:7773929}.; 	0.99997	0.53296	-0.141298762	42.87567823	3.46519	0.12617	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	22.48	91	chr12	25361439	chr12:25361439	TA	T	22.48	PASS	AN=0;DP=91	GT	0/1
chr12	29521181	29521181	C	A	exonic	ERGIC2	.	nonsynonymous SNV	ERGIC2:NM_016570:exon4:c.G255T:p.K85N	0.320357206	0.678925092	0.000717702	.	0.84052	0.08503	-0.339715008	30.06605331	9.56131	0.35232	0.098	0.318	T	0.563	0.365	P	0.487	0.454	P	0.000	0.559	D	0.915	0.365	D	2.38	0.688	M	.	.	.	-2.07	0.537	N	0.192	0.282	-0.273	0.758	T	0.327	0.696	T	0.010	0.257	T	5.379	0.729	25.9	0.998	0.917	0.953	0.640	D	c	0.319	0.368	0.059	0.152	0.732	0.924	0	5.37	0.769	0.998	0.291	0.875	0.382	1.000	0.715	1.000	0.888	16.644	0.850	.	.	.	0.5	.	57	chr12	29521181	chr12:29521181	C	A	.	PASS	AN=0;DP=57	GT	0/1
chr12	31595764	31595764	C	A	exonic	DENND5B	.	nonsynonymous SNV	DENND5B:NM_144973:exon7:c.G1957T:p.G653W,DENND5B:NM_001308339:exon9:c.G2062T:p.G688W	0.999945504	5.45E-05	3.62E-13	.	.	.	-0.440847477	24.59896202	5379.04327	15.1245	0.001	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.695	0.791	M	3.38	0.098	T	-4.2	0.778	D	0.897	0.897	-1.050	0.143	T	0.092	0.352	T	0.024	0.470	T	7.733	0.955	35	0.996	0.754	0.981	0.796	D	c	0.796	0.752	1.000	0.747	0.706	0.609	0	4.77	0.603	7.705	0.835	0.892	0.403	1.000	0.715	1.000	0.888	18.000	0.891	.	.	.	0.5	.	34	chr12	31595764	chr12:31595764	C	A	.	PASS	AN=0;DP=34	GT	0/1
chr12	40011027	40011027	T	-	intronic	ABCD2	.	.	.	2.97E-06	0.927390257	0.072606773	.	0.08475	0.19889	-0.091746757	46.91554612	167.46052	2.82724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	16	chr12	40011025	chr12:40011025	CTT	CT,C	76	PASS	AN=2;DP=16	GT	1/0
chr12	40011026	40011027	TT	-	intronic	ABCD2	.	.	.	2.97E-06	0.927390257	0.072606773	.	0.08475	0.19889	-0.091746757	46.91554612	167.46052	2.82724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	16	chr12	40011025	chr12:40011025	CTT	CT,C	76	PASS	AN=2;DP=16	GT	1/0
chr12	48184255	48184256	AG	-	intronic	HDAC7	.	.	.	0.998019873	0.001980126	4.64E-10	.	0.1103	.	-0.038558137	50.51899033	940.4494	5.94619	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	51	chr12	48184254	chr12:48184254	AAG	A	53	PASS	AN=2;DP=51	GT	0/1
chr12	48191101	48191101	C	T	intronic	HDAC7	.	.	.	0.998019873	0.001980126	4.64E-10	.	0.1103	.	-0.038558137	50.51899033	940.4494	5.94619	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	212	chr12	48191101	chr12:48191101	C	T	76	PASS	AN=2;DP=212	GT	0/1
chr12	58157466	58157466	G	T	exonic	CYP27B1	.	synonymous SNV	CYP27B1:NM_000785:exon8:c.C1341A:p.P447P	3.60E-06	0.806445692	0.193550707	.	0.09767	0.39937	-0.404032746	26.53338051	111.70148	2.30098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	chr12	58157466	chr12:58157466	G	T	.	PASS	AN=0;DP=69	GT	0/1
chr12	62148744	62148744	G	T	exonic	FAM19A2	.	nonsynonymous SNV	FAM19A2:NM_178539:exon3:c.C168A:p.N56K	0.54745717	0.438689922	0.013852908	.	0.48543	0.09934	0.21326276	67.71644256	15.92723	0.56478	0.017	0.555	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	0.984	0.810	D	2.52	0.738	M	.	.	.	-5.93	0.895	D	0.352	0.415	-0.189	0.780	T	0.421	0.767	T	0.070	0.709	D	5.694	0.777	26.8	0.998	0.909	0.962	0.676	D	c	0.739	0.709	0.000	0.071	0.554	0.246	0	5.42	0.786	4.717	0.614	1.048	0.713	1.000	0.715	1.000	0.888	10.800	0.455	.	.	.	0.5	59	38	chr12	62148744	chr12:62148744	G	T	59	PASS	AN=2;DP=38	GT	0/1
chr12	104461712	104461712	T	-	intronic	HCFC2	.	.	.	0.994468276	0.005531718	5.69E-09	.	0.54137	0.20015	0.084621747	60.31493277	202.17732	3.06842	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	46	chr12	104461711	chr12:104461711	CT	C	43	PASS	AN=2;DP=46	GT	0/1
chr12	108012065	108012065	A	C	exonic	BTBD11	.	nonsynonymous SNV	BTBD11:NM_001017523:exon8:c.A973C:p.S325R,BTBD11:NM_001018072:exon10:c.A2362C:p.S788R	0.993432981	0.00656701	8.66E-09	.	0.42445	0.12301	-0.462894052	23.62585515	7389.82344	18.4572	0.047	0.403	D	0.838	0.715	P	0.367	0.649	B	0.000	0.843	D	1.000	0.810	D	1.355	0.339	L	1.28	0.396	T	-1.65	0.395	N	0.562	0.647	-0.867	0.508	T	0.172	0.515	T	0.019	0.417	T	3.696	0.501	23.3	0.998	0.917	0.959	0.666	D	c	0.473	0.512	1.000	0.489	0.638	0.428	0	5.07	0.680	5.381	0.657	1.199	0.960	1.000	0.715	1.000	0.888	15.123	0.720	.	.	.	0.5	.	62	chr12	108012065	chr12:108012065	A	C	.	PASS	AN=0;DP=62	GT	0/1
chr12	109696754	109696754	G	T	intronic	ACACB	.	.	.	5.12E-22	0.999983957	1.60E-05	.	0.16354	0.41174	-1.974635129	1.775182826	3979.35991	12.47962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	74	chr12	109696754	chr12:109696754	G	T	.	PASS	AN=0;DP=74	GT	0/1
chr12	109921356	109921356	C	A	UTR5	UBE3B	NM_130466:c.-1C>A;NM_001270449:c.-1C>A;NM_001270450:c.-1C>A;NM_001270451:c.-1C>A;NM_183415:c.-1C>A	.	.	0.009387706	0.990612131	1.63E-07	.	0.19362	0.09343	-2.232421897	1.315168672	170.30974	2.84773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	chr12	109921356	chr12:109921356	C	A	.	PASS	AN=0;DP=47	GT	0/1
chr12	111375005	111375005	T	C	ncRNA_exonic	LINC01405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	75	chr12	111375005	chr12:111375005	T	C	.	PASS	AN=0;DP=75	GT	0/1
chr12	111885600	111885600	C	G	exonic	SH2B3	.	synonymous SNV	SH2B3:NM_001291424:exon6:c.C771G:p.S257S,SH2B3:NM_005475:exon7:c.C1377G:p.S459S	0.00592219	0.972368399	0.021709411	DISEASE: Celiac disease 13 (CELIAC13) [MIM:612011]: A multifactorial, chronic disorder of the small intestine caused by intolerance to gluten. It is characterized by immune-mediated enteropathy associated with failed intestinal absorption, and malnutrition. In predisposed individuals, the ingestion of gluten- containing food such as wheat and rye induces a flat jejunal mucosa with infiltration of lymphocytes. {ECO:0000269|PubMed:18311140}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, insulin-dependent (IDDM) [MIM:222100]: A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:17554260}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.78211	0.35815	.	.	1095.64678	6.33313	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	186	chr12	111885600	chr12:111885600	C	G	121	PASS	AN=2;DP=186	GT	0/1
chr12	120806124	120806124	C	-	intronic	MSI1	.	.	.	0.997146451	0.002853413	1.36E-07	.	0.66447	0.10166	-0.161524709	41.6430762	9.92984	0.36366	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	134	chr12	120806123	chr12:120806123	TC	T	93	PASS	AN=2;DP=134	GT	0/1
chr12	122803726	122803726	C	G	intronic	CLIP1	.	.	.	0.968496014	0.031503986	1.39E-10	.	0.46737	0.3229	-1.098660656	6.95329087	8478.17859	19.85973	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	18	chr12	122803726	chr12:122803726	C	G	61	PASS	AN=2;DP=18	GT	0/1
chr12	130923006	130923006	G	A	exonic	RIMBP2	.	synonymous SNV	RIMBP2:NM_015347:exon10:c.C1509T:p.T503T,RIMBP2:NM_001351227:exon11:c.C1560T:p.T520T,RIMBP2:NM_001351226:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351228:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351229:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351230:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351231:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351232:exon12:c.C1560T:p.T520T,RIMBP2:NM_001351233:exon13:c.C1233T:p.T411T	0.292582176	0.707410338	7.49E-06	.	0.1263	0.10358	-2.070835943	1.615947157	308.7902	3.74029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	169	chr12	130923006	chr12:130923006	G	A	.	PASS	AN=0;DP=169	GT	0/1
chr12	132635999	132635999	G	T	intronic	NOC4L	.	.	.	.	.	.	.	0.5431	0.11298	-1.280491183	5.16631281	149.35551	2.66469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	chr12	132635999	chr12:132635999	G	T	.	PASS	AN=0;DP=47	GT	0/1
chr13	20006737	20006737	C	T	intronic	TPTE2	.	.	.	3.69E-08	0.98450594	0.015494023	.	0.07785	0.18826	-0.178111357	40.44585987	120.84753	2.39632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	86	chr13	20006737	chr13:20006737	C	T	60	PASS	AN=2;DP=86	GT	0/1
chr13	28519633	28519633	C	G	intergenic	PDX1;LINC00543	dist=19182;dist=8030	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	15	chr13	28519633	chr13:28519633	C	G	.	PASS	AN=0;DP=15	GT	0/1
chr13	46946629	46946629	G	T	UTR5	RUBCNL	NM_001286762:c.-19C>A;NM_001349772:c.-19C>A;NM_025113:c.-19C>A;NM_001286761:c.-19C>A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	chr13	46946629	chr13:46946629	G	T	.	PASS	AN=0;DP=23	GT	0/1
chr13	102047543	102047543	G	T	exonic	NALCN	.	synonymous SNV	NALCN:NM_001350748:exon3:c.C282A:p.G94G,NALCN:NM_001350749:exon3:c.C282A:p.G94G,NALCN:NM_001350750:exon3:c.C282A:p.G94G,NALCN:NM_001350751:exon3:c.C282A:p.G94G,NALCN:NM_052867:exon3:c.C282A:p.G94G	0.000169004	0.999830996	3.03E-11	DISEASE: Hypotonia, infantile, with psychomotor retardation and characteristic facies (IHPRF) [MIM:615419]: A neurodegenerative disease characterized by variable degrees of hypotonia, speech impairment, intellectual disability, pyramidal signs, subtle facial dysmorphism, and chronic constipation. Some patients manifest neuroaxonal dystrophy, optic atrophy, unmyelinated axons and spheroid bodies in tissue biopsies. {ECO:0000269|PubMed:23749988, ECO:0000269|PubMed:24075186}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]: A disease characterized by congenital contractures of the limbs and face, resulting in characteristic facial features, abnormal tone, most commonly manifested as hypotonia, and variable degrees of developmental delay. {ECO:0000269|PubMed:25683120}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43129	0.10307	-1.611264137	2.984194385	137.54866	2.55255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	58	chr13	102047543	chr13:102047543	G	T	80	PASS	AN=2;DP=58	GT	0/1
chr13	102106265	102106265	C	A	exonic	ITGBL1	.	synonymous SNV	ITGBL1:NM_001271755:exon2:c.C130A:p.R44R,ITGBL1:NM_004791:exon2:c.C130A:p.R44R	0.170877824	0.828540578	0.000581598	.	0.17697	0.12974	0.64123826	83.97617363	1434.7471	7.07106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	chr13	102106265	chr13:102106265	C	A	.	PASS	AN=0;DP=27	GT	0/1
chr13	103449265	103449265	T	C	exonic	KDELC1	.	nonsynonymous SNV	KDELC1:NM_024089:exon2:c.A277G:p.K93E	6.42E-06	0.892032262	0.10796132	.	0.13538	0.0976	-0.091746757	46.91554612	4102.6627	12.70963	0.094	0.313	T	0.172	0.271	B	0.155	0.328	B	0.000	0.497	D	1.000	0.493	D	2.62	0.769	M	-1.82	0.841	D	-1.58	0.381	N	0.539	0.577	-0.026	0.817	T	0.576	0.847	D	0.057	0.668	D	2.440	0.354	19.08	0.997	0.835	0.952	0.634	D	c	0.159	0.290	1.000	0.747	0.706	0.609	0	5.69	0.883	3.377	0.519	0.961	0.567	1.000	0.715	1.000	0.888	16.248	0.822	Immunoglobulin E-set|Immunoglobulin-like fold	.	.	0.5	74	56	chr13	103449265	chr13:103449265	T	C	74	PASS	AN=2;DP=56	GT	0/1
chr13	111944635	111944635	A	G	exonic	ARHGEF7	.	nonsynonymous SNV	ARHGEF7:NM_001320854:exon14:c.A1600G:p.T534A,ARHGEF7:NM_001330598:exon17:c.A1834G:p.T612A,ARHGEF7:NM_001113512:exon18:c.A2218G:p.T740A,ARHGEF7:NM_001330597:exon19:c.A1834G:p.T612A,ARHGEF7:NM_145735:exon19:c.A2305G:p.T769A,ARHGEF7:NM_001113511:exon20:c.A2368G:p.T790A	0.953985931	0.046013857	2.13E-07	.	0.22379	0.62409	-1.03976177	7.802547771	94.43621	2.0915	1.0	0.026	T	0.0	0.026	B	0.0	0.040	B	0.003	0.357	N	0.937	0.810	D	1.1	0.281	L	0.76	0.608	T	-0.27	0.114	N	0.043	0.023	-1.095	0.048	T	0.077	0.309	T	0.006	0.155	T	0.702	0.161	8.841	0.829	0.140	0.680	0.334	D	c	-0.664	-0.444	0.986	0.310	0.372	0.050	0	3.24	0.361	1.431	0.343	-0.252	0.090	1.000	0.715	0.994	0.587	7.416	0.261	.	.	.	0.5	41	53	chr13	111944635	chr13:111944635	A	G	41	PASS	AN=2;DP=53	GT	0/1
chr14	19807304	19807304	T	A	intergenic	DUXAP10;LINC01296	dist=114388;dist=72905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	108	chr14	19807304	chr14:19807304	T	A	.	PASS	AN=0;DP=108	GT	0/1
chr14	19889720	19889720	G	C	ncRNA_intronic	BMS1P22;DUXAP10;LINC01296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.337	0.066	0.545	0.456	0.036	0.003	0.017	N	n	-0.404	-0.229	0.000	0.012	0.075	0.013	0	.	.	0.939	0.284	0.209	0.254	0.004	0.165	0.004	0.083	.	.	.	.	.	0.5	109	486	chr14	19889720	chr14:19889720	G	C	109	PASS	AN=2;DP=486	GT	0/1
chr14	21931820	21931820	C	G	exonic	RAB2B	.	nonsynonymous SNV	RAB2B:NM_001163380:exon5:c.G331C:p.E111Q,RAB2B:NM_032846:exon6:c.G469C:p.E157Q	0.000147822	0.659028489	0.340823689	.	0.37953	0.11262	0.014844891	54.94810097	24.84507	0.81541	0.001	0.784	D	0.979	0.585	D	0.846	0.587	P	0.000	0.629	D	1	0.810	D	0.965	0.241	L	-1.19	0.784	T	-2.57	0.555	D	0.546	0.583	0.051	0.833	D	0.532	0.827	D	0.046	0.626	D	6.274	0.866	29.0	0.998	0.847	0.985	0.837	D	c	0.731	0.780	1.000	0.747	0.732	0.924	0	6.01	0.974	7.681	0.833	0.932	0.445	1.000	0.715	1.000	0.888	19.286	0.940	P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	56	48	chr14	21931820	chr14:21931820	C	G	56	PASS	AN=2;DP=48	GT	0/1
chr14	22038042	22038042	C	A	exonic	OR10G3	.	synonymous SNV	OR10G3:NM_001005465:exon1:c.G834T:p.T278T	0.234560474	0.645560257	0.119879269	.	0.12713	0.09782	1.174022298	92.72823779	733.81635	5.37359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	106	chr14	22038042	chr14:22038042	C	A	99	PASS	AN=2;DP=106	GT	0/1
chr14	23445934	23445934	G	C	UTR5	AJUBA	NM_198086:c.-1633C>G	.	.	0.833400048	0.166570625	2.93E-05	.	0.11613	0.11895	.	.	120.81183	2.39516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	49	chr14	23445934	chr14:23445934	G	C	63	PASS	AN=2;DP=49	GT	0/1
chr14	24610079	24610079	C	T	intronic	EMC9	.	.	.	0.000353828	0.606584552	0.39306162	.	0.19996	0.09543	0.283038099	71.26680821	78.56922	1.87008	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	196	chr14	24610079	chr14:24610079	C	T	59	PASS	AN=2;DP=196	GT	0/1
chr14	47120678	47120678	G	A	exonic	RPL10L	.	stopgain	RPL10L:NM_080746:exon1:c.C262T:p.R88X	0.02605492	0.787247686	0.186697394	.	0.97891	0.12334	0.17280645	65.75843359	88.18617	2.01137	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.141	0.973	37	0.998	0.916	0.835	0.423	D	c	0.658	0.470	0.000	0.048	0.487	0.133	0	2.27	0.274	6.074	0.707	0.953	0.551	1.000	0.715	1.000	0.888	11.021	0.467	Ribosomal protein L10e/L16	.	.	0.5	.	49	chr14	47120678	chr14:47120678	G	A	.	PASS	AN=0;DP=49	GT	0/1
chr14	53064965	53064965	T	-	intronic	GPR137C	.	.	.	0.695444477	0.303743533	0.000811989	.	0.18845	.	-0.315847836	31.68789809	2850.01654	10.09383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	26	chr14	53064964	chr14:53064964	AT	A	40	PASS	AN=2;DP=26	GT	0/1
chr14	67648273	67648273	G	A	UTR3	GPHN	NM_020806:c.*619G>A;NM_001024218:c.*619G>A	.	.	0.999981473	1.85E-05	1.29E-13	DISEASE: Molybdenum cofactor deficiency, complementation group C (MOCODC) [MIM:615501]: A form of molybdenum cofactor deficiency, an autosomal recessive metabolic disorder leading to the pleiotropic loss of molybdoenzyme activities. It is clinically characterized by onset in infancy of poor feeding, intractable seizures, severe psychomotor retardation, and death in early childhood in most patients. {ECO:0000269|PubMed:11095995, ECO:0000269|PubMed:22040219}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13794	0.40936	0.062575634	58.74026893	27.01369	0.87259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	chr14	67648273	chr14:67648273	G	A	.	PASS	AN=0;DP=46	GT	0/1
chr14	68221767	68221767	C	T	splicing	ZFYVE26	NM_015346:exon37:c.6986+1G>A	.	.	1.04E-11	0.999999984	1.60E-08	DISEASE: Spastic paraplegia 15, autosomal recessive (SPG15) [MIM:270700]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG15 is a complex form associated with additional neurological symptoms such as cognitive deterioration or mental retardation, axonal neuropathy, mild cerebellar signs, and, less frequently, a central hearing deficit, decreased visual acuity, or retinal degeneration. {ECO:0000269|PubMed:18394578, ECO:0000269|PubMed:19084844, ECO:0000269|PubMed:19805727}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.0833	0.10527	-0.274087418	33.5928285	2850.19714	10.09609	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.773	0.789	27.0	0.996	0.723	0.998	0.992	D	c	1.136	0.988	1.000	0.747	0.156	0.027	0	5.31	0.750	7.310	0.781	0.935	0.490	1.000	0.715	0.967	0.454	19.337	0.943	.	.	.	0.5	43	52	chr14	68221767	chr14:68221767	C	T	43	PASS	AN=2;DP=52	GT	0/1
chr14	74876120	74876120	G	T	exonic	SYNDIG1L	.	nonsynonymous SNV	SYNDIG1L:NM_001105579:exon2:c.C328A:p.Q110K	0.003664182	0.629708936	0.366626881	.	0.14052	.	0.571462851	81.99457419	795.52044	5.55885	1.0	0.010	T	0.008	0.135	B	0.011	0.145	B	0.684	0.061	N	1	0.090	N	2.135	0.597	M	-3.63	0.951	D	-0.64	0.187	N	0.169	0.204	-0.221	0.772	T	0.721	0.905	D	0.037	0.575	D	-1.358	0.020	0.004	0.562	0.054	0.437	0.269	N	c	-0.604	-0.574	0.999	0.371	0.615	0.372	0	3.69	0.413	2.897	0.481	0.994	0.605	0.344	0.255	0.004	0.083	13.224	0.592	.	.	.	0.5	.	46	chr14	74876120	chr14:74876120	G	T	.	PASS	AN=0;DP=46	GT	0/1
chr14	75279493	75279493	C	T	intronic	YLPM1	.	.	.	0.999933059	6.69E-05	3.39E-19	.	.	0.10158	-2.445873847	1.020287804	805.81445	5.59253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	21	chr14	75279493	chr14:75279493	C	T	50	PASS	AN=2;DP=21	GT	0/1
chr14	77492786	77492786	G	A	exonic	IRF2BPL	.	synonymous SNV	IRF2BPL:NM_024496:exon1:c.C1350T:p.G450G	0.968935346	0.031017133	4.75E-05	.	0.69645	0.11157	.	.	62.7394	1.62021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	92	chr14	77492786	chr14:77492786	G	A	.	PASS	AN=0;DP=92	GT	0/1
chr14	89629000	89629000	C	A	exonic	FOXN3	.	nonsynonymous SNV	FOXN3:NM_005197:exon6:c.G1165T:p.D389Y,FOXN3:NM_001085471:exon7:c.G1231T:p.D411Y	0.90779936	0.092051233	0.000149407	.	0.74209	0.17554	-0.356299879	29.31115829	47.54211	1.33837	0.002	0.721	D	0.997	0.689	D	0.863	0.596	P	0.000	0.491	D	0.999	0.462	D	2.395	0.694	M	-0.02	0.629	T	-3.17	0.650	D	0.739	0.736	-0.309	0.747	T	0.383	0.739	T	0.061	0.684	D	5.522	0.750	26.3	0.994	0.620	0.996	0.980	D	c	0.748	0.758	1.000	0.747	0.707	0.730	0	5.95	0.964	7.883	0.857	0.066	0.173	1.000	0.715	0.928	0.402	19.988	0.973	.	.	.	0.5	.	83	chr14	89629000	chr14:89629000	C	A	.	PASS	AN=0;DP=83	GT	0/1
chr14	94088721	94088721	C	T	exonic	UNC79	.	synonymous SNV	UNC79:NM_020818:exon30:c.C4611T:p.L1537L,UNC79:NM_001346218:exon31:c.C5292T:p.L1764L	1	2.61E-11	1.21E-30	.	0.13734	0.1172	-1.113491624	6.634819533	491.26186	4.56078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	chr14	94088721	chr14:94088721	C	T	.	PASS	AN=0;DP=23	GT	0/1
chr14	104515928	104515928	T	-	intronic	TDRD9	.	.	.	3.82E-07	0.999438651	0.000560967	.	0.12943	0.10013	-0.191064116	39.27813163	513.83114	4.63761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	36	chr14	104515927	chr14:104515927	CT	C	44	PASS	AN=2;DP=36	GT	0/1
chr14	105905065	105905065	G	T	exonic	MTA1	.	stopgain	MTA1:NM_001203258:exon2:c.G85T:p.E29X,MTA1:NM_004689:exon2:c.G85T:p.E29X	0.999747857	0.000252143	7.46E-11	.	0.88976	0.22648	-1.061810361	7.519462137	2414.87209	9.12745	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.744	0.977	38	0.996	0.756	0.986	0.847	D	c	1.018	0.822	1.000	0.747	0.672	0.522	0	4.91	0.638	9.838	0.983	0.949	0.536	1.000	0.715	0.961	0.442	15.172	0.724	Bromo adjacent homology (BAH) domain	.	.	0.5	.	80	chr14	105905065	chr14:105905065	G	T	.	PASS	AN=0;DP=80	GT	0/1
chr14	106579211	106579211	A	T	intergenic	ADAM6;LINC00226	dist=140853;dist=165058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr14	106579211	chr14:106579211	A	T	.	PASS	AN=0;DP=55	GT	0/1
chr15	20434040	20434040	T	A	intergenic	NONE;CHEK2P2	dist=NONE;dist=53957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	95	chr15	20434040	chr15:20434040	T	A	.	PASS	AN=0;DP=95	GT	0/1
chr15	20450231	20450231	C	A	intergenic	NONE;CHEK2P2	dist=NONE;dist=37766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	551	chr15	20450231	chr15:20450231	C	A	126	PASS	AN=2;DP=551	GT	0/1
chr15	20489389	20489389	G	C	ncRNA_intronic	CHEK2P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	146	chr15	20489389	chr15:20489389	G	C	78	PASS	AN=2;DP=146	GT	0/1
chr15	22368600	22368600	G	C	exonic;splicing	OR4M2;LINC02203	NR_015416:exon9:c.1264+1G>C	nonsynonymous SNV	OR4M2:NM_001004719:exon1:c.G25C:p.V9L	.	.	.	.	.	.	.	.	.	.	0.006	0.614	D	0.258	0.297	B	0.126	0.311	B	0.001	0.424	D	0.780	0.293	N	2.505	0.732	M	5.64	0.008	T	-2.37	0.522	N	0.395	0.454	-1.133	0.017	T	0.006	0.021	T	0.004	0.091	T	2.568	0.370	19.90	0.990	0.492	0.632	0.318	D	c	-0.194	-0.226	0.999	0.383	0.487	0.133	0	2.5	0.292	0.492	0.220	0.681	0.295	0.094	0.225	0.584	0.286	10.808	0.455	.	.	.	0.5	73	76	chr15	22368600	chr15:22368600	G	C	73	PASS	AN=2;DP=76	GT	0/1
chr15	22369145	22369145	C	T	exonic	OR4M2	.	synonymous SNV	OR4M2:NM_001004719:exon1:c.C570T:p.A190A	.	.	.	.	0.05315	0.08153	3.177250279	99.31587639	740.16744	5.40199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	54	chr15	22369145	chr15:22369145	C	T	.	PASS	AN=0;DP=54	GT	0/1
chr15	22383141	22383141	C	T	exonic	OR4N4	.	synonymous SNV	OR4N4:NM_001005241:exon1:c.C669T:p.C223C	0.018050601	0.724040025	0.257909374	.	0.09536	0.07409	2.241610517	98.18353385	4448.2419	13.37082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	123	chr15	22383141	chr15:22383141	C	T	85	PASS	AN=2;DP=123	GT	0/1
chr15	22413972	22413972	C	A	ncRNA_exonic	OR4N3P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	96	chr15	22413972	chr15:22413972	C	A	.	PASS	AN=0;DP=96	GT	0/1
chr15	24921380	24921380	G	A	exonic	NPAP1	.	nonsynonymous SNV	NPAP1:NM_018958:exon1:c.G366A:p.M122I	0.273009366	0.721810072	0.005180563	.	0.05519	0.05806	3.546886998	99.49280491	286.08933	3.62008	0.082	0.332	T	0.001	0.067	B	0.0	0.013	B	0.005	0.010	N	1	0.090	N	0	0.065	N	3.37	0.059	T	-0.84	0.229	N	0.057	0.040	-0.978	0.356	T	0.009	0.034	T	0.000	0.001	T	-1.330	0.021	0.004	0.729	0.098	0.001	0.009	N	c	-1.563	-1.664	0.069	0.155	0.487	0.133	0	-3.13	0.049	-0.735	0.050	0.535	0.282	0.000	0.063	0.009	0.108	0.246	0.002	.	.	.	0.5	.	91	chr15	24921380	chr15:24921380	G	A	.	PASS	AN=0;DP=91	GT	0/1
chr15	30850264	30850264	G	C	intergenic	LOC100288203;DNM1P50	dist=67748;dist=10537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	136	chr15	30850264	chr15:30850264	G	C	124	PASS	AN=2;DP=136	GT	0/1
chr15	31233063	31233063	A	C	UTR3	MTMR10	NM_017762:c.*610T>G	.	.	0.035049797	0.964614838	0.000335366	.	0.04354	.	0.378498378	75.58386412	720.47875	5.32943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	54	19	chr15	31233063	chr15:31233063	A	C	54	PASS	AN=2;DP=19	GT	1/1
chr15	36887201	36887201	A	G	intronic	C15orf41	.	.	.	0.015552565	0.958545112	0.025902323	DISEASE: Anemia, congenital dyserythropoietic, 1B (CDAN1B) [MIM:615631]: An autosomal recessive blood disorder characterized by morphological abnormalities of erythroblasts, ineffective erythropoiesis, macrocytic anemia and secondary hemochromatosis. It is occasionally associated with bone abnormalities, especially of the hands and feet (acrodysostosis), nail hypoplasia, and scoliosis. Ultrastructural features include internuclear chromatin bridges connecting some nearly completely separated erythroblasts and an abnormal appearance (spongy or Swiss-cheese appearance) of the heterochromatin in a high proportion of the erythroblasts. {ECO:0000269|PubMed:23716552}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20546	0.10734	-0.005381972	53.50908233	4297.62941	13.04105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	36	chr15	36887201	chr15:36887201	A	G	40	PASS	AN=2;DP=36	GT	0/1
chr15	42438404	42438404	C	G	exonic	PLA2G4F	.	synonymous SNV	PLA2G4F:NM_213600:exon14:c.G1455C:p.A485A	1.40E-09	0.985845067	0.014154932	.	0.06296	0.09823	1.32640619	94.10238264	1110.4377	6.37148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	94	chr15	42438404	chr15:42438404	C	G	118	PASS	AN=2;DP=94	GT	1/0
chr15	43638146	43638146	G	T	exonic	ADAL	.	nonsynonymous SNV	ADAL:NM_001012969:exon8:c.G520T:p.V174F,ADAL:NM_001159280:exon9:c.G520T:p.V174F,ADAL:NM_001324364:exon9:c.G520T:p.V174F,ADAL:NM_001324365:exon9:c.G520T:p.V174F,ADAL:NM_001324366:exon9:c.G520T:p.V174F,ADAL:NM_001324367:exon9:c.G520T:p.V174F,ADAL:NM_001324368:exon9:c.G520T:p.V174F	8.52E-09	0.044008879	0.955991112	.	0.06081	0.11351	0.260991686	70.25831564	135.20538	2.52983	0.001	0.784	D	0.993	0.657	D	0.971	0.742	D	0.000	0.843	D	1	0.810	D	3.35	0.913	M	-3.72	0.954	D	-4.13	0.759	D	0.976	0.980	1.058	0.983	D	0.936	0.979	D	0.446	0.943	D	6.431	0.887	29.8	0.996	0.738	0.986	0.846	D	c	0.943	0.904	1.000	0.747	0.732	0.924	0	5.87	0.942	7.503	0.803	1.048	0.713	1.000	0.715	0.987	0.523	18.072	0.893	Adenosine/AMP deaminase domain|Metal-dependent hydrolase	.	.	0.5	85	57	chr15	43638146	chr15:43638146	G	T	85	PASS	AN=2;DP=57	GT	1/0
chr15	44818174	44818174	A	-	UTR3	CTDSPL2	NM_016396:c.*1802delA	.	.	0.995978214	0.004021723	6.38E-08	.	0.20513	0.11371	-0.0274281	51.65723048	83.72355	1.94762	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	16	chr15	44818173	chr15:44818173	CA	C	41	PASS	AN=2;DP=16	GT	0/1
chr15	49584749	49584749	G	C	intronic	GALK2	.	.	.	8.74E-06	0.924426156	0.075565103	.	0.20809	0.14099	-0.179930907	40.35739561	96.73851	2.12614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	34	chr15	49584749	chr15:49584749	G	C	53	PASS	AN=2;DP=34	GT	0/1
chr15	56435086	56435086	G	A	exonic	RFX7	.	synonymous SNV	RFX7:NM_022841:exon4:c.C291T:p.A97A	0.999680946	0.000319054	1.32E-10	.	0.76512	0.10256	.	.	372.49082	4.07209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	43	chr15	56435086	chr15:56435086	G	A	72	PASS	AN=2;DP=43	GT	0/1
chr15	63447893	63447893	C	G	exonic	RPS27L	.	nonsynonymous SNV	RPS27L:NM_015920:exon3:c.G153C:p.Q51H	0.335851902	0.603407942	0.060740156	.	0.35212	0.08617	0.101211609	60.95777306	22.08009	0.7413	0.008	0.599	D	0.977	0.566	D	0.926	0.644	D	0.000	0.843	D	0.999	0.463	D	.	.	.	.	.	.	-4.7	0.806	D	0.937	0.931	-0.385	0.725	T	0.364	0.725	T	0.027	0.500	D	4.623	0.619	24.5	0.997	0.795	0.876	0.469	D	c	0.429	0.400	1.000	0.747	0.660	0.490	0	2.71	0.310	4.090	0.572	0.935	0.490	1.000	0.715	0.997	0.653	9.976	0.408	Ribosomal protein S27e, zinc-binding domain|Zinc-binding ribosomal protein	.	.	0.5	71	47	chr15	63447893	chr15:63447893	C	G	71	PASS	AN=2;DP=47	GT	0/1
chr15	67999548	67999548	C	T	intronic	MAP2K5	.	.	.	0.475918461	0.524072679	8.86E-06	.	0.38366	0.21895	-0.692458599	14.96815287	37.4829	1.11572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	chr15	67999548	chr15:67999548	C	T	.	PASS	AN=0;DP=32	GT	0/1
chr15	71256253	71256253	A	G	exonic	LRRC49	.	synonymous SNV	LRRC49:NM_001199017:exon9:c.A918G:p.L306L,LRRC49:NM_017691:exon9:c.A903G:p.L301L,LRRC49:NM_001199018:exon10:c.A771G:p.L257L,LRRC49:NM_001284357:exon10:c.A873G:p.L291L	0.446510312	0.553478597	1.11E-05	.	0.18522	0.11023	-0.666770504	15.86459071	4621.78815	13.66012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	44	chr15	71256253	chr15:71256253	A	G	83	PASS	AN=2;DP=44	GT	1/0
chr15	74510992	74510992	G	A	intergenic	STRA6;CCDC33	dist=8946;dist=17638	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	149	chr15	74510992	chr15:74510992	G	A	113	PASS	AN=2;DP=149	GT	0/1
chr15	76463300	76463300	G	T	intronic	TMEM266	.	.	.	.	.	.	.	0.25737	.	0.20030965	67.3566879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr15	76463300	chr15:76463300	G	T	.	PASS	AN=0;DP=42	GT	0/1
chr15	83216008	83216008	T	-	intronic	CPEB1	.	.	.	0.999591314	0.000408684	1.20E-09	.	0.40504	0.10369	-0.556537043	19.72753008	3672.85414	11.77381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	53	chr15	83216007	chr15:83216007	CT	C	42	PASS	AN=2;DP=53	GT	0/1
chr15	86286780	86286780	G	C	exonic	AKAP13	.	nonsynonymous SNV	AKAP13:NM_001270546:exon28:c.G3979C:p.E1327Q,AKAP13:NM_006738:exon36:c.G8128C:p.E2710Q,AKAP13:NM_007200:exon36:c.G8116C:p.E2706Q	0.84956602	0.15043398	4.29E-15	.	0.2224	0.22007	1.988827491	97.64095305	3944.37006	12.42106	0.008	0.586	D	0.993	0.670	D	0.782	0.615	P	.	.	.	0.629	0.328	D	2.075	0.572	M	0.84	0.475	T	-1.2	0.305	N	0.34	0.401	-0.464	0.700	T	0.251	0.621	T	0.022	0.455	T	3.840	0.518	23.4	0.998	0.850	0.982	0.802	D	c	0.609	0.577	1.000	0.747	0.707	0.730	0	5.73	0.897	6.416	0.730	1.048	0.713	1.000	0.715	0.039	0.156	17.069	0.864	.	.	.	0.5	65	51	chr15	86286780	chr15:86286780	G	C	65	PASS	AN=2;DP=51	GT	0/1
chr15	89416087	89416087	A	T	intronic	ACAN	.	.	.	0.999993945	6.06E-06	1.71E-15	DISEASE: Spondyloepiphyseal dysplasia type Kimberley (SEDK) [MIM:608361]: Spondyloepiphyseal dysplasias are a heterogeneous group of congenital chondrodysplasias that specifically affect epiphyses and vertebrae. The autosomal dominant SEDK is associated with premature degenerative arthropathy. {ECO:0000269|PubMed:16080123}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spondyloepimetaphyseal dysplasia aggrecan type (SEMD- ACAN) [MIM:612813]: A bone disease characterized by severe short stature, macrocephaly, severe midface hypoplasia, short neck, barrel chest and brachydactyly. The radiological findings comprise long bones with generalized irregular epiphyses with widened metaphyses, especially at the knees, platyspondyly, and multiple cervical-vertebral clefts. {ECO:0000269|PubMed:19110214}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteochondritis dissecans short stature and early-onset osteoarthritis (OD) [MIM:165800]: A type of osteochondritis defined as a separation of cartilage and subchondral bone from the surrounding tissue, primarily affecting the knee, ankle and elbow joints. It is clinically characterized by multiple osteochondritic lesions in knees and/or hips and/or elbows, disproportionate short stature and early-onset osteoarthritis. {ECO:0000269|PubMed:20137779}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3407	0.5702	1.284310712	93.77211607	15528.89086	26.89264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	55	chr15	89416087	chr15:89416087	A	T	88	PASS	AN=2;DP=55	GT	1/0
chr15	93534774	93534774	C	G	intronic	CHD2	.	.	.	0.999999999	1.15E-09	1.23E-26	DISEASE: Epileptic encephalopathy, childhood-onset (EEOC) [MIM:615369]: A severe form of epilepsy characterized by onset of multiple seizure types in the first few years of life and associated with poor prognosis. Affected individuals have cognitive regression and intellectual disability. {ECO:0000269|PubMed:23708187}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.56985	0.10377	-1.745389579	2.37084218	175.7961	2.88554	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	48	chr15	93534774	chr15:93534774	C	G	65	PASS	AN=2;DP=48	GT	0/1
chr16	737687	737687	G	C	exonic	WDR24	.	synonymous SNV	WDR24:NM_032259:exon2:c.C534G:p.T178T	0.004702416	0.98892357	0.006374014	.	0.17124	0.10703	-0.461076406	23.66124086	1952.56454	8.13191	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	chr16	737687	chr16:737687	G	C	.	PASS	AN=0;DP=79	GT	0/1
chr16	1821294	1821294	A	G	exonic	NME3	.	nonsynonymous SNV	NME3:NM_002513:exon2:c.T164C:p.L55P	2.37E-06	0.086504203	0.913493423	.	0.27797	0.18492	.	.	94.46567	2.09186	0.001	0.784	D	1.0	0.899	D	0.989	0.769	D	0.001	0.408	D	1	0.810	D	3.675	0.945	H	0.41	0.571	T	-5.19	0.836	D	0.821	0.809	0.013	0.825	D	0.419	0.765	T	0.900	0.993	D	6.246	0.862	28.9	0.998	0.882	0.937	0.586	D	c	0.736	0.596	1.000	0.747	0.767	0.994	0	3.52	0.393	6.967	0.757	1.004	0.623	1.000	0.715	0.999	0.750	11.893	0.517	.	.	.	0.5	.	65	chr16	1821294	chr16:1821294	A	G	.	PASS	AN=0;DP=65	GT	0/1
chr16	2348569	2348569	C	A	intronic	ABCA3	.	.	.	7.48E-08	0.999990122	9.80E-06	DISEASE: Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]: A rare lung disorder due to impaired surfactant homeostasis. It is characterized by alveolar filling with floccular material that stains positive using the periodic acid- Schiff method and is derived from surfactant phospholipids and protein components. Excessive lipoproteins accumulation in the alveoli results in severe respiratory distress. {ECO:0000269|PubMed:15044640}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13416	0.16987	-1.477690451	3.709601321	188.10316	2.97844	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	chr16	2348569	chr16:2348569	C	A	.	PASS	AN=0;DP=36	GT	0/1
chr16	5040768	5040768	G	T	exonic	SEC14L5	.	nonsynonymous SNV	SEC14L5:NM_014692:exon5:c.G346T:p.V116F	6.57E-10	0.408296631	0.591703368	.	0.15183	.	-1.703090605	2.535975466	83.7768	1.94866	0.001	0.784	D	1.0	0.899	D	0.997	0.850	D	0.000	0.537	D	1	0.810	D	2.79	0.817	M	2.21	0.184	T	-4.03	0.743	D	0.729	0.728	-0.781	0.563	T	0.148	0.475	T	0.058	0.674	D	6.411	0.885	29.7	0.996	0.712	0.984	0.824	D	c	0.865	0.784	1.000	0.747	0.615	0.372	0	4.37	0.517	9.492	0.969	1.048	0.713	1.000	0.715	0.953	0.430	17.101	0.865	PRELI/MSF1 domain	.	.	0.5	.	48	chr16	5040768	chr16:5040768	G	T	.	PASS	AN=0;DP=48	GT	0/1
chr16	18437726	18437726	C	A	ncRNA_exonic	LOC100288162;PKD1P4-NPIPA8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	242	chr16	18437726	chr16:18437726	C	A	.	PASS	AN=0;DP=242	GT	0/1
chr16	19222944	19222944	G	T	intronic	SYT17	.	.	.	0.02363635	0.962035787	0.014327863	.	.	0.13066	-1.265702118	5.237084218	47.70433	1.3417	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	143	chr16	19222944	chr16:19222944	G	T	58	PASS	AN=2;DP=143	GT	0/1
chr16	20824587	20824588	TA	-	exonic	REXO5	.	frameshift deletion	REXO5:NM_001144924:exon3:c.214_215del:p.Y72Cfs*54,REXO5:NM_001199053:exon3:c.214_215del:p.Y72Cfs*54,REXO5:NM_030941:exon3:c.214_215del:p.Y72Cfs*54	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	90	chr16	20824586	chr16:20824586	GTA	G	41	PASS	AN=2;DP=90	GT	0/1
chr16	28845869	28845869	C	T	exonic	ATXN2L	.	nonsynonymous SNV	ATXN2L:NM_001308230:exon18:c.C2306T:p.S769L,ATXN2L:NM_007245:exon18:c.C2288T:p.S763L,ATXN2L:NM_017492:exon18:c.C2288T:p.S763L,ATXN2L:NM_145714:exon18:c.C2288T:p.S763L,ATXN2L:NM_148414:exon18:c.C2288T:p.S763L,ATXN2L:NM_148415:exon18:c.C2288T:p.S763L,ATXN2L:NM_148416:exon18:c.C2288T:p.S763L	0.999950396	4.96E-05	5.82E-14	.	0.45112	0.12083	-1.725143594	2.447511205	101.85413	2.1834	0.002	0.784	D	0.936	0.504	P	0.795	0.561	P	0.000	0.629	D	1.000	0.497	D	1.905	0.510	L	0.65	0.531	T	-2.82	0.595	D	0.325	0.656	-0.903	0.477	T	0.198	0.554	T	0.082	0.739	D	6.868	0.929	33	0.999	0.983	0.977	0.765	D	c	0.442	0.512	1.000	0.747	0.672	0.522	0	5.72	0.893	4.389	0.592	0.935	0.490	0.987	0.361	0.998	0.697	18.643	0.913	.	.	.	0.5	.	148	chr16	28845869	chr16:28845869	C	T	.	PASS	AN=0;DP=148	GT	0/1
chr16	28906289	28906289	C	A	intronic	ATP2A1	.	.	.	7.04E-09	0.998563754	0.001436239	DISEASE: Brody myopathy (BRM) [MIM:601003]: A disorder of muscle function that is characterized by painless muscle cramping and exercise-induced impairment of muscle relaxation. {ECO:0000269|PubMed:10914677}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78274	.	-1.392555112	4.269874971	168.67085	2.83491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	chr16	28906289	chr16:28906289	C	A	.	PASS	AN=0;DP=59	GT	0/1
chr16	31368547	31368547	C	A	intronic	ITGAX	.	.	.	6.11E-05	0.999936982	1.90E-06	.	0.09861	.	-0.915030414	9.837225761	3879.17486	12.28742	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	63	chr16	31368547	chr16:31368547	C	A	.	PASS	AN=0;DP=63	GT	0/1
chr16	32198297	32198297	C	-	ncRNA_intronic	HERC2P4;LOC102723753	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.53	39	chr16	32198296	chr16:32198296	AC	A	11.53	PASS	AN=0;DP=39	GT	0/1
chr16	32896603	32896603	C	A	upstream	SLC6A10P	dist=140	.	.	.	.	.	.	0.09544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	326	chr16	32896603	chr16:32896603	C	A	.	PASS	AN=0;DP=326	GT	0/1
chr16	54967692	54967692	G	C	exonic	IRX5	.	nonsynonymous SNV	IRX5:NM_001252197:exon3:c.G1356C:p.L452F,IRX5:NM_005853:exon3:c.G1359C:p.L453F	.	.	.	DISEASE: Hamamy syndrome (HMMS) [MIM:611174]: A syndrome characterized by severe hypertelorism, upslanting palpebral fissures, brachycephaly, abnormal ears, sloping shoulders, enamel hypoplasia, and osteopenia with repeated fractures. Additional features include myopia, mild to moderate sensorineural hearing loss, gonadal anomalies and borderline intelligence. {ECO:0000269|PubMed:22581230}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66381	0.13039	.	.	1652.69996	7.51371	0.045	0.912	D	0.998	0.715	D	0.996	0.832	D	0.001	0.434	D	1	0.810	D	1.04	0.263	L	0.15	0.608	T	-1.07	0.475	N	0.369	0.431	-0.567	0.662	T	0.296	0.668	T	0.022	0.446	T	2.369	0.346	18.62	0.986	0.426	0.941	0.598	D	c	0.604	0.608	1.000	0.747	0.598	0.340	0	4.77	0.603	5.274	0.652	1.048	0.713	1.000	0.715	1.000	0.888	17.973	0.890	.	.	.	0.5	.	142	chr16	54967692	chr16:54967692	G	C	.	PASS	AN=0;DP=142	GT	0/1
chr16	56391118	56391119	TG	-	UTR3	GNAO1	NM_020988:c.*1132_*1133delTG	.	.	0.984288177	0.015702972	8.85E-06	DISEASE: Epileptic encephalopathy, early infantile, 17 (EIEE17) [MIM:615473]: A severe neurologic disorder characterized by onset of intractable seizures in the first weeks or months of life and usually associated with EEG abnormalities. Affected infants have very poor psychomotor development and may have brain abnormalities, such as cerebral atrophy or thin corpus callosum. Some patients may show involuntary movements. {ECO:0000269|PubMed:23993195}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24762	0.17859	-0.736552314	13.93606983	11.79169	0.42714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.17	37	chr16	56391117	chr16:56391117	CTG	C	11.17	PASS	AN=0;DP=37	GT	0/1
chr16	67116095	67116095	G	A	intronic	CBFB	.	.	.	0.905733874	0.09410794	0.000158186	DISEASE: Note=A chromosomal aberration involving CBFB is associated with acute myeloid leukemia of M4EO subtype. Pericentric inversion inv(16)(p13;q22). The inversion produces a fusion protein that consists of the 165 N-terminal residues of CBF-beta (PEPB2) with the tail region of MYH11. {ECO:0000269|PubMed:8351518}.; 	0.85519	0.21981	-0.009020804	52.8544468	11.84242	0.42885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr16	67116095	chr16:67116095	G	A	.	PASS	AN=0;DP=42	GT	0/1
chr16	67840192	67840192	G	A	intronic	RANBP10	.	.	.	0.951824229	0.04817459	1.18E-06	.	0.5861	0.11289	-0.843147538	11.2762444	72.21908	1.77081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	152	chr16	67840192	chr16:67840192	G	A	.	PASS	AN=0;DP=152	GT	0/1
chr16	69364876	69364876	C	A	exonic	COG8	.	nonsynonymous SNV	COG8:NM_032382:exon5:c.G1705T:p.A569S	1.87E-05	0.693345213	0.306636056	DISEASE: Congenital disorder of glycosylation 2H (CDG2H) [MIM:611182]: CDGs are a family of severe inherited diseases caused by a defect in protein N-glycosylation. They are characterized by under-glycosylated serum proteins. These multisystem disorders present with a wide variety of clinical features, such as disorders of the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:17331980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.28449	0.10981	-0.222203495	37.54423213	266.21683	3.50111	0.696	0.042	T	0.006	0.126	B	0.01	0.139	B	0.123	0.189	N	0.987	0.246	N	0	0.065	N	0.98	0.421	T	0.42	0.034	N	0.099	0.134	-1.048	0.149	T	0.049	0.208	T	0.013	0.316	T	1.681	0.263	14.30	0.705	0.090	0.930	0.568	D	c	-0.545	-0.337	1.000	0.747	0.442	0.072	0	5.45	0.796	2.942	0.485	0.917	0.428	0.851	0.302	0.072	0.177	17.125	0.865	.	.	.	0.5	.	56	chr16	69364876	chr16:69364876	C	A	.	PASS	AN=0;DP=56	GT	0/1
chr16	69364877	69364877	C	A	exonic	COG8	.	nonsynonymous SNV	COG8:NM_032382:exon5:c.G1704T:p.Q568H	1.87E-05	0.693345213	0.306636056	DISEASE: Congenital disorder of glycosylation 2H (CDG2H) [MIM:611182]: CDGs are a family of severe inherited diseases caused by a defect in protein N-glycosylation. They are characterized by under-glycosylated serum proteins. These multisystem disorders present with a wide variety of clinical features, such as disorders of the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:17331980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.28449	0.10981	-0.222203495	37.54423213	266.21683	3.50111	0.055	0.384	T	0.162	0.268	B	0.054	0.244	B	0.284	0.149	N	0.926	0.272	N	1.1	0.281	L	0.9	0.453	T	-0.88	0.238	N	0.106	0.152	-1.066	0.104	T	0.070	0.286	T	0.020	0.425	T	1.900	0.289	15.59	0.925	0.213	0.832	0.420	D	c	-0.422	-0.333	1.000	0.747	0.442	0.072	0	3.48	0.388	1.339	0.333	0.917	0.428	0.835	0.300	0.068	0.175	9.680	0.390	.	.	.	0.5	.	56	chr16	69364877	chr16:69364877	C	A	.	PASS	AN=0;DP=56	GT	0/1
chr16	81157187	81157187	C	A	intronic	PKD1L2	.	.	.	2.37E-09	0.020877049	0.979122949	.	0.09644	0.07722	6.86111443	99.88794527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	chr16	81157187	chr16:81157187	C	A	.	PASS	AN=0;DP=44	GT	0/1
chr16	89986075	89986075	G	T	exonic	MC1R	.	nonsynonymous SNV	MC1R:NM_002386:exon1:c.G409T:p.A137S	3.25E-07	0.052370692	0.947628983	DISEASE: Melanoma, cutaneous malignant 5 (CMM5) [MIM:613099]: A malignant neoplasm of melanocytes, arising de novo or from a pre- existing benign nevus, which occurs most often in the skin but also may involve other sites. {ECO:0000269|PubMed:17434924, ECO:0000269|PubMed:19338054}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	.	0.68939	0.34168906	73.72611465	1416.53832	7.03613	0.012	0.654	D	0.7	0.399	P	0.519	0.463	P	0.001	0.392	U	0.994	0.236	N	3.31	0.908	M	2.11	0.199	T	-2.03	0.466	N	0.058	0.332	-1.056	0.128	T	0.082	0.323	T	0.015	0.355	T	4.232	0.567	23.9	0.996	0.738	0.669	0.330	D	c	-0.007	-0.082	1.000	0.747	0.615	0.372	0	1.64	0.228	2.657	0.461	0.091	0.195	0.997	0.399	0.004	0.083	9.907	0.404	GPCR, rhodopsin-like, 7TM	.	.	0.5	117	107	chr16	89986075	chr16:89986075	G	T	117	PASS	AN=2;DP=107	GT	1/0
chr16	90030423	90030423	T	G	intronic	DEF8	.	.	.	0.389991488	0.609924177	8.43E-05	.	0.16968	0.10329	-0.021969881	52.14673272	223.67964	3.23402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	224	chr16	90030423	chr16:90030423	T	G	85	PASS	AN=2;DP=224	GT	0/1
chr17	11343	11343	C	T	intronic	DOC2B	.	.	.	0.382719812	0.476953142	0.140327046	.	0.22422	0.11084	.	.	58.48664	1.54921	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	74	chr17	11343	chr17:11343	C	T	.	PASS	AN=0;DP=74	GT	0/1
chr17	982599	982599	T	A	exonic	ABR	.	nonsynonymous SNV	ABR:NM_001092:exon5:c.A560T:p.K187M,ABR:NM_001159746:exon6:c.A533T:p.K178M,ABR:NM_001322840:exon6:c.A533T:p.K178M,ABR:NM_001322841:exon6:c.A1448T:p.K483M,ABR:NM_021962:exon6:c.A671T:p.K224M	0.999949479	5.05E-05	1.49E-12	.	0.59342	.	-1.03976177	7.802547771	211.79342	3.13829	0.002	0.721	D	0.979	0.764	D	0.905	0.736	P	0.000	0.629	D	0.999	0.453	D	2.725	0.800	M	-0.13	0.648	T	-3.2	0.658	D	0.556	0.686	-0.257	0.762	T	0.405	0.755	T	0.115	0.795	D	6.051	0.833	28.0	0.996	0.750	0.982	0.806	D	c	0.593	0.532	1.000	0.747	0.767	0.994	0	4.12	0.473	5.317	0.654	0.964	0.580	1.000	0.715	1.000	0.888	9.380	0.373	Dbl homology (DH) domain	.	.	0.5	.	55	chr17	982599	chr17:982599	T	A	.	PASS	AN=0;DP=55	GT	0/1
chr17	1174703	1174703	G	C	downstream	BHLHA9	dist=138	.	.	.	.	.	DISEASE: Split-hand/foot malformation with long bone deficiency 3 (SHFLD3) [MIM:612576]: A disease characterized by the association of split-hand/foot malformation with long bone deficiency involving the tibia and fibula. Split-hand/foot malformation is a limb malformation involving the central rays of the autopod. Phenotypic expression is extremely variable between and within families, and even between limbs of a single patient, ranging from syndactyly and oligodactyly to the most severe monodactyly with only a single phalanx. Limb features include median clefts of the hands and feet, and aplasia and/or hypoplasia of the phalanges, metacarpals, and metatarsals. {ECO:0000269|PubMed:22147889}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry. A copy number variation (CNV) resulting in BHLHA9 duplications is a necessary but not sufficient susceptibility factor for Split-hand/foot malformation with long bone deficiency, a highly variable phenotype with reduced penetrance, particularly in females (PubMed:22147889). {ECO:0000269|PubMed:22147889}.; DISEASE: Syndactyly, mesoaxial synostotic, with phalangeal reduction (MSSD) [MIM:609432]: An autosomal recessive, non- syndromic digit anomaly characterized by mesoaxial osseous synostosis at a metacarpal level, reduction of one or more phalanges, hypoplasia of distal phalanges of preaxial and postaxial digits, clinodactyly of fifth fingers, and preaxial fusion of toes. {ECO:0000269|PubMed:25466284}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	.	.	13.47449	0.48957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	340	chr17	1174703	chr17:1174703	G	C	142	PASS	AN=2;DP=340	GT	0/1
chr17	1359255	1359255	C	T	exonic	CRK	.	nonsynonymous SNV	CRK:NM_005206:exon1:c.G157A:p.E53K,CRK:NM_016823:exon1:c.G157A:p.E53K	0.864536311	0.135055982	0.000407707	.	0.73088	0.53296	-0.339715008	30.06605331	5.16406	0.19181	0.002	0.721	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	1.305	0.328	L	1.82	0.885	T	-3.75	0.711	D	0.463	0.753	-1.044	0.161	T	0.131	0.443	T	0.835	0.987	D	6.949	0.934	33	0.999	0.992	0.933	0.577	D	c	0.689	0.684	1.0	0.983	0.442	0.072	0	4.93	0.643	7.593	0.818	0.907	0.419	1.000	0.715	0.998	0.697	16.011	0.801	SH2 domain	.	.	0.5	.	52	chr17	1359255	chr17:1359255	C	T	.	PASS	AN=0;DP=52	GT	0/1
chr17	6665416	6665416	G	T	intronic	XAF1	.	.	.	2.07E-08	0.073341496	0.926658483	.	0.05763	0.08526	0.995816767	90.62278839	600.13477	4.95792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	96	chr17	6665416	chr17:6665416	G	T	114	PASS	AN=2;DP=96	GT	1/0
chr17	6920052	6920052	G	A	ncRNA_intronic	MIR497HG;RNASEK-C17orf49	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	83	chr17	6920052	chr17:6920052	G	A	.	PASS	AN=0;DP=83	GT	0/1
chr17	6978296	6978296	G	T	UTR3	CLEC10A	NM_006344:c.*77C>A;NM_182906:c.*77C>A;NM_001330070:c.*77C>A	.	.	4.25E-08	0.203022746	0.796977211	.	0.05732	0.1098	1.218120595	93.15876386	329.25844	3.85744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	95	chr17	6978296	chr17:6978296	G	T	.	PASS	AN=0;DP=95	GT	0/1
chr17	7363094	7363094	A	-	UTR3	ZBTB4	NM_020899:c.*2165delT;NM_001128833:c.*2165delT	.	.	0.998490203	0.001509768	2.89E-08	.	0.3783	0.08224	-0.10469683	45.64755839	312.5211	3.76241	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	63	chr17	7363093	chr17:7363093	GA	G	54	PASS	AN=2;DP=63	GT	0/1
chr17	8049417	8049417	G	A	exonic	PER1	.	nonsynonymous SNV	PER1:NM_002616:exon17:c.C2077T:p.P693S	0.875748962	0.124251034	4.54E-09	.	0.81937	0.22945	-1.889004548	1.981599434	289.79879	3.64159	0.144	0.335	T	0.139	0.470	B	0.04	0.432	B	0.007	0.315	N	1.000	0.182	N	1.7	0.440	L	2.62	0.367	T	-1.71	0.406	N	0.088	0.217	-1.066	0.103	T	0.077	0.308	T	0.017	0.381	T	-0.276	0.070	0.752	0.994	0.613	0.935	0.581	D	c	-0.363	-0.342	1.000	0.480	0.732	0.924	0	4.47	0.536	3.083	0.496	0.142	0.226	0.263	0.248	0.006	0.095	11.954	0.521	.	.	.	0.5	.	79	chr17	8049417	chr17:8049417	G	A	.	PASS	AN=0;DP=79	GT	0/1
chr17	8062649	8062649	C	A	UTR3	VAMP2	NM_001330125:c.*1524G>T;NM_014232:c.*1524G>T	.	.	0.837117601	0.159707638	0.003174761	.	0.42512	0.11262	-0.053113545	49.38664779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	104	chr17	8062649	chr17:8062649	C	A	.	PASS	AN=0;DP=104	GT	0/1
chr17	10219247	10219247	G	T	exonic	MYH13	.	nonsynonymous SNV	MYH13:NM_003802:exon28:c.C3834A:p.N1278K	1.89E-29	0.014239931	0.985760069	.	0.48597	0.1881	-0.635977455	16.74333569	5547.032	15.40045	0.057	0.379	T	0.06	0.217	B	0.314	0.398	B	.	.	.	0.982	0.250	N	2.39	0.691	M	-1.11	0.775	T	-1.37	0.340	N	0.092	0.143	-0.238	0.767	T	0.522	0.822	D	0.072	0.714	D	4.382	0.587	24.1	0.998	0.882	0.361	0.252	N	c	-0.290	-0.338	0.000	0.012	0.497	0.185	0	1.08	0.194	-0.472	0.066	0.939	0.529	0.000	0.063	1.000	0.888	8.421	0.317	Myosin tail	.	.	0.5	76	105	chr17	10219247	chr17:10219247	G	T	76	PASS	AN=2;DP=105	GT	0/1
chr17	18051883	18051883	G	A	splicing	MYO15A	NM_016239:exon31:c.6764+1G>A	.	.	.	.	.	.	0.38072	0.15993	-1.25610141	5.349138948	5977.14295	16.09179	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.605	0.763	26.5	0.995	0.687	0.992	0.925	D	c	1.108	0.930	1.000	0.747	0.078	0.016	0	4.3	0.504	9.480	0.969	0.953	0.551	1.000	0.715	1.000	0.888	16.520	0.841	.	.	.	0.5	.	78	chr17	18051883	chr17:18051883	G	A	.	PASS	AN=0;DP=78	GT	0/1
chr17	20416895	20416895	A	C	intergenic	KRT16P3;CDRT15L2	dist=9084;dist=66142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	262	chr17	20416895	chr17:20416895	A	C	83	PASS	AN=2;DP=262	GT	0/1
chr17	26684787	26684787	G	A	exonic	TMEM199	.	nonsynonymous SNV	TMEM199:NM_152464:exon1:c.G94A:p.A32T	0.000653685	0.737375253	0.261971062	.	0.18423	0.10808	0.373041938	75.29488087	1107.44888	6.35994	0.204	0.200	T	0.963	0.537	D	0.444	0.441	B	0.010	0.301	N	0.991	0.241	N	2.14	0.601	M	1.39	0.338	T	-0.78	0.216	N	0.243	0.306	-1.058	0.123	T	0.058	0.242	T	0.014	0.346	T	1.149	0.205	11.48	0.787	0.120	0.910	0.525	D	c	-0.169	-0.157	1.0	0.983	0.442	0.072	0	4.84	0.620	3.615	0.537	0.953	0.551	0.994	0.380	0.078	0.180	14.974	0.708	.	.	.	0.5	.	199	chr17	26684787	chr17:26684787	G	A	.	PASS	AN=0;DP=199	GT	0/1
chr17	27044323	27044323	G	C	exonic	RAB34	.	nonsynonymous SNV	RAB34:NM_001256281:exon1:c.C404G:p.S135W	4.68E-06	0.849259752	0.150735569	.	0.49492	0.14267	-0.60427181	17.74593064	14.52455	0.522	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	61	chr17	27044323	chr17:27044323	G	C	83	PASS	AN=2;DP=61	GT	0/1
chr17	27419327	27419327	C	A	intronic	MYO18A	.	.	.	0.999417504	0.000582496	3.26E-16	.	0.45342	0.14389	-1.618952458	2.895730125	551.10541	4.7741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	chr17	27419327	chr17:27419327	C	A	.	PASS	AN=0;DP=49	GT	0/1
chr17	33805119	33805119	A	T	exonic	SLFN12L	.	synonymous SNV	SLFN12L:NM_001195790:exon3:c.T1179A:p.I393I	2.35E-05	0.501639472	0.498337059	.	0.08168	.	2.771030479	99.00920028	1908.34734	8.04469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	chr17	33805119	chr17:33805119	A	T	.	PASS	AN=0;DP=35	GT	0/1
chr17	36358089	36358089	G	A	ncRNA_intronic	LOC440434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	102	chr17	36358089	chr17:36358089	G	A	.	PASS	AN=0;DP=102	GT	0/1
chr17	36875820	36875820	G	A	exonic	MLLT6	.	nonsynonymous SNV	MLLT6:NM_005937:exon13:c.G1993A:p.E665K	0.998762157	0.001237842	7.29E-10	DISEASE: Note=A chromosomal aberration involving MLLT6 is associated with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.50287	0.15426	-0.020150552	52.25288983	264.58482	3.48969	.	.	.	0.996	0.670	D	0.99	0.774	D	0.000	0.513	D	1	0.810	D	1.895	0.505	L	.	.	.	.	.	.	0.232	0.721	-1.157	0.008	T	0.071	0.288	T	0.008	0.223	T	4.628	0.620	24.5	0.999	0.955	0.979	0.776	D	c	0.677	0.661	1.000	0.747	0.726	0.872	0	4.73	0.593	7.708	0.835	1.029	0.652	1.000	0.715	1.000	0.888	16.627	0.848	.	.	.	0.5	.	119	chr17	36875820	chr17:36875820	G	A	.	PASS	AN=0;DP=119	GT	0/1
chr17	39776818	39776818	A	-	intronic	KRT17	.	.	.	7.07E-06	0.722413326	0.2775796	DISEASE: Pachyonychia congenita 2 (PC2) [MIM:167210]: An autosomal dominant ectodermal dysplasia characterized by hypertrophic nail dystrophy resulting in onchyogryposis (thickening and increase in curvature of the nail), palmoplantar keratoderma and hyperhidrosis, follicular hyperkeratosis, multiple epidermal cysts, absent/sparse eyebrow and body hair, and by the presence of natal teeth. {ECO:0000269|PubMed:10571744, ECO:0000269|PubMed:11348474, ECO:0000269|PubMed:11874497, ECO:0000269|PubMed:11886499, ECO:0000269|PubMed:15102078, ECO:0000269|PubMed:15795125, ECO:0000269|PubMed:16250206, ECO:0000269|PubMed:16620218, ECO:0000269|PubMed:16625196, ECO:0000269|PubMed:17719747, ECO:0000269|PubMed:18547302, ECO:0000269|PubMed:19470054, ECO:0000269|PubMed:21326300, ECO:0000269|PubMed:23278621, ECO:0000269|PubMed:23855588, ECO:0000269|PubMed:7539673, ECO:0000269|PubMed:9008238, ECO:0000269|PubMed:9767294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Steatocystoma multiplex (SM) [MIM:184500]: Disease characterized by round or oval cystic tumors widely distributed on the back, anterior trunk, arms, scrotum, and thighs. {ECO:0000269|PubMed:16620218, ECO:0000269|PubMed:9008238, ECO:0000269|PubMed:9767294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=KRT16 and KRT17 are coexpressed only in pathological situations such as metaplasias and carcinomas of the uterine cervix and in psoriasis vulgaris.; 	.	0.22756	-0.244249595	36.17008728	729.66866	5.36212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.61	102	chr17	39776817	chr17:39776817	GA	G	12.61	PASS	AN=0;DP=102	GT	0/1
chr17	42255660	42255660	C	T	exonic	ASB16	.	nonsynonymous SNV	ASB16:NM_080863:exon5:c.C1264T:p.R422W	2.42E-10	0.073433168	0.926566831	.	0.22798	0.10536	1.580015895	95.77140835	5016.34156	14.46226	0.102	0.302	T	0.97	0.550	D	0.567	0.479	P	0.521	0.117	N	1	0.090	N	1.15	0.294	L	0.92	0.445	T	-1.54	0.373	N	0.247	0.302	-1.048	0.149	T	0.103	0.379	T	0.009	0.246	T	5.280	0.714	25.7	0.998	0.897	0.223	0.215	N	c	0.028	0.005	1.000	0.451	0.646	0.450	0	4.34	0.511	1.253	0.323	0.068	0.175	0.000	0.063	0.003	0.074	13.142	0.587	SOCS box domain	.	.	0.5	.	114	chr17	42255660	chr17:42255660	C	T	.	PASS	AN=0;DP=114	GT	0/1
chr17	44953931	44953931	G	A	exonic	WNT9B	.	synonymous SNV	WNT9B:NM_003396:exon4:c.G921A:p.R307R	0.051616811	0.861298955	0.087084234	.	0.12092	0.18289	0.532823122	80.96249115	202.94359	3.07608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	101	chr17	44953931	chr17:44953931	G	A	88	PASS	AN=2;DP=101	GT	0/1
chr17	47486893	47486903	TGTTTTTTTTT	-	intronic	PHB	.	.	.	0.82163215	0.177514223	0.000853627	.	0.87417	0.68456	0.03689118	56.64071715	11.35938	0.40904	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	73	chr17	47486892	chr17:47486892	GTGTTTTTTTTT	G	76	PASS	AN=2;DP=73	GT	0/1
chr17	48195470	48195470	G	T	intronic	SAMD14	.	.	.	0.02026443	0.975990271	0.003745299	.	0.19905	0.10658	-0.53631094	20.53550366	50.42659	1.39709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	60	chr17	48195470	chr17:48195470	G	T	.	PASS	AN=0;DP=60	GT	0/1
chr17	48750766	48750766	C	T	intronic	ABCC3	.	.	.	2.62E-14	0.989877188	0.010122812	.	0.11549	0.27947	0.690669139	85.21467327	889.61134	5.81122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	65	chr17	48750766	chr17:48750766	C	T	82	PASS	AN=2;DP=65	GT	0/1
chr17	48750768	48750768	G	T	intronic	ABCC3	.	.	.	2.62E-14	0.989877188	0.010122812	.	0.11549	0.27947	0.690669139	85.21467327	889.61134	5.81122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	66	chr17	48750768	chr17:48750768	G	T	81	PASS	AN=2;DP=66	GT	0/1
chr17	55334367	55334367	C	-	intronic	MSI2	.	.	.	0.963858042	0.036127911	1.40E-05	DISEASE: Note=Chromosomal aberrations involving MSI2 may contribute to disease progression in chronic myeloid leukemia. Translocation t(7;17)(p15;q23) with HOXA9; translocation t(7;17)(q32-34;q23). {ECO:0000269|PubMed:12649177}.; 	0.22637	0.09832	0.12689526	63.00424628	34.77251	1.05981	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	58	chr17	55334366	chr17:55334366	TC	T	67	PASS	AN=2;DP=58	GT	0/1
chr17	56332206	56332206	C	A	exonic	LPO	.	synonymous SNV	LPO:NM_001160102:exon7:c.C891A:p.A297A,LPO:NM_006151:exon9:c.C1140A:p.A380A	2.91E-11	0.264081682	0.735918318	.	0.15837	0.32199	-1.240018202	5.461193678	1144.41107	6.45117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	chr17	56332206	chr17:56332206	C	A	.	PASS	AN=0;DP=48	GT	0/1
chr17	59974795	59974795	T	-	intronic	INTS2	.	.	.	0.999806217	0.000193783	3.25E-13	.	0.77276	0.13043	-0.620857637	17.3566879	100.80715	2.17423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	101	chr17	59974794	chr17:59974794	CT	C	64	PASS	AN=2;DP=101	GT	0/1
chr17	61838289	61838289	T	C	exonic	CCDC47	.	synonymous SNV	CCDC47:NM_020198:exon6:c.A720G:p.P240P	0.002588177	0.994331313	0.00308051	.	0.46552	0.10992	-0.624497208	17.16206653	32.82785	1.01862	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	97	chr17	61838289	chr17:61838289	T	C	.	PASS	AN=0;DP=97	GT	0/1
chr17	61949621	61949621	G	T	exonic	CSH2	.	nonsynonymous SNV	CSH2:NM_022645:exon3:c.C234A:p.D78E,CSH2:NM_020991:exon5:c.C519A:p.D173E	0.458223921	0.515305	0.026471079	.	0.04737	0.07342	-0.139478553	43.29440906	29.18154	0.93272	0.044	0.784	D	0.887	0.715	P	0.86	0.818	P	0.002	0.009	N	1	0.810	D	2.675	0.786	M	-2.3	0.885	D	-2.76	0.634	D	0.516	0.569	-0.268	0.759	T	0.868	0.956	D	0.018	0.404	T	3.095	0.432	22.5	0.995	0.660	0.671	0.330	D	c	0.430	0.263	0.000	0.042	0.447	0.083	0	2.96	0.332	0.749	0.258	0.973	0.593	0.999	0.424	0.739	0.319	6.177	0.195	Four-helical cytokine, core|Four-helical cytokine-like, core	.	.	0.5	123	452	chr17	61949621	chr17:61949621	G	T	123	PASS	AN=2;DP=452	GT	0/1
chr17	62290515	62290515	C	A	exonic	TEX2	.	nonsynonymous SNV	TEX2:NM_001288732:exon2:c.G1063T:p.G355W,TEX2:NM_001288733:exon2:c.G1063T:p.G355W,TEX2:NM_018469:exon2:c.G1063T:p.G355W	0.44097988	0.559019647	4.74E-07	.	0.17386	0.08006	-0.946125119	9.377211607	521.90393	4.66418	0.001	0.784	D	0.999	0.764	D	0.975	0.717	D	0.000	0.843	D	0.998	0.445	D	1.67	0.430	L	0.46	0.563	T	-2.27	0.506	N	0.593	0.620	-0.538	0.673	T	0.305	0.676	T	0.053	0.654	D	6.215	0.858	28.7	0.946	0.245	0.931	0.571	D	c	0.696	0.709	1.000	0.747	0.615	0.372	0	6.03	0.978	4.527	0.600	0.935	0.490	1.000	0.715	0.912	0.389	20.557	0.993	.	.	.	0.5	.	44	chr17	62290515	chr17:62290515	C	A	.	PASS	AN=0;DP=44	GT	0/1
chr17	68175166	68175167	AG	-	UTR3	KCNJ2	NM_000891:c.*2702_*2703delAG	.	.	0.820229028	0.178898897	0.000872075	DISEASE: Long QT syndrome 7 (LQT7) [MIM:170390]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Long QT syndrome type 7 manifests itself as a clinical triad consisting of potassium-sensitive periodic paralysis, ventricular ectopy and dysmorphic features. {ECO:0000269|PubMed:11371347, ECO:0000269|PubMed:12148092, ECO:0000269|PubMed:12163457, ECO:0000269|PubMed:16571646, ECO:0000269|PubMed:17324964}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Short QT syndrome 3 (SQT3) [MIM:609622]: A heart disorder characterized by idiopathic persistently and uniformly short QT interval on ECG in the absence of structural heart disease in affected individuals. It causes syncope and sudden death. SQT3 has a unique ECG phenotype characterized by asymmetrical T waves. {ECO:0000269|PubMed:15761194}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atrial fibrillation, familial, 9 (ATFB9) [MIM:613980]: A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. {ECO:0000269|PubMed:15922306}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42866	0.22085	-0.582225231	18.44184949	8.98775	0.32999	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	32	chr17	68175165	chr17:68175165	TAG	T	52	PASS	AN=2;DP=32	GT	0/1
chr17	73774999	73774999	C	T	exonic	H3F3B	.	synonymous SNV	H3F3B:NM_005324:exon3:c.G174A:p.S58S	0.80972478	0.185480955	0.004794265	.	0.29831	.	-0.207437529	38.2814343	2211.25884	8.6579	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	234	chr17	73774999	chr17:73774999	C	T	.	PASS	AN=0;DP=234	GT	0/1
chr17	78444425	78444425	C	G	UTR3	NPTX1	NM_002522:c.*188G>C	.	.	0.426444497	0.566089052	0.007466451	.	0.3732	0.18467	-0.291981272	33.20358575	668.26251	5.17027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	91	chr17	78444425	chr17:78444425	C	G	60	PASS	AN=2;DP=91	GT	0/1
chr17	78445556	78445556	G	T	exonic	NPTX1	.	synonymous SNV	NPTX1:NM_002522:exon4:c.C1053A:p.G351G	0.426444497	0.566089052	0.007466451	.	0.3732	0.18467	-0.291981272	33.20358575	668.26251	5.17027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	346	chr17	78445556	chr17:78445556	G	T	129	PASS	AN=2;DP=346	GT	0/1
chr18	9814142	9814142	A	C	intronic	RAB31	.	.	.	0.054033484	0.863833858	0.082132658	.	0.06168	0.10905	-0.141298762	42.87567823	10.46141	0.38035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	17	chr18	9814142	chr18:9814142	A	C	.	PASS	AN=0;DP=17	GT	0/1
chr18	12254880	12254880	C	A	exonic	CIDEA	.	nonsynonymous SNV	CIDEA:NM_001318383:exon1:c.C65A:p.P22H	0.014628439	0.873805652	0.111565909	.	0.15442	0.18847	0.595326758	82.66100495	171.63036	2.85715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	106	chr18	12254880	chr18:12254880	C	A	.	PASS	AN=0;DP=106	GT	0/1
chr18	14144670	14144670	G	T	intergenic	ZNF519;ANKRD20A5P	dist=12181;dist=34426	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	chr18	14144670	chr18:14144670	G	T	.	PASS	AN=0;DP=50	GT	0/1
chr18	14799099	14799099	G	C	splicing	ANKRD30B	NM_001145029:exon21:c.2030-1G>C	.	.	1.49E-09	0.94288369	0.057116308	.	.	.	1.06196211	91.507431	2417.32649	9.13836	.	.	.	.	.	.	.	.	.	.	.	.	0.998	0.449	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.766	0.167	9.250	0.826	0.138	0.370	0.254	N	c	0.384	0.010	0.000	0.012	0.061	0.009	0	0.968	0.187	2.105	0.412	0.372	0.274	0.997	0.399	0.258	0.229	5.318	0.151	.	.	.	0.5	101	97	chr18	14799099	chr18:14799099	G	C	101	PASS	AN=2;DP=97	GT	0/1
chr18	19109914	19109914	G	A	UTR3	ESCO1	NM_052911:c.*390C>T	.	.	0.998809461	0.001190536	3.28E-09	.	0.87705	0.10278	-0.242430445	36.22906346	103.25615	2.19516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	chr18	19109914	chr18:19109914	G	A	.	PASS	AN=0;DP=33	GT	0/1
chr18	22642715	22642715	A	C	intronic	ZNF521	.	.	.	0.999979351	2.06E-05	8.30E-13	DISEASE: Note=A chromosomal aberration involving ZNF521 is found in acute lymphoblastic leukemia. Translocation t(9;18)(p13;q11.2) with PAX5. The translocation generates the PAX5-ZNF521 oncogene consisting of the N-terminus part of PAX5 and the C-terminus part of ZNF521. {ECO:0000269|PubMed:17344859}.; 	0.71744	0.1082	-1.767443354	2.317763623	91.92438	2.06319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	83	chr18	22642715	chr18:22642715	A	C	51	PASS	AN=2;DP=83	GT	0/1
chr18	28979237	28979237	G	T	exonic	DSG4	.	nonsynonymous SNV	DSG4:NM_001134453:exon9:c.G1008T:p.M336I,DSG4:NM_177986:exon9:c.G1008T:p.M336I	6.32E-05	0.999718181	0.000218611	DISEASE: Hypotrichosis 6 (HYPT6) [MIM:607903]: A condition characterized by the presence of less than the normal amount of hair and abnormal hair follicles and shafts, which are thin and atrophic. The disorder affects the trunk and extremities as well as the scalp, and the eyebrows and eyelashes may also be involved, whereas beard, pubic, and axillary hairs are largely spared. In addition, patients can develop hyperkeratotic follicular papules, erythema, and pruritus in affected areas. In some patients with congenital hypotrichosis, monilethrix-like hairs showing elliptical nodes have been observed. {ECO:0000269|PubMed:15191570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Autoantibodies against DSG4 are found in patients with pemphigus vulgaris. Pemphigus vulgaris is a potentially lethal skin disease in which epidermal blisters occur as the result of the loss of cell-cell adhesion.; 	0.30616	0.1655	1.833561474	97.05119132	578.83724	4.87526	0.354	0.121	T	0.074	0.226	B	0.06	0.256	B	0.001	0.419	D	0.896	0.278	N	0.865	0.215	L	0.73	0.507	T	-1.15	0.295	N	0.227	0.319	-1.048	0.149	T	0.061	0.255	T	0.006	0.145	T	1.575	0.251	13.71	0.944	0.242	0.270	0.229	N	c	-0.462	-0.318	0.998	0.364	0.487	0.133	0	3.57	0.399	-0.173	0.098	1.048	0.713	0.001	0.137	1.000	0.888	1.997	0.032	Cadherin|Cadherin-like	.	.	0.5	71	68	chr18	28979237	chr18:28979237	G	T	71	PASS	AN=2;DP=68	GT	0/1
chr18	34424156	34424156	T	-	intronic	KIAA1328	.	.	.	6.07E-05	0.894567113	0.105372162	.	0.32449	.	0.040529541	57.15380986	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	35	chr18	34424155	chr18:34424155	AT	A	59	PASS	AN=2;DP=35	GT	0/1
chr18	52892720	52892720	C	T	UTR3	TCF4	NM_001306207:c.*2546G>A;NM_001306208:c.*2546G>A;NM_001243234:c.*2546G>A;NM_001348217:c.*2546G>A;NM_001243226:c.*2546G>A;NM_001348218:c.*2546G>A;NM_001348220:c.*2546G>A;NM_001243236:c.*2546G>A;NM_003199:c.*2546G>A;NM_001243230:c.*2546G>A;NM_001243233:c.*2546G>A;NM_001243235:c.*2546G>A;NM_001243227:c.*2546G>A;NM_001243228:c.*2546G>A;NM_001243231:c.*2546G>A;NM_001243232:c.*2546G>A;NM_001348219:c.*2546G>A;NM_001083962:c.*2546G>A;NM_001330605:c.*2546G>A;NM_001330604:c.*2546G>A;NM_001348216:c.*2546G>A;NM_001348213:c.*2546G>A;NM_001348211:c.*2546G>A;NM_001348214:c.*2546G>A;NM_001348212:c.*2546G>A;NM_001348215:c.*2546G>A	.	.	0.999866544	0.000133455	1.58E-11	DISEASE: Pitt-Hopkins syndrome (PTHS) [MIM:610954]: A syndrome characterized by mental retardation, wide mouth and distinctive facial features, and intermittent hyperventilation followed by apnea. Features include intellectual disability with severe speech impairment, normal growth parameters at birth, postnatal microcephaly, breathing anomalies, severe motor developmental delay, motor incoordination, ocular anomalies, constipation, seizures, typical behavior and subtle brain abnormalities. {ECO:0000269|PubMed:17436254, ECO:0000269|PubMed:17436255, ECO:0000269|PubMed:18728071, ECO:0000269|PubMed:19235238, ECO:0000269|PubMed:20184619, ECO:0000269|PubMed:22045651}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Corneal dystrophy, Fuchs endothelial, 3 (FECD3) [MIM:613267]: A late-onset form of Fuchs endothelial corneal dystrophy, a disease caused by loss of endothelium of the central cornea. It is characterized by focal wart-like guttata that arise from Descemet membrane and develop in the central cornea, epithelial blisters, reduced vision and pain. Descemet membrane is thickened by abnormal collagenous deposition. {ECO:0000269|PubMed:24255041, ECO:0000269|PubMed:25168903, ECO:0000269|PubMed:25593321}. Note=The disease is caused by mutations affecting the gene represented in this entry. Causative mutations are heterozygous TCF4 intronic trinucleotide repeat expansions (CTG)n. {ECO:0000269|PubMed:24255041, ECO:0000269|PubMed:25168903, ECO:0000269|PubMed:25593321}.; 	0.97117	0.2956	-0.558357437	19.54470394	19.31829	0.66532	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	48	chr18	52892720	chr18:52892720	C	T	59	PASS	AN=2;DP=48	GT	0/1
chr18	77254233	77254233	C	G	intronic	NFATC1	.	.	.	0.969219888	0.030779726	3.86E-07	.	0.26703	0.65916	-1.846676608	2.052370842	1895.12903	8.00523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	164	chr18	77254233	chr18:77254233	C	G	103	PASS	AN=2;DP=164	GT	0/1
chr18	77254927	77254927	A	T	intronic	NFATC1	.	.	.	0.969219888	0.030779726	3.86E-07	.	0.26703	0.65916	-1.846676608	2.052370842	1895.12903	8.00523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	122	chr18	77254927	chr18:77254927	A	T	.	PASS	AN=0;DP=122	GT	0/1
chr19	3620937	3620937	C	A	intronic	CACTIN	.	.	.	0.999345096	0.0006549	3.77E-09	.	0.11116	.	-0.753139731	13.67067705	1251.44006	6.67662	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr19	3620937	chr19:3620937	C	A	.	PASS	AN=0;DP=55	GT	0/1
chr19	5787245	5787245	G	A	intronic	DUS3L	.	.	.	2.45E-09	0.447364589	0.552635408	.	0.16355	.	-0.685180376	15.32200991	3219.59367	10.81274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	172	chr19	5787245	chr19:5787245	G	A	87	PASS	AN=2;DP=172	GT	0/1
chr19	10084813	10084813	C	A	intronic	COL5A3	.	.	.	7.12E-07	0.999999288	2.65E-11	.	0.45391	.	0.135796279	63.57631517	15615.64674	27.11541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	chr19	10084813	chr19:10084813	C	A	.	PASS	AN=0;DP=51	GT	0/1
chr19	10599904	10599904	C	T	exonic	KEAP1	.	nonsynonymous SNV	KEAP1:NM_012289:exon5:c.G1672A:p.G558R,KEAP1:NM_203500:exon5:c.G1672A:p.G558R	0.251629058	0.748110764	0.000260179	.	0.23809	0.20935	-1.133409319	6.434300543	28.06422	0.90037	0.002	0.721	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	3.04	0.868	M	-1.64	0.825	D	-2.86	0.601	D	0.957	0.955	0.795	0.944	D	0.792	0.929	D	0.291	0.906	D	7.438	0.951	34	0.999	0.995	0.996	0.982	D	c	0.935	0.862	1.000	0.747	0.672	0.522	0	5.56	0.836	7.701	0.834	0.887	0.390	1.000	0.715	0.977	0.480	17.087	0.864	Galactose oxidase, beta-propeller	.	.	0.5	155	210	chr19	10599904	chr19:10599904	C	T	155	PASS	AN=2;DP=210	GT	1/0
chr19	11917481	11917481	C	G	exonic	ZNF491	.	nonsynonymous SNV	ZNF491:NM_152356:exon3:c.C713G:p.T238R	5.13E-07	0.405347903	0.594651584	.	0.19959	.	0.88921411	89.24274593	196.96831	3.03569	0.0	0.912	D	0.999	0.764	D	0.967	0.699	D	.	.	.	0.943	0.374	D	1.53	0.389	L	1.78	0.257	T	-4.81	0.807	D	0.171	0.214	-0.860	0.513	T	0.130	0.439	T	0.001	0.010	T	4.157	0.557	23.8	0.979	0.360	0.001	0.004	N	c	-0.249	-0.575	0.249	0.187	0.554	0.246	0	0.981	0.188	0.146	0.159	0.643	0.292	0.000	0.063	0.007	0.100	9.569	0.384	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	86	13	chr19	11917481	chr19:11917481	C	G	86	PASS	AN=2;DP=13	GT	1/0
chr19	13049577	13049577	G	A	exonic	CALR	.	synonymous SNV	CALR:NM_004343:exon1:c.G84A:p.L28L	0.938728555	0.061218724	5.27E-05	.	0.8981	0.86884	-0.624497208	17.16206653	79.72032	1.88685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	151	chr19	13049577	chr19:13049577	G	A	.	PASS	AN=0;DP=151	GT	0/1
chr19	13049578	13049578	G	A	exonic	CALR	.	nonsynonymous SNV	CALR:NM_004343:exon1:c.G85A:p.D29N	0.938728555	0.061218724	5.27E-05	.	0.8981	0.86884	-0.624497208	17.16206653	79.72032	1.88685	0.081	0.334	T	0.139	0.259	B	0.112	0.300	B	0.000	0.843	D	1	0.810	D	2.795	0.818	M	0.71	0.512	T	-3.96	0.735	D	0.122	0.137	-0.843	0.525	T	0.192	0.545	T	0.021	0.434	T	4.183	0.561	23.8	0.998	0.867	0.982	0.806	D	c	0.307	0.442	1.0	0.983	0.442	0.072	0	5.82	0.927	6.327	0.727	1.048	0.713	1.000	0.715	0.997	0.653	18.849	0.922	Concanavalin A-like lectin/glucanase domain	.	.	0.5	.	152	chr19	13049578	chr19:13049578	G	A	.	PASS	AN=0;DP=152	GT	0/1
chr19	15367816	15367816	C	G	exonic	BRD4	.	nonsynonymous SNV	BRD4:NM_001330384:exon8:c.G1510C:p.E504Q,BRD4:NM_014299:exon8:c.G1510C:p.E504Q,BRD4:NM_058243:exon8:c.G1510C:p.E504Q	0.999993446	6.55E-06	1.03E-14	DISEASE: Note=A chromosomal aberration involving BRD4 is found in a rare, aggressive, and lethal carcinoma arising in midline organs of young people. Translocation t(15;19)(q14;p13) with NUT which produces a BRD4-NUT fusion protein. {ECO:0000269|PubMed:11733348, ECO:0000269|PubMed:12543779}.; 	0.42814	0.18694	-1.480759435	3.686010852	185.92351	2.96128	0.002	0.721	D	0.999	0.764	D	0.994	0.807	D	0.000	0.629	D	1	0.810	D	3.41	0.920	M	2.33	0.187	T	-2.94	0.614	D	0.559	0.621	-0.579	0.657	T	0.201	0.557	T	0.030	0.528	D	2.780	0.395	21.3	0.999	0.949	0.981	0.798	D	c	0.896	0.848	1.000	0.747	0.672	0.522	0	5.36	0.765	7.905	0.864	0.935	0.490	1.000	0.715	0.997	0.653	17.898	0.888	.	.	.	0.5	127	215	chr19	15367816	chr19:15367816	C	G	127	PASS	AN=2;DP=215	GT	0/1
chr19	16472812	16472812	A	-	intronic	EPS15L1	.	.	.	0.970002535	0.029997462	3.00E-09	.	0.14632	0.12662	-2.125742609	1.509790045	75.39978	1.81746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	105	chr19	16472811	chr19:16472811	GA	G	56	PASS	AN=2;DP=105	GT	0/1
chr19	18276930	18276930	G	T	intronic	PIK3R2	.	.	.	0.939626884	0.060371032	2.08E-06	DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387]: A syndrome characterized by megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome. {ECO:0000269|PubMed:22729224}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.47036	0.41833	-0.534490515	20.70063694	216.25734	3.17643	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	0.055	0.037	.	.	.	.	.	.	.	.	.	-0.137	0.081	1.468	0.187	0.006	0.089	0.146	N	n	-0.268	-0.222	0.290	0.191	0.563	0.310	0	-6.35	0.018	-0.578	0.059	-0.982	0.023	0.000	0.063	0.001	0.043	2.325	0.039	.	.	.	0.5	.	53	chr19	18276930	chr19:18276930	G	T	.	PASS	AN=0;DP=53	GT	0/1
chr19	18544469	18544469	G	A	intronic	SSBP4	.	.	.	0.961658882	0.038337822	3.30E-06	.	0.20604	0.10821	-0.293801652	32.93819297	37.43039	1.11514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	102	chr19	18544469	chr19:18544469	G	A	66	PASS	AN=2;DP=102	GT	0/1
chr19	21116959	21116959	G	A	intronic	ZNF85	.	.	.	2.28E-10	0.03733675	0.962663249	.	0.16722	0.10724	2.577929865	98.74970512	348.08165	3.9535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	105	chr19	21116959	chr19:21116959	G	A	.	PASS	AN=0;DP=105	GT	0/1
chr19	33602761	33602761	A	T	exonic	GPATCH1	.	stopgain	GPATCH1:NM_018025:exon12:c.A1717T:p.K573X	3.44E-05	0.999944147	2.14E-05	.	0.12487	.	-0.211293113	37.76244397	310.91302	3.75292	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.329	0.990	41	0.996	0.722	0.905	0.514	D	c	0.669	0.530	0.999	0.388	0.732	0.924	0	4.49	0.540	3.281	0.511	1.193	0.911	1.000	0.715	0.999	0.750	11.972	0.522	.	.	.	0.5	.	57	chr19	33602761	chr19:33602761	A	T	.	PASS	AN=0;DP=57	GT	0/1
chr19	36564438	36564438	-	C	intronic	WDR62	.	.	.	3.70E-13	0.994431562	0.005568438	.	0.44098	.	0.576763804	82.17740033	516.14972	4.64667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	202	chr19	36564438	chr19:36564438	G	GC	97	PASS	AN=2;DP=202	GT	0/1
chr19	36821265	36821265	-	T	ncRNA_exonic	LINC00665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	484	chr19	36821265	chr19:36821265	A	AT	71	PASS	AN=2;DP=484	GT	0/1
chr19	37240210	37240210	G	C	exonic	ZNF850	.	nonsynonymous SNV	ZNF850:NM_001267779:exon4:c.C1636G:p.Q546E,ZNF850:NM_001193552:exon5:c.C1732G:p.Q578E	0.188901355	0.810621156	0.000477489	.	.	.	.	.	250.53864	3.41057	.	.	.	0.013	0.154	B	0.026	0.195	B	.	.	.	1	0.090	N	0.51	0.135	N	2.35	0.162	T	.	.	.	0.121	0.135	.	.	.	.	.	.	0.003	0.074	T	-2.385	0.004	0.001	0.425	0.031	0.000	0.001	N	n	-0.138	0.315	0.002	0.089	0.563	0.310	0	-2.22	0.065	-2.693	0.009	0.579	0.285	0.000	0.063	0.003	0.074	4.475	0.111	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	91	170	chr19	37240210	chr19:37240210	G	C	91	PASS	AN=2;DP=170	GT	0/1
chr19	37966783	37966783	G	A	exonic	ZNF570	.	nonsynonymous SNV	ZNF570:NM_001321991:exon3:c.G34A:p.E12K,ZNF570:NM_144694:exon3:c.G34A:p.E12K,ZNF570:NM_001300993:exon4:c.G202A:p.E68K	0.001232864	0.958398443	0.040368693	.	0.21459	.	-0.093566408	46.7386176	63.63192	1.63442	0.172	0.226	T	0.435	0.339	B	0.078	0.271	B	.	.	.	1	0.810	D	2.125	0.592	M	5.59	0.009	T	-2.02	0.465	N	0.286	0.345	-0.588	0.653	T	0.003	0.011	T	0.059	0.678	D	2.370	0.346	18.62	0.994	0.614	0.687	0.336	D	c	-0.082	-0.027	0.001	0.082	0.615	0.372	0	3.01	0.337	0.869	0.275	-0.227	0.095	0.953	0.330	0.448	0.262	6.155	0.194	Krueppel-associated box	.	.	0.5	70	72	chr19	37966783	chr19:37966783	G	A	70	PASS	AN=2;DP=72	GT	0/1
chr19	40877780	40877780	G	T	exonic	PLD3	.	synonymous SNV	PLD3:NM_001031696:exon9:c.G879T:p.A293A,PLD3:NM_001291311:exon9:c.G879T:p.A293A,PLD3:NM_012268:exon9:c.G879T:p.A293A	0.015972164	0.97872065	0.005307186	DISEASE: Alzheimer disease 19 (AD19) [MIM:615711]: A late-onset form of Alzheimer disease, a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituent of these plaques is the neurotoxic amyloid-beta-APP 40-42 peptide (s), derived proteolytically from the transmembrane precursor protein APP by sequential secretase processing. The cytotoxic C- terminal fragments (CTFs) and the caspase-cleaved products such as C31 derived from APP, are also implicated in neuronal death. {ECO:0000269|PubMed:24336208, ECO:0000269|PubMed:25832409, ECO:0000269|PubMed:25832410}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry. Disease association is, however, under debate. Some studies support PLD3 involvement in Alzheimer disease (PubMed:24336208, PubMed:25832410 and PubMed:25832409), while others do not (Ref.8, Ref.11 and Ref.12). {ECO:0000269|PubMed:24336208, ECO:0000269|PubMed:25832408, ECO:0000269|PubMed:25832409, ECO:0000269|PubMed:25832410, ECO:0000269|PubMed:25832411, ECO:0000269|PubMed:25832413}.; 	0.2945	0.12854	-0.512444034	21.55579146	50.17338	1.39128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	chr19	40877780	chr19:40877780	G	T	.	PASS	AN=0;DP=67	GT	0/1
chr19	42620946	42620946	C	-	intronic	POU2F2	.	.	.	0.97379428	0.026199392	6.33E-06	.	0.49246	0.27788	-0.538132194	20.26421326	113.2753	2.31761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	140	chr19	42620945	chr19:42620945	AC	A	56	PASS	AN=2;DP=140	GT	0/1
chr19	46299147	46299149	CCT	-	exonic	RSPH6A	.	nonframeshift deletion	RSPH6A:NM_030785:exon6:c.2132_2134del:p.E711del	2.55E-08	0.471013996	0.528985978	.	0.0719	.	-1.056370776	7.578438311	752.26224	5.4399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	26	chr19	46299146	chr19:46299146	CCCT	C	58	PASS	AN=2;DP=26	GT	0/1
chr19	49982166	49982166	C	-	exonic	FLT3LG	.	frameshift deletion	FLT3LG:NM_001204503:exon5:c.343delC:p.S118Afs*23,FLT3LG:NM_001204502:exon6:c.343delC:p.S118Afs*23,FLT3LG:NM_001278637:exon6:c.97delC:p.S36Afs*23,FLT3LG:NM_001278638:exon6:c.97delC:p.S36Afs*23,FLT3LG:NM_001459:exon6:c.343delC:p.S118Afs*23	0.950828698	0.049022409	0.000148893	.	0.24328	0.14299	-0.560178693	19.30879925	10.2966	0.3755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	254	chr19	49982165	chr19:49982165	GC	G	79	PASS	AN=2;DP=254	GT	0/1
chr19	50155916	50155918	CCT	-	exonic	SCAF1	.	nonframeshift deletion	SCAF1:NM_021228:exon7:c.2270_2272del:p.S763del	0.998787539	0.001212458	3.42E-09	.	0.19731	0.14899	.	.	621.53803	5.02803	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	61	chr19	50155915	chr19:50155915	GCCT	G	55	PASS	AN=2;DP=61	GT	0/1
chr19	50795557	50795557	C	A	exonic	MYH14	.	nonsynonymous SNV	MYH14:NM_024729:exon35:c.C5044A:p.R1682S,MYH14:NM_001077186:exon36:c.C5068A:p.R1690S,MYH14:NM_001145809:exon37:c.C5167A:p.R1723S	0.999847921	0.000152079	6.12E-17	DISEASE: Deafness, autosomal dominant, 4A (DFNA4A) [MIM:600652]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:15015131, ECO:0000269|PubMed:16222661}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peripheral neuropathy, myopathy, hoarseness, and hearing loss (PNMHH) [MIM:614369]: A complex phenotype of progressive peripheral neuropathy and distal myopathy, with later onset of hoarseness and hearing loss. Affected individuals develop distal muscle weakness at a mean age of 10.6 years, followed by progressive atrophy of these muscles. The lower limbs are more severely affected than the upper limbs, and the muscle weakness first affects anterior leg muscles and later posterior leg muscles. {ECO:0000269|PubMed:21480433}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22477	0.14506	-2.236665977	1.309271054	1826.33006	7.88079	0.003	0.682	D	0.988	0.637	D	0.804	0.633	P	.	.	.	0.892	0.278	N	2.475	0.721	M	-1.29	0.795	T	-5.25	0.840	D	0.631	0.670	-0.173	0.784	T	0.598	0.857	D	0.336	0.919	D	6.375	0.880	29.5	0.997	0.801	0.924	0.554	D	c	0.191	0.047	0.762	0.235	0.742	0.980	0	2.93	0.329	4.460	0.596	0.798	0.323	1.000	0.715	0.036	0.153	11.278	0.482	Myosin tail	.	.	0.5	130	170	chr19	50795557	chr19:50795557	C	A	130	PASS	AN=2;DP=170	GT	0/1
chr19	51128360	51128360	A	G	intronic	SYT3	.	.	.	0.225605579	0.772766785	0.001627636	.	0.20106	0.09277	-1.243653018	5.372729417	44.09263	1.26585	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	chr19	51128360	chr19:51128360	A	G	.	PASS	AN=0;DP=56	GT	0/1
chr19	53209576	53209576	T	C	exonic	ZNF611	.	synonymous SNV	ZNF611:NM_001161500:exon5:c.A732G:p.S244S,ZNF611:NM_001161501:exon5:c.A525G:p.S175S,ZNF611:NM_001161499:exon6:c.A732G:p.S244S,ZNF611:NM_030972:exon7:c.A732G:p.S244S	1.16E-17	0.000188316	0.999811684	.	0.14705	.	0.806491657	87.72705827	2377.17021	9.04647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	chr19	53209576	chr19:53209576	T	C	.	PASS	AN=0;DP=40	GT	0/1
chr19	54822670	54822670	T	A	exonic	LILRA5	.	synonymous SNV	LILRA5:NM_181986:exon4:c.A690T:p.T230T,LILRA5:NM_181879:exon5:c.A726T:p.T242T	4.63E-08	0.115503403	0.88449655	.	0.07382	0.07049	-0.846787714	11.05803255	17.69999	0.61899	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	17	chr19	54822670	chr19:54822670	T	A	87	PASS	AN=2;DP=17	GT	1/0
chr19	55179336	55179336	G	A	exonic	LILRB4	.	nonsynonymous SNV	LILRB4:NM_001278429:exon11:c.G1303A:p.E435K,LILRB4:NM_001278426:exon12:c.G1213A:p.E405K,LILRB4:NM_001278427:exon12:c.G1210A:p.E404K,LILRB4:NM_001278428:exon12:c.G1213A:p.E405K	4.67E-08	0.374227412	0.625772542	.	0.07232	.	4.538441647	99.74640245	2838.35258	10.07119	0.023	0.491	D	0.86	0.485	P	0.118	0.367	B	.	.	.	1	0.090	N	2.165	0.608	M	6.83	0.005	T	-2.24	0.501	N	0.548	0.584	-0.896	0.484	T	0.002	0.006	T	0.001	0.006	T	1.309	0.222	12.32	0.986	0.427	0.027	0.072	N	c	-0.458	-0.659	0.001	0.073	0.624	0.395	0	1.12	0.196	1.049	0.298	-0.113	0.115	0.002	0.151	0.344	0.245	4.724	0.122	.	.	.	0.5	58	183	chr19	55179336	chr19:55179336	G	A	58	PASS	AN=2;DP=183	GT	0/1
chr19	56056943	56056943	C	T	upstream	SBK3	dist=34	.	.	.	.	.	.	.	.	.	.	322.31624	3.81234	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	107	chr19	56056943	chr19:56056943	C	T	.	PASS	AN=0;DP=107	GT	0/1
chr20	2290399	2290399	G	A	exonic	TGM3	.	nonsynonymous SNV	TGM3:NM_003245:exon2:c.G104A:p.G35D	9.87E-06	0.984994274	0.014995859	.	0.35958	0.21918	-0.211293113	37.76244397	1529.88306	7.26777	0.001	0.784	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1.000	0.588	D	3.65	0.943	H	-1.12	0.776	T	-6.22	0.904	D	0.927	0.919	0.538	0.911	D	0.683	0.890	D	0.157	0.838	D	4.558	0.610	24.4	0.998	0.874	0.980	0.785	D	c	0.592	0.451	0.991	0.321	0.497	0.185	0	4.56	0.555	6.635	0.740	1.044	0.665	1.000	0.715	0.351	0.246	13.386	0.601	Immunoglobulin E-set|Immunoglobulin-like fold|Transglutaminase, N-terminal	.	.	0.5	.	37	chr20	2290399	chr20:2290399	G	A	.	PASS	AN=0;DP=37	GT	0/1
chr20	2636266	2636266	G	C	exonic	NOP56	.	nonsynonymous SNV	NOP56:NM_006392:exon7:c.G783C:p.L261F	0.97325682	0.026742908	2.73E-07	DISEASE: Spinocerebellar ataxia 36 (SCA36) [MIM:614153]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA36 is characterized by complicated clinical features, with ataxia as the first symptom, followed by characteristic late-onset involvement of the motor neuron system. Ataxic symptoms, such as gait and truncal instability, ataxic dysarthria, and uncoordinated limbs, start in late forties to fifties. Characteristically, affected individuals exhibit tongue atrophy with fasciculation. Progression of motor neuron involvement is typically limited to the tongue and main proximal skeletal muscles in both upper and lower extremities. {ECO:0000269|PubMed:21683323}. Note=The disease is caused by mutations affecting the gene represented in this entry. Caused by large hexanucleotide CGCCTG repeat expansions within intron 1. These expansions induce RNA foci and sequester the RNA-binding protein SRSF2. In addition, the transcription of MIR1292, a microRNA gene located just 19 bp 3' of the GGCCTG repeat, is significantly decreased.; 	0.99035	0.37745	-0.442665927	24.53408823	2441.81313	9.18965	0.042	0.416	D	0.229	0.689	B	0.202	0.672	B	0.000	0.629	D	1	0.810	D	3.365	0.914	M	-1.26	0.792	T	-3.76	0.712	D	0.823	0.811	0.458	0.900	D	0.604	0.859	D	0.083	0.742	D	4.962	0.667	25.1	0.999	0.960	0.961	0.674	D	c	0.547	0.532	1.000	0.747	0.722	0.854	0	4.9	0.635	3.981	0.564	1.048	0.713	1.000	0.715	1.000	0.888	15.613	0.764	Nop domain	.	.	0.5	65	69	chr20	2636266	chr20:2636266	G	C	65	PASS	AN=2;DP=69	GT	0/1
chr20	4201344	4201344	-	T	UTR3	ADRA1D	NM_000678:c.*825_*826insA	.	.	.	.	.	.	0.14449	0.11771	0.156217551	64.82071243	229.7736	3.27584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	26	chr20	4201344	chr20:4201344	A	AT	51	PASS	AN=2;DP=26	GT	0/1
chr20	5155828	5155828	G	T	splicing	CDS2	NM_003818:exon3:c.195-1G>T	.	.	6.78E-05	0.977355656	0.022576536	.	0.08157	0.08152	-0.315847836	31.68789809	624.29254	5.04006	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.201	0.702	25.5	0.995	0.686	0.998	0.992	D	c	1.213	1.054	1.000	0.747	0.140	0.025	0	5.1	0.688	9.972	0.991	1.048	0.713	1.000	0.715	0.880	0.369	17.433	0.874	.	.	.	0.5	.	28	chr20	5155828	chr20:5155828	G	T	.	PASS	AN=0;DP=28	GT	0/1
chr20	5974276	5974276	A	G	exonic	MCM8	.	nonsynonymous SNV	MCM8:NM_001281522:exon17:c.A2224G:p.R742G,MCM8:NM_001281520:exon18:c.A2365G:p.R789G,MCM8:NM_001281521:exon18:c.A2485G:p.R829G,MCM8:NM_032485:exon18:c.A2365G:p.R789G,MCM8:NM_182802:exon18:c.A2317G:p.R773G	1.93E-10	0.954436717	0.045563282	DISEASE: Premature ovarian failure 10 (POF10) [MIM:612885]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:25437880}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24617	0.19778	1.407269618	94.78650625	3710.46351	11.88891	0.022	0.486	D	0.214	0.305	B	0.139	0.319	B	0.000	0.843	D	0.999	0.466	D	2.395	0.694	M	4.08	0.030	T	-3.62	0.695	D	0.857	0.872	-0.994	0.315	T	0.017	0.069	T	0.017	0.384	T	4.539	0.608	24.3	0.994	0.619	0.941	0.599	D	c	0.118	0.272	0.701	0.227	0.732	0.924	0	5.82	0.927	4.299	0.586	1.199	0.960	1.000	0.715	1.000	0.888	12.092	0.528	MCM domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	78	51	chr20	5974276	chr20:5974276	A	G	78	PASS	AN=2;DP=51	GT	0/1
chr20	9498657	9498657	-	CTGCCAGCAGGAGGGGC	intronic	LAMP5	.	.	.	3.84E-08	0.10400326	0.895996702	.	0.42339	.	0.260991686	70.25831564	2514.20203	9.34534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	22	chr20	9498657	chr20:9498657	T	TCTGCCAGCAGGAGGGGC	52	PASS	AN=2;DP=22	GT	0/1
chr20	20373844	20373844	C	T	UTR3	RALGAPA2	NM_020343:c.*89G>A	.	.	8.49E-06	0.999991501	1.10E-08	.	0.21358	0.10195	-2.30816515	1.203113942	547.52089	4.75813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	95	chr20	20373844	chr20:20373844	C	T	88	PASS	AN=2;DP=95	GT	0/1
chr20	21695452	21695452	C	A	UTR3	PAX1	NM_006192:c.*11C>A;NM_001257096:c.*252C>A	.	.	0.616084026	0.382224632	0.001691342	DISEASE: Otofaciocervical syndrome 2 (OFC2) [MIM:615560]: A disorder characterized by facial dysmorphism, cup-shaped low-set ears, preauricular fistulas, hearing loss, branchial defects, skeletal anomalies including vertebral defects, low-set clavicles, winged scapulae, sloping shoulders, and mild intellectual disability. {ECO:0000269|PubMed:23851939}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.80187	0.30248	0.350995466	74.37485256	224.51285	3.24104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	74	chr20	21695452	chr20:21695452	C	A	.	PASS	AN=0;DP=74	GT	0/1
chr20	23066469	23066469	C	-	exonic	CD93	.	frameshift deletion	CD93:NM_012072:exon1:c.361delG:p.E121Rfs*78	7.82E-10	0.075948416	0.924051584	.	0.15486	0.28768	-0.148789446	42.29771172	256.90385	3.44823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	164	chr20	23066468	chr20:23066468	TC	T	67	PASS	AN=2;DP=164	GT	0/1
chr20	23584198	23584198	A	T	exonic	CST9	.	synonymous SNV	CST9:NM_001008693:exon2:c.T429A:p.G143G	0.095109295	0.769080073	0.135810632	.	0.08285	0.10564	0.505321956	80.00707714	973.5092	6.03439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	63	chr20	23584198	chr20:23584198	A	T	101	PASS	AN=2;DP=63	GT	1/0
chr20	30745722	30745722	G	C	exonic	TM9SF4	.	nonsynonymous SNV	TM9SF4:NM_014742:exon14:c.G1455C:p.Q485H	0.999970772	2.92E-05	1.94E-12	.	0.27945	0.11262	-0.514264485	21.41424864	53.66935	1.45942	0.008	0.586	D	0.781	0.899	P	0.668	0.850	P	0.000	0.629	D	1	0.810	D	2.47	0.719	M	0.83	0.478	T	-3.66	0.700	D	0.618	0.641	-0.194	0.778	T	0.365	0.726	T	0.020	0.421	T	6.528	0.899	31	0.997	0.836	0.992	0.926	D	c	0.817	0.780	1.000	0.747	0.707	0.730	0	4.96	0.650	7.700	0.834	1.048	0.713	1.000	0.715	1.000	0.888	18.422	0.905	.	.	.	0.5	135	206	chr20	30745722	chr20:30745722	G	C	135	PASS	AN=2;DP=206	GT	0/1
chr20	34186928	34186928	C	T	ncRNA_intronic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	117	chr20	34186928	chr20:34186928	C	T	.	PASS	AN=0;DP=117	GT	0/1
chr20	34188547	34188547	C	A	ncRNA_exonic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	chr20	34188547	chr20:34188547	C	A	.	PASS	AN=0;DP=39	GT	0/1
chr20	34188688	34188688	C	A	ncRNA_exonic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	chr20	34188688	chr20:34188688	C	A	.	PASS	AN=0;DP=40	GT	0/1
chr20	34190005	34190005	C	A	ncRNA_intronic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	107	chr20	34190005	chr20:34190005	C	A	.	PASS	AN=0;DP=107	GT	0/1
chr20	34191771	34191771	C	T	ncRNA_exonic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	92	chr20	34191771	chr20:34191771	C	T	84	PASS	AN=2;DP=92	GT	0/1
chr20	34191777	34191777	C	T	ncRNA_exonic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	94	chr20	34191777	chr20:34191777	C	T	94	PASS	AN=2;DP=94	GT	0/1
chr20	34191816	34191816	C	T	ncRNA_exonic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	98	chr20	34191816	chr20:34191816	C	T	90	PASS	AN=2;DP=98	GT	0/1
chr20	34194189	34194189	C	A	ncRNA_intronic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	chr20	34194189	chr20:34194189	C	A	.	PASS	AN=0;DP=67	GT	0/1
chr20	34205387	34205387	G	A	intronic	SPAG4	.	.	.	0.110567923	0.888145117	0.00128696	.	0.14706	0.11092	0.551232944	81.48148148	141.82474	2.59876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	chr20	34205387	chr20:34205387	G	A	.	PASS	AN=0;DP=87	GT	0/1
chr20	34207681	34207681	G	A	intronic	SPAG4	.	.	.	0.110567923	0.888145117	0.00128696	.	0.14706	0.11092	0.551232944	81.48148148	141.82474	2.59876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	95	chr20	34207681	chr20:34207681	G	A	.	PASS	AN=0;DP=95	GT	0/1
chr20	34214751	34214751	G	C	intronic	CPNE1	.	.	.	3.87E-07	0.942364799	0.057634814	.	0.11193	0.18648	1.001272896	90.72304789	5735.67228	15.69514	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	163	chr20	34214751	chr20:34214751	G	C	115	PASS	AN=2;DP=163	GT	0/1
chr20	34855890	34855890	G	T	intergenic	AAR2;DLGAP4	dist=11027;dist=38355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	91	chr20	34855890	chr20:34855890	G	T	.	PASS	AN=0;DP=91	GT	0/1
chr20	43961750	43961750	C	A	intronic	SDC4	.	.	.	0.011803491	0.847335334	0.140861176	.	0.26113	0.20685	-0.161524709	41.6430762	2463.14431	9.23969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	chr20	43961750	chr20:43961750	C	A	.	PASS	AN=0;DP=28	GT	0/1
chr20	55099658	55099658	G	T	intronic	GCNT7	.	.	.	.	.	.	.	0.03282	.	.	.	752.86612	5.44146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	84	chr20	55099658	chr20:55099658	G	T	.	PASS	AN=0;DP=84	GT	0/1
chr20	57276241	57276241	G	C	ncRNA_intronic	STX16-NPEPL1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	208	chr20	57276241	chr20:57276241	G	C	65	PASS	AN=2;DP=208	GT	0/1
chr20	60892812	60892812	C	A	exonic	LAMA5	.	nonsynonymous SNV	LAMA5:NM_005560:exon54:c.G7262T:p.R2421L	0.943037981	0.056962019	9.75E-22	.	0.70971	.	3.125188892	99.28049068	9086.1435	20.60876	0.247	0.173	T	0.08	0.230	B	0.051	0.240	B	0.986	0.079	U	1	0.090	N	2.125	0.592	M	2.9	0.101	T	-2.57	0.555	D	0.1	0.103	-0.969	0.374	T	0.021	0.091	T	0.028	0.505	D	3.729	0.505	23.3	0.950	0.253	0.146	0.183	N	c	-1.149	-1.191	1.000	0.454	0.707	0.730	0	-3.58	0.043	-1.086	0.035	-1.185	0.016	0.000	0.063	0.370	0.249	10.203	0.421	Laminin alpha, domain I	.	.	0.5	108	113	chr20	60892812	chr20:60892812	C	A	108	PASS	AN=2;DP=113	GT	0/1
chr20	61460243	61460243	C	-	intronic	COL9A3	.	.	.	3.25E-05	0.999944225	2.33E-05	DISEASE: Multiple epiphyseal dysplasia 3 (EDM3) [MIM:600969]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:10090888}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. {ECO:0000269|PubMed:11308397, ECO:0000269|PubMed:25381065}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Susceptibility to intervertebral disk disease is conferred by variant p.Arg103Trp (PubMed:11308397). {ECO:0000269|PubMed:11308397}.; 	0.4977	.	0.611719262	82.96768106	2646.06911	9.64989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	145	chr20	61460242	chr20:61460242	TC	T	86	PASS	AN=2;DP=145	GT	0/1
chr20	62203414	62203414	T	C	intronic	HELZ2	.	.	.	1.26E-09	0.999300381	0.000699618	.	.	.	-0.147490202	42.30360934	4463.72358	13.40473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	122	chr20	62203414	chr20:62203414	T	C	.	PASS	AN=0;DP=122	GT	0/1
chr21	14469814	14469814	C	T	ncRNA_intronic	ANKRD30BP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	71	chr21	14469814	chr21:14469814	C	T	.	PASS	AN=0;DP=71	GT	0/1
chr21	14756846	14756846	C	A	intergenic	ANKRD30BP2;MIR3156-3	dist=266275;dist=21859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	chr21	14756846	chr21:14756846	C	A	.	PASS	AN=0;DP=39	GT	0/1
chr21	30255396	30255396	-	A	intronic	N6AMT1	.	.	.	0.009871785	0.821358578	0.168769637	.	0.48968	0.09594	0.72761005	86.08162302	1301.02352	6.78541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	16.15	37	chr21	30255396	chr21:30255396	G	GA	16.15	PASS	AN=0;DP=37	GT	0/1
chr21	32253409	32253409	A	T	exonic	KRTAP11-1	.	stopgain	KRTAP11-1:NM_175858:exon1:c.T435A:p.C145X	0.00426873	0.662516423	0.333214847	.	0.22409	0.09008	0.659651797	84.35362114	3007.85811	10.41393	.	.	.	.	.	.	.	.	.	0.012	0.291	N	1.000	0.548	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.303	0.962	35	0.989	0.474	0.164	0.192	N	c	0.137	-0.081	0.000	0.029	0.487	0.133	0	0.372	0.153	0.081	0.146	-0.546	0.048	0.645	0.279	0.981	0.494	8.509	0.322	.	.	.	0.5	119	94	chr21	32253409	chr21:32253409	A	T	119	PASS	AN=2;DP=94	GT	1/0
chr21	33725043	33725043	G	A	exonic	URB1	.	synonymous SNV	URB1:NM_014825:exon19:c.C2589T:p.I863I	.	.	.	.	0.19883	0.09434	2.699225953	98.89124794	843.19169	5.68362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	chr21	33725043	chr21:33725043	G	A	.	PASS	AN=0;DP=24	GT	0/1
chr21	43299197	43299197	G	A	exonic	PRDM15	.	nonsynonymous SNV	PRDM15:NM_022115:exon2:c.C155T:p.A52V	0.753744615	0.246255384	1.22E-09	.	0.0747	0.10154	-2.001084103	1.733899505	875.44322	5.75655	0.069	0.355	T	0.099	0.241	B	0.01	0.139	B	.	.	.	1	0.810	D	0	0.065	N	2.89	0.102	T	-0.21	0.103	N	0.088	0.084	-0.985	0.337	T	0.014	0.056	T	0.270	0.899	D	3.673	0.498	23.3	0.996	0.732	0.002	0.010	N	c	-0.654	-0.578	1.000	0.747	0.623	0.393	0	1.37	0.211	0.388	0.203	-0.175	0.105	0.643	0.279	0.996	0.625	8.310	0.310	.	.	.	0.5	.	38	chr21	43299197	chr21:43299197	G	A	.	PASS	AN=0;DP=38	GT	0/1
chr21	43829538	43829538	G	A	exonic	UBASH3A	.	nonsynonymous SNV	UBASH3A:NM_001001895:exon3:c.G175A:p.D59N,UBASH3A:NM_001243467:exon3:c.G175A:p.D59N,UBASH3A:NM_018961:exon3:c.G175A:p.D59N	3.97E-07	0.944205183	0.055794419	.	0.15909	0.14549	-0.87816671	10.58032555	520.99741	4.66093	0.269	0.496	T	0.118	0.251	B	0.031	0.206	B	0.376	0.134	N	1	0.090	N	0	0.065	N	2.0	0.215	T	0.2	0.049	N	0.082	0.092	-1.013	0.259	T	0.024	0.101	T	0.007	0.188	T	-0.269	0.071	0.778	0.956	0.269	0.611	0.311	D	c	-0.925	-0.871	0.994	0.333	0.447	0.083	0	0.446	0.157	2.291	0.430	-0.312	0.078	0.967	0.338	0.001	0.043	7.201	0.249	UBA-like|Ubiquitin-associated domain	.	.	0.5	.	48	chr21	43829538	chr21:43829538	G	A	.	PASS	AN=0;DP=48	GT	0/1
chr21	47614405	47614405	C	A	exonic	LSS	.	nonsynonymous SNV	LSS:NM_001145437:exon19:c.G1748T:p.R583L,LSS:NM_001001438:exon20:c.G1988T:p.R663L,LSS:NM_001145436:exon20:c.G1955T:p.R652L,LSS:NM_002340:exon20:c.G1988T:p.R663L	0.000604838	0.999353008	4.22E-05	.	0.09964	0.38626	0.540106923	81.09813635	1845.09003	7.92325	0.152	0.327	T	0.995	0.670	D	0.805	0.566	P	0.000	0.843	D	1	0.810	D	2.755	0.808	M	1.97	0.221	T	-4.99	0.829	D	0.796	0.824	-1.141	0.013	T	0.078	0.312	T	0.045	0.620	D	5.650	0.770	26.7	0.996	0.740	0.965	0.692	D	c	0.480	0.465	1.000	0.747	0.707	0.730	0	5.07	0.680	7.647	0.825	0.935	0.490	1.000	0.715	0.289	0.235	18.434	0.905	Squalene cyclase, C-terminal|Terpene synthase, conserved site|Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid;Squalene cyclase, C-terminal|Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid	.	.	0.5	116	102	chr21	47614405	chr21:47614405	C	A	116	PASS	AN=2;DP=102	GT	1/0
chr22	16255875	16255875	G	T	downstream	POTEH	dist=457	.	.	.	.	.	.	0.04666	0.08864	.	.	531.82086	4.70466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	250	chr22	16255875	chr22:16255875	G	T	109	PASS	AN=2;DP=250	GT	0/1
chr22	20137169	20137169	G	A	intronic	CCDC188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	128	chr22	20137169	chr22:20137169	G	A	116	PASS	AN=2;DP=128	GT	0/1
chr22	20847401	20847401	C	A	intronic	KLHL22	.	.	.	0.702611047	0.297235373	0.00015358	.	0.52594	0.11209	-1.199555187	5.761972163	26.86408	0.8677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	chr22	20847401	chr22:20847401	C	A	.	PASS	AN=0;DP=29	GT	0/1
chr22	21470329	21470329	C	A	ncRNA_intronic	BCRP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	174	chr22	21470329	chr22:21470329	C	A	.	PASS	AN=0;DP=174	GT	0/1
chr22	26422845	26422845	C	A	exonic	MYO18B	.	stopgain	MYO18B:NM_001318245:exon43:c.C6908A:p.S2303X,MYO18B:NM_032608:exon43:c.C6905A:p.S2302X	2.61E-15	0.99999606	3.94E-06	.	0.16167	0.10792	1.205427351	93.02311866	5231.65918	14.90607	.	.	.	.	.	.	.	.	.	0.005	0.329	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.780	0.978	38	0.991	0.513	0.308	0.240	N	c	0.235	-0.047	0.697	0.226	0.554	0.246	0	3.57	0.399	2.155	0.417	0.935	0.490	0.057	0.215	0.282	0.234	8.680	0.332	.	.	.	0.5	90	85	chr22	26422845	chr22:26422845	C	A	90	PASS	AN=2;DP=85	GT	0/1
chr22	27019121	27019121	C	A	intronic	CRYBA4	.	.	.	6.69E-08	0.257581927	0.742418006	DISEASE: Cataract 23 (CTRCT23) [MIM:610425]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT23 is a zonular cataract. Zonular or lamellar cataracts are opacities, broad or narrow, usually consisting of powdery white dots affecting only certain layers or zones between the cortex and nucleus of an otherwise clear lens. The opacity may be so dense as to render the entire central region of the lens completely opaque, or so translucent that vision is hardly if at all impeded. Zonular cataracts generally do not involve the embryonic nucleus, though sometimes they involve the fetal nucleus. Usually sharply separated from a clear cortex outside them, they may have projections from their outer edges known as riders or spokes. {ECO:0000269|PubMed:16960806}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20946	0.13306	0.21689899	68.12927577	150.50912	2.67784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	chr22	27019121	chr22:27019121	C	A	.	PASS	AN=0;DP=43	GT	0/1
chr22	29130347	29130347	-	T	intronic	CHEK2	.	.	.	1.18E-15	0.005518936	0.994481064	DISEASE: Li-Fraumeni syndrome 2 (LFS2) [MIM:609265]: A highly penetrant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:11719428}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Prostate cancer (PC) [MIM:176807]: A malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. {ECO:0000269|PubMed:12533788}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Osteogenic sarcoma (OSRC) [MIM:259500]: A sarcoma originating in bone-forming cells, affecting the ends of long bones. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:12094328, ECO:0000269|PubMed:21618645, ECO:0000269|PubMed:25619829}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. {ECO:0000269|PubMed:12094328}.; 	0.98514	0.65565	-0.134019284	43.90776126	138.54243	2.56375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	20	chr22	29130347	chr22:29130347	G	GT	72	PASS	AN=2;DP=20	GT	0/1
chr22	30517869	30517869	G	T	intronic	HORMAD2	.	.	.	3.45E-05	0.584244147	0.415721368	.	0.14701	0.09455	0.927856124	89.70276008	116.45113	2.34686	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	34	chr22	30517869	chr22:30517869	G	T	51	PASS	AN=2;DP=34	GT	0/1
chr22	30772228	30772228	-	T	ncRNA_intronic	KIAA1656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.73	84	chr22	30772228	chr22:30772228	C	CT,CTT	21.73	PASS	AN=0;DP=84	GT	0/1/.
chr22	30772228	30772228	-	TT	ncRNA_intronic	KIAA1656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.73	84	chr22	30772228	chr22:30772228	C	CT,CTT	21.73	PASS	AN=0;DP=84	GT	0/1/.
chr22	31019042	31019042	C	G	exonic	TCN2	.	synonymous SNV	TCN2:NM_000355:exon8:c.C1194G:p.L398L,TCN2:NM_001184726:exon8:c.C1113G:p.L371L	0.022289553	0.974456378	0.003254069	DISEASE: Transcobalamin II deficiency (TCN2 deficiency) [MIM:275350]: Results in various forms of anemia. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21133	0.56503	1.934667198	97.487615	1919.33765	8.06455	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	89	chr22	31019042	chr22:31019042	C	G	107	PASS	AN=2;DP=89	GT	0/1
chr22	37771139	37771139	C	A	exonic	ELFN2	.	nonsynonymous SNV	ELFN2:NM_052906:exon3:c.G436T:p.A146S	0.849015287	0.150440504	0.000544209	.	0.18208	.	-1.835411529	2.081858929	137.02578	2.54496	0.111	0.290	T	0.989	0.609	D	0.907	0.627	P	0.000	0.843	D	1	0.810	D	1.09	0.274	L	0.56	0.546	T	-1.05	0.275	N	0.457	0.509	-0.628	0.637	T	0.269	0.641	T	0.035	0.560	D	4.486	0.601	24.3	0.994	0.648	0.993	0.939	D	c	0.605	0.586	1.000	0.747	0.701	0.575	0	4.66	0.577	7.796	0.843	0.823	0.336	1.000	0.715	1.000	0.888	17.923	0.888	Leucine-rich repeat domain, L domain-like	.	.	0.5	71	70	chr22	37771139	chr22:37771139	C	A	71	PASS	AN=2;DP=70	GT	0/1
chr22	39802424	39802424	G	A	intronic	TAB1	.	.	.	0.003995811	0.987970242	0.008033946	.	0.35773	0.30319	-1.217968826	5.638122199	305.94322	3.72456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	31	chr22	39802424	chr22:39802424	G	A	60	PASS	AN=2;DP=31	GT	0/1
chrX	24760277	24760277	C	-	intronic	POLA1	.	.	.	0.999999525	4.75E-07	1.72E-17	.	0.99571	0.30271	-0.795417163	12.5324369	61.5917	1.59962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	54	chrX	24760276	chrX:24760276	AC	A	98	PASS	AN=2;DP=54	GT	0/1
chrX	36178819	36178819	C	A	exonic	CFAP47	.	nonsynonymous SNV	CFAP47:NM_001304548:exon39:c.C5959A:p.P1987T	.	.	.	.	0.06402	.	0.371224249	75.12384996	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.282	0.121	5.518	0.584	0.058	0.735	0.357	D	.	.	.	0.000	0.064	.	.	.	2.99	0.335	3.862	0.555	-0.046	0.123	0.992	0.373	0.035	0.152	9.479	0.379	.	.	.	0.5	.	36	chrX	36178819	chrX:36178819	C	A	.	PASS	AN=0;DP=36	GT	0/1
chrX	38169858	38169858	C	-	intronic	RPGR	.	.	.	0.997857546	0.00214244	1.37E-08	DISEASE: Retinitis pigmentosa 3 (RP3) [MIM:300029]: A X-linked retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. In RP3, affected males have a severe phenotype, and carrier females show a wide spectrum of clinical features ranging from completely asymptomatic to severe retinitis pigmentosa. Heterozygous women can manifest a form of choroidoretinal degeneration which is distinguished from other types by the absence of visual defects in the presence of a brilliant, scintillating, golden-hued, patchy appearance most striking around the macula, called a tapetal-like retinal reflex. {ECO:0000269|PubMed:10482958, ECO:0000269|PubMed:10737996, ECO:0000269|PubMed:10932196, ECO:0000269|PubMed:10937588, ECO:0000269|PubMed:10970770, ECO:0000269|PubMed:11180598, ECO:0000269|PubMed:11992260, ECO:0000269|PubMed:12657579, ECO:0000269|PubMed:14564670, ECO:0000269|PubMed:8673101, ECO:0000269|PubMed:8817343, ECO:0000269|PubMed:9399904, ECO:0000269|PubMed:9855162}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa and sinorespiratory infections with or without deafness (RPDSI) [MIM:300455]: A disease characterized by the association primary ciliary dyskinesia features with retinitis pigmentosa. Some patients also manifest deafness. {ECO:0000269|PubMed:12920075, ECO:0000269|PubMed:14627685}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy, X-linked 1 (CORDX1) [MIM:304020]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. In cone-rod dystrophy X-linked type 1 the degree of rod-photoreceptor involvement can be variable, with degeneration increasing as the disease progresses. Affected individuals (essentially all of whom are males) present with decreased visual acuity, myopia, photophobia, abnormal color vision, full peripheral visual fields, decreased photopic electroretinographic responses, and granularity of the macular retinal pigment epithelium. Although penetrance appears to be nearly 100%, there is variable expressivity with respect to age at onset and severity of symptoms. {ECO:0000269|PubMed:11857109}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular degeneration, X-linked, atrophic (MDXLA) [MIM:300834]: An ocular disorder characterized by macular atrophy causing progressive loss of visual acuity with minimal peripheral visual impairment. Some patients manifest extensive macular degeneration plus peripheral loss of retinal pigment epithelium and choriocapillaries. Full-field electroretinograms (ERGs) show normal cone and rod responses in some affected males despite advanced macular degeneration. {ECO:0000269|PubMed:12160730}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.5423	.	2.802177104	99.03868837	2307.37975	8.90096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	33	chrX	38169857	chrX:38169857	TC	T	65	PASS	AN=2;DP=33	GT	0/1
chrX	128927042	128927042	T	C	exonic	SASH3	.	synonymous SNV	SASH3:NM_018990:exon7:c.T879C:p.N293N	0.891377605	0.108394024	0.000228371	.	0.3591	0.26327	-0.448125345	24.19202642	28.8003	0.92063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	chrX	128927042	chrX:128927042	T	C	.	PASS	AN=0;DP=48	GT	0/1
